Table of Contents

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 10-Q

(Mark One)

xQUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended September 30, 2012

March 31, 2013

Or

¨TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from             to             

Commission file number: 001-31719

Molina Healthcare, Inc.

(Exact name of registrant as specified in its charter)

Delaware 13-4204626

Delaware13-4204626
(State or other jurisdiction of

incorporation or organization)

 

(I.R.S. Employer

Identification No.)

200 Oceangate, Suite 100

Long Beach, California

 90802
(Address of principal executive offices) (Zip Code)

(562) 435-3666

(Registrant’s telephone number, including area code)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes  xý    No  ¨

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).    Yes  xý    No  ¨

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer

xAccelerated filer¨

Non-acceleratedLarge accelerated filer

xAccelerated filer¨
 
Non-accelerated filer
¨ (Do not check if a smaller reporting company)
Smaller reporting company¨

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    Yes  ¨    No  xý

The number of shares of the issuer’s Common Stock outstanding as of OctoberApril 19, 2012,2013, was approximately 46,583,300.

45,416,300.



Table of Contents

MOLINA HEALTHCARE, INC.

Index

 

 

1

2

3

4

6

26

50

50
 

51

51

52

52

53



Table of Contents

PART I — FINANCIAL INFORMATION
Item 1.

Item 1.Financial Statements.

Financial Statements.


1


MOLINA HEALTHCARE, INC.

CONSOLIDATED BALANCE SHEETS

   September 30,
2012
  December 31,
2011
 
   (Amounts in thousands,
except per-share data)
 
   (Unaudited)    
ASSETS  

Current assets:

   

Cash and cash equivalents

  $715,480   $493,827  

Investments

   356,895    336,916  

Receivables

   156,909    167,898  

Income tax refundable

   33,530    11,679  

Deferred income taxes

   21,533    18,327  

Prepaid expenses and other current assets

   30,002    19,435  
  

 

 

  

 

 

 

Total current assets

   1,314,349    1,048,082  

Property, equipment, and capitalized software, net

   210,972    190,934  

Deferred contract costs

   67,516    54,582  

Intangible assets, net

   85,033    101,796  

Goodwill and indefinite-lived intangible assets

   151,088    153,954  

Auction rate securities

   13,523    16,134  

Restricted investments

   44,488    46,164  

Receivable for ceded life and annuity contracts

   —      23,401  

Other assets

   20,098    17,099  
  

 

 

  

 

 

 
  $1,907,067   $1,652,146  
  

 

 

  

 

 

 
LIABILITIES AND STOCKHOLDERS’ EQUITY  

Current liabilities:

   

Medical claims and benefits payable

  $536,463   $402,476  

Accounts payable and accrued liabilities

   151,029    147,214  

Deferred revenue

   143,301    50,947  

Current maturities of long-term debt

   1,143    1,197  
  

 

 

  

 

 

 

Total current liabilities

   831,936    601,834  

Long-term debt

   260,551    216,929  

Deferred income taxes

   37,478    33,127  

Liability for ceded life and annuity contracts

   —      23,401  

Other long-term liabilities

   22,101    21,782  
  

 

 

  

 

 

 

Total liabilities

   1,152,066    897,073  
  

 

 

  

 

 

 

Stockholders’ equity:

   

Common stock, $0.001 par value; 80,000 shares authorized; outstanding: 46,571 shares at September 30, 2012 and 45,815 shares at December 31, 2011

   46    46  

Preferred stock, $0.001 par value; 20,000 shares authorized, no shares issued and outstanding

   —      —    

Additional paid-in capital

   280,728    266,022  

Accumulated other comprehensive loss

   (330  (1,405

Retained earnings

   474,557    490,410  
  

 

 

  

 

 

 

Total stockholders’ equity

   755,001    755,073  
  

 

 

  

 

 

 
  $1,907,067   $1,652,146  
  

 

 

  

 

 

 

 March 31,
2013
 December 31,
2012
 
(Amounts in thousands,
except per-share data)
 (Unaudited)  
ASSETS   
Current assets:   
Cash and cash equivalents$1,169,511
 $795,770
Investments341,946
 342,845
Receivables150,251
 149,682
Deferred income taxes25,753
 32,443
Prepaid expenses and other current assets39,577
 28,386
Total current assets1,727,038
 1,349,126
Property, equipment, and capitalized software, net237,735
 221,443
Deferred contract costs53,813
 58,313
Intangible assets, net72,864
 77,711
Goodwill and indefinite-lived intangible assets151,088
 151,088
Auction rate securities13,600
 13,419
Restricted investments55,117
 44,101
Derivative asset147,385
 
Other assets29,449
 19,621
 $2,488,089
 $1,934,822
LIABILITIES AND STOCKHOLDERS’ EQUITY   
Current liabilities:   
Medical claims and benefits payable$491,145
 $494,530
Accounts payable and accrued liabilities159,986
 184,034
Deferred revenue135,804
 141,798
Income taxes payable14,944
 6,520
Current maturities of long-term debt1,167
 1,155
Total current liabilities803,046
 828,037
Long-term debt642,005
 261,784
Deferred income taxes31,353
 37,900
Derivative liabilities223,647
 1,307
Other long-term liabilities23,839
 23,480
Total liabilities1,723,890
 1,152,508
Stockholders’ equity:   
Common stock, $0.001 par value; 80,000 shares authorized; outstanding: 45,415 shares at March 31, 2013 and 46,762 shares at December 31, 201245
 47
Preferred stock, $0.001 par value; 20,000 shares authorized, no shares issued and outstanding
 
Additional paid-in capital234,236
 285,524
Accumulated other comprehensive loss(197) (457)
Treasury stock, at cost; 111 shares at December 31, 2012
 (3,000)
Retained earnings530,115
 500,200
Total stockholders’ equity764,199
 782,314
 $2,488,089
 $1,934,822
See accompanying notes.


2


MOLINA HEALTHCARE, INC.

CONSOLIDATED STATEMENTS OF OPERATIONS

   Three Months Ended   Nine Months Ended 
   September 30,   September 30, 
   2012  2011   2012  2011 
   (Amounts in thousands, except 
   net (loss) income per share) 
   (Unaudited) 

Revenue:

      

Premium revenue

  $1,488,718   $1,138,230    $4,308,439   $3,348,438  

Service revenue

   48,422    37,728     132,351    111,290  

Investment income

   1,171    764     3,996    3,804  

Rental income

   1,879    —       5,408    —    
  

 

 

  

 

 

   

 

 

  

 

 

 

Total revenue

   1,540,190    1,176,722     4,450,194    3,463,532  
  

 

 

  

 

 

   

 

 

  

 

 

 

Expenses:

      

Medical care costs

   1,314,571    959,158     3,823,136    2,822,049  

Cost of service revenue

   37,004    34,584     98,111    105,020  

General and administrative expenses

   127,500    99,610     379,208    290,967  

Premium tax expenses

   37,894    36,374     120,953    110,633  

Depreciation and amortization

   16,034    13,430     47,446    38,587  
  

 

 

  

 

 

   

 

 

  

 

 

 

Total expenses

   1,533,003    1,143,156     4,468,854    3,367,256  
  

 

 

  

 

 

   

 

 

  

 

 

 

Operating income (loss)

   7,187    33,566     (18,660  96,276  

Interest expense

   4,315    4,380     12,421    11,666  
  

 

 

  

 

 

   

 

 

  

 

 

 

Income (loss) before income taxes

   2,872    29,186     (31,081  84,610  

Income tax (benefit) expense

   (492  10,236     (15,228  30,832  
  

 

 

  

 

 

   

 

 

  

 

 

 

Net income (loss)

  $3,364   $18,950    $(15,853 $53,778  
  

 

 

  

 

 

   

 

 

  

 

 

 

Net income (loss) per share:

      

Basic

  $0.07   $0.41    $(0.34 $1.18  
  

 

 

  

 

 

   

 

 

  

 

 

 

Diluted

  $0.07   $0.41    $(0.34 $1.16  
  

 

 

  

 

 

   

 

 

  

 

 

 

Weighted average shares outstanding:

      

Basic

   46,546    45,834     46,301    45,693  
  

 

 

  

 

 

   

 

 

  

 

 

 

Diluted

   46,880    46,296     46,301    46,334  
  

 

 

  

 

 

   

 

 

  

 

 

 

INCOME

 Three Months Ended
 March 31,
 2013 2012
 
(Amounts in thousands, except
net income per share)
(Unaudited)
Revenue:   
Premium revenue$1,534,608
 $1,325,406
Service revenue49,756
 42,205
Investment income1,529
 1,717
Rental and other income4,694
 4,259
Total revenue1,590,587
 1,373,587
Expenses:   
Medical care costs1,288,754
 1,130,988
Cost of service revenue39,770
 30,494
General and administrative expenses141,407
 121,474
Premium tax expenses37,000
 42,186
Depreciation and amortization16,565
 15,025
Total expenses1,523,496
 1,340,167
Operating income67,091
 33,420
Other expenses (income):   
Interest expense13,037
 4,298
Other income(131) 
Total other expenses12,906
 4,298
Income before income taxes54,185
 29,122
Income tax expense24,270
 11,033
Net income$29,915
 $18,089
Net income per share:   
Basic$0.65
 $0.39
Diluted$0.64
 $0.39
Weighted average shares outstanding:   
Basic45,981
 45,998
Diluted46,443
 46,887

See accompanying notes.



3


MOLINA HEALTHCARE, INC.

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME

   Three Months Ended  Nine Months Ended 
   September 30,  September 30, 
   2012   2011  2012  2011 
   (Amounts in thousands) 
   (Unaudited) 

Net income (loss)

  $3,364    $18,950   $(15,853 $53,778  

Other comprehensive income, net of tax:

      

Unrealized gain (loss) on investments

   455     (165  1,075    430  
  

 

 

   

 

 

  

 

 

  

 

 

 

Other comprehensive income (loss)

   455     (165  1,075    430  
  

 

 

   

 

 

  

 

 

  

 

 

 

Comprehensive income (loss)

  $3,819    $18,785   $(14,778 $54,208  
  

 

 

   

 

 

  

 

 

  

 

 

 

 Three Months Ended
 March 31,
 2013 2012
 
(Amounts in thousands)
(Unaudited)
Net income$29,915
 $18,089
Other comprehensive income, net of tax:   
Unrealized gain on investments260
 296
Other comprehensive income260
 296
Comprehensive income$30,175
 $18,385

See accompanying notes.



4


MOLINA HEALTHCARE, INC.

CONSOLIDATED STATEMENTS OF CASH FLOWS

   Nine Months Ended 
   September 30, 
   2012  2011 
   (Amounts in thousands) 
   (Unaudited) 

Operating activities:

   

Net (loss) income

  $(15,853 $53,778  

Adjustments to reconcile net (loss) income to net cash provided by operating activities:

   

Depreciation and amortization

   58,289    52,414  

Deferred income taxes

   1,166    8,069  

Stock-based compensation

   15,448    12,723  

Gain on sale of subsidiary

   (2,390  —    

Non-cash interest on convertible senior notes

   4,414    4,095  

Change in fair value of interest rate swap agreement

   1,270    —    

Amortization of premium/discount on investments

   5,166    5,300  

Amortization of deferred financing costs

   825    2,451  

Tax deficiency from employee stock compensation

   (159  (647

Changes in operating assets and liabilities:

   

Receivables

   10,989    5,411  

Prepaid expenses and other current assets

   (10,574  (1,819

Medical claims and benefits payable

   133,987    6,699  

Accounts payable and accrued liabilities

   (9,030  246  

Deferred revenue

   92,354    25,400  

Income taxes

   (21,878  (18,957
  

 

 

  

 

 

 

Net cash provided by operating activities

   264,024    155,163  
  

 

 

  

 

 

 

Investing activities:

   

Purchases of equipment

   (52,548  (45,921

Purchases of investments

   (234,465  (258,209

Sales and maturities of investments

   213,665    226,413  

Proceeds from sale of subsidiary, net of cash surrendered

   9,162    —    

Net cash paid in business combinations

   —      (3,253

Increase in deferred contract costs

   (18,799  (32,765

Increase in restricted investments

   (3,034  (8,394

Change in other noncurrent assets and liabilities

   (4,775  (533
  

 

 

  

 

 

 

Net cash used in investing activities

   (90,794  (122,662
  

 

 

  

 

 

 

Financing activities:

   

Amount borrowed under credit facility

   60,000    —    

Repayment of amount borrowed under credit facility

   (20,000  —    

Principal payments on term loan

   (846  —    

Treasury stock purchases

   —      (7,000

Credit facility fees paid

   —      (1,125

Proceeds from employee stock plans

   5,571    5,640  

Excess tax benefits from employee stock compensation

   3,698    1,590  
  

 

 

  

 

 

 

Net cash provided by (used in) financing activities

   48,423    (895
  

 

 

  

 

 

 

Net increase in cash and cash equivalents

   221,653    31,606  

Cash and cash equivalents at beginning of period

   493,827    455,886  
  

 

 

  

 

 

 

Cash and cash equivalents at end of period

  $715,480   $487,492  
  

 

 

  

 

 

 

 Three Months Ended
 March 31,
 2013 2012
 
(Amounts in thousands)
(Unaudited)
Operating activities:   
Net income$29,915
 $18,089
Adjustments to reconcile net income to net cash provided by operating activities:   
Depreciation and amortization21,799
 18,339
Deferred income taxes(16) 8,263
Stock-based compensation4,421
 4,666
Gain on sale of subsidiary
 (1,747)
Non-cash interest on convertible senior notes3,723
 1,443
Change in fair value of derivatives(119) 
Amortization of premium/discount on investments1,502
 1,850
Amortization of deferred financing costs1,248
 258
Tax deficiency from employee stock compensation(42) (31)
Changes in operating assets and liabilities:   
Receivables(569) (54,356)
Prepaid expenses and other current assets(8,956) (5,640)
Medical claims and benefits payable(3,385) 53,357
Accounts payable and accrued liabilities(31,847) (34,796)
Deferred revenue(5,994) 44,543
Income taxes8,424
 (3,663)
Net cash provided by operating activities20,104
 50,575
Investing activities:   
Purchases of equipment(11,167) (13,505)
Purchases of investments(76,012) (88,199)
Sales and maturities of investments75,647
 65,767
Proceeds from sale of subsidiary, net of cash surrendered
 9,162
Increase in deferred contract costs1,756
 (12,993)
Increase in restricted investments(11,016) (493)
Change in other non-current assets and liabilities(408) (2,457)
Net cash used in investing activities(21,200) (42,718)
Financing activities:   
Proceeds from issuance of 1.125% Notes, net of deferred issuance costs537,973
 
Purchase of call option relating to 1.125% Notes(149,331) 
Proceeds from issuance of warrants75,074
 
Treasury stock purchases(50,000) 
Repayment of amounts borrowed under credit facility(40,000) 
Amount borrowed under credit facility
 10,000
Principal payments on term loan(291) (301)
Proceeds from employee stock plans235
 2,748
Excess tax benefits from employee stock compensation1,177
 3,592
Net cash provided by financing activities374,837
 16,039
Net increase in cash and cash equivalents373,741
 23,896
Cash and cash equivalents at beginning of period795,770
 493,827
Cash and cash equivalents at end of period$1,169,511
 $517,723

5


MOLINA HEALTHCARE, INC.

CONSOLIDATED STATEMENTS OF CASH FLOWS - (continued)

   Nine Months Ended
September 30,
 
   2012  2011 
   (Amounts in thousands) 
   (Unaudited) 

Supplemental cash flow information:

   

Cash paid during the period for:

   

Income taxes

  $1,074   $43,550  
  

 

 

  

 

 

 

Interest

  $5,663   $5,026  
  

 

 

  

 

 

 

Schedule of non-cash investing and financing activities:

   

Common stock used for stock-based compensation

  $9,852   $3,751  
  

 

 

  

 

 

 

Details of sale of subsidiary:

   

Decrease in carrying value of assets

  $30,942   $—    

Decrease in carrying value of liabilities

   (24,170  —    

Gain on sale

   2,390    —    
  

 

 

  

 

 

 

Proceeds from sale of subsidiary, net of cash surrendered

  $9,162   $—    
  

 

 

  

 

 

 

 Three Months Ended
 March 31,
 2013 2012
 (Amounts in thousands)
 (Unaudited)
Supplemental cash flow information:   
Cash paid during the period for:   
Income taxes$14,712
 $1,057
Interest$17,065
 $799
Schedule of non-cash investing and financing activities:   
Retirement of treasury stock$53,000
 $
Common stock used for stock-based compensation$4,644
 $8,768
Details of sale of subsidiary:   
Decrease in carrying value of assets$
 $30,942
Decrease in carrying value of liabilities
 (23,527)
Gain on sale
 1,747
Proceeds from sale of subsidiary, net of cash surrendered$
 $9,162

See accompanying notes.



6


MOLINA HEALTHCARE, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
March 31, 2013

(Unaudited)

September 30, 2012

1. Basis of Presentation

Organization and Operations

Molina Healthcare, Inc. provides quality and cost-effective Medicaid-related solutions to meet the health care needs of low-income families and individuals and to assist state agencies in their administration of the Medicaid program. We report our financial performance based ontworeportable segments: Health Plans and Molina Medicaid Solutions.

Our Health Plans segment comprises health plans in California, Florida, Michigan, New Mexico, Ohio, Texas, Utah, Washington, and Wisconsin, and includes our direct delivery business. As of September 30, 2012,March 31, 2013, these health plans served approximately1.8 millionmembers eligible for Medicaid, Medicare, and other government-sponsored health care programs for low-income families and individuals. The health plans are operated by our respective wholly owned subsidiaries in those states, each of which is licensed as a health maintenance organization, or HMO. Our direct delivery business consists of primary care community clinics in California, Florida, New Mexico, and Washington; additionally, we manage three county-owned primary care clinics under a contract with Fairfax County, Virginia.

Washington.

Our health plans’ state Medicaid contracts generally have terms ofthree to fouryears with annual adjustments to premium rates. These contracts are renewable at the discretion of the state. In general, either the state Medicaid agency or the health plan may terminate the state contract with or without cause upon 30 days to nine months with prior written notice. cause.Most of these contracts contain renewal options that are exercisable by the state. Our health plan subsidiaries have generally been successful in obtaining the renewal of their contracts in each state prior to the actual expiration ofretaining their contracts. Our state contracts are generally at greatest risk of loss when a state issues a new request for proposals, or RFP, subject to competitive bidding by other health plans. If one of our health plans is not a successful responsive bidder to a state RFP, its contract may be subject to non-renewal. For instance, on February 17, 2012, the Division of Purchasing of the Missouri Office of Administration notified us that our Missouri health plan was not awarded a contract under the Missouri HealthNet Managed Care Request for Proposal; therefore, our Missouri health plan’s prior contract with the state expired without renewal on June 30, 2012 subject to certain transition obligations. For the six months ended June 30, 2012, our Missouri health plan contributed premium revenue of $113.8 million, or 4.1% of total premium revenue, and comprised 79,000 members, or 4.3% of total Health Plans segment membership as of June 30, 2012.

Our state Medicaid contracts may be periodically adjusted to include or exclude certain health benefits (such as pharmacy services, behavioral health services, or long-term care services); populations (such as the aged, blind or disabled, or ABD); and regions or service areas. For example, our Texas health plan added significant membership effective March 1, 2012, in service areas we had not previously served (the Hidalgo and El Paso service areas); and among populations we had not previously served within existing service areas, such as the Temporary Assistance for Needy Families, or TANF, population in the Dallas service area. Additionally, the health benefits provided to our TANF and ABD members in Texas under our contracts with the state were expanded to include inpatient facility and pharmacy services.

services effective March 1, 2012.

Our Molina Medicaid Solutions segment provides business processing and information technology development and administrative services to Medicaid agencies in Idaho, Louisiana, Maine, New Jersey, and West Virginia, and drug rebate administration services in Florida.

On July 13, 2012, our Molina Medicaid Solutions segment received full federal certification of its Medicaid Management Information System, or MMIS, in the state of Idaho from the Centers for Medicare and Medicaid Services, or CMS. As a result of the CMS certification, the state of Idaho is entitled to receive federal reimbursement of 75% of its MMIS operations costs retroactive to June 1, 2010, the date that the system first began processing claims.

On June 9, 2011, Molina Medicaid Solutions received notice from the state of Louisiana that the state intendsintended to award the contract for a replacement MMISMedicaid Management Information System (MMIS) to another companya different vendor, CNSI. However, in March 2013, the state of Louisiana cancelled its contract award to CNSI. CNSI is currently challenging the contract cancellation. The state has informed us that we will continue to perform under our current contract until a successor is named. Subject to the pending challenge, it is currently uncertain whether a new RFP will be issued, and if so, when it will be issued. At such time as a new RFP may be issued, we intend to respond to the state's RFP. For the ninethree months ended September 30, 2012, March 31, 2013, our revenue under the Louisiana MMIS contract was approximately $38.8$10.1 million, or 29.3% 20.3%of total service revenue. We expect that we will continue to perform under this contract through implementation and acceptance of the successor MMIS. Based uponSo long as our past experience and our knowledge of the Louisiana MMIS bid process, we believe that implementation and acceptance of the successor MMIS will not occur until 2014 at the earliest. Through implementation and acceptance of the successor MMIScontract continues, we expect to recognize approximately $40$40 million inof service revenue annually under our Louisiana MMISthis contract.

Consolidation and Interim Financial Information

The consolidated financial statements include the accounts of Molina Healthcare, Inc., its subsidiaries and variable interest entities in which Molina Healthcare, Inc. is considered to be the primary beneficiary. Such variable interest entities are insignificant to our consolidated financial position and results of operations. In the opinion of management, all adjustments considered necessary for a fair presentation of the results as of the date and for the interim periods presented have been included; such adjustments consist of normal recurring adjustments. All significant intercompany balances and transactions

7


have been eliminated. The consolidated results of operations for the current interim period are not necessarily indicative of the results for the entire year ending December 31, 2012. Financial information related to subsidiaries acquired during any year is included only for periods subsequent to their acquisition.

2013.

The unaudited consolidated interim financial statements have been prepared under the assumption that users of the interim financial data have either read or have access to our audited consolidated financial statements for the fiscal year ended December 31, 2011.2012. Accordingly, certain disclosures that would substantially duplicate the disclosures contained in the December 31, 20112012 audited consolidated financial statements have been omitted. These unaudited consolidated interim financial statements should be read in conjunction with our December 31, 20112012 audited consolidated financial statements.

Reclassifications

We have reclassified certain amounts in the 20112012 consolidated statementbalance sheet, and statements of income and cash flows to conform to the 20122013 presentation.

2. Significant Accounting Policies

Revenue Recognition

Premium Revenue – Health Plans Segment

Premium revenue is fixed in advance of the periods covered and, except as described below, is not generally subject to significant accounting estimates. Premium revenues are recognized in the month that members are entitled to receive health care services.

Certain components of premium revenue are subject to accounting estimates. The components of premium revenue subject to estimation fall into two categories:

(1) Contractual provisions that may limit revenue based upon the costs incurred or the profits realized under a specific contract.contract:These are contractual provisions that require the health plan to return premiums to the extent that certain thresholds are not met. In some instances premiums are returned when medical costs fall below a certain percentage of gross premiums; or when administrative costs or profits exceed a certain percentage of gross premiums. In other instances, premiums are partially determined by the acuity of care provided to members (risk adjustment). To the extent that our expenses and profits change from the amounts previously reported (due to changes in estimates), our revenue earned for those periods will also change. In all of these instances, our revenue is only subject to estimate due to the fact that the thresholds themselves contain elements (expense or profit) that are subject to estimate. While we have adequate experience and data to make sound estimates of our expenses or profits, changes to those estimates may be necessary, which in turn willwould lead to changes in our estimates of revenue. In general, a change in estimate relating to expense or profit would offset any related change in estimate to premium, resulting in no or small impact to net income. The following contractual provisions fall into this category:

California Health Plan Medical Cost Floors (Minimums):A portion of certain premiums received by our California health plan may be returned to the state if certain minimum amounts are not spent on defined medical care costs. We recorded a liability under the terms of these contract provisions of $0.5approximately $0.3 million at both March 31, 2013, and $1.0 million at September 30, 2012, and December 31, 2011, respectively.2012

.

Florida Health Plan Medical Cost Floor (Minimum) for Behavioral Health:A portion of premiums received by our Florida health plan may be returned to the state if certain minimum amounts are not spent on defined behavioral health care costs. At both September 30, 2012,March 31, 2013, and December 31, 2011,2012, we had not recorded any liability under the terms of this contract provision since behavioral health expenses are not less than the contractual floor.

New Mexico Health Plan Medical Cost Floors (Minimums) and Administrative Cost and Profit Ceilings (Maximums):Our contract with the state of New Mexico directs that a portion of premiums received may be returned to the state if certain minimum amounts are not spent on defined medical care costs, or if administrative costs or profit (as defined) exceed certain amounts. At both September 30, 2012,March 31, 2013, and December 31, 2011,2012, we had not recorded any liability under the terms of these contract provisions.

Texas Health Plan Profit Sharing:Under our contract with the state of Texas, there is a profit-sharing agreement under which we pay a rebate to the state of Texas if our Texas health plan generates pretax income, as defined in the contract, above a certain specified percentage, as determined in accordance with a tiered rebate schedule. We are limited in the amount of administrative costs that we may deduct in calculating the rebate, if any. As a result of profits in excess of the amount we are allowed to fully retain, we had accrued an aggregate liability of approximately $3.2$3.1 million and $0.7$3.2 million pursuant to our profit-sharing agreement with the state of Texas at September 30, 2012,March 31, 2013, and December 31, 2011,2012, respectively.


8


Washington Health Plan Medical Cost Floors (Minimums):A portion of certain premiums received by our Washington health plan may be returned to the state if certain minimum amounts are not spent on defined medical care costs. We recorded a liability under the terms of these contract provisions of approximately $1.0 million at March 31, 2013. At both September 30, 2012, and December 31, 2011,2012, we had not recorded any liability under the terms of this contract provision since medical expenses arewere not less than the contractual floor.

Medicare Revenue Risk Adjustment:Based on member encounter data that we submit to CMS, our Medicare premiums are subject to retroactive adjustment for both member risk scores and member pharmacy cost experience for up to two years after the original year of service. This adjustment takes into account the acuity of each member’s medical needs relative to what was anticipated when premiums were originally set for that member. In the event that a member requires less acute medical care than was anticipated by the original premium amount, CMS may recover premium from us. In the event that a member requires more acute medical care than was anticipated by the original premium amount, CMS may pay us additional retroactive premium. A similar retroactive reconciliation is undertaken by CMS for our Medicare members’ pharmacy utilization. We estimate the amount of Medicare revenue that will ultimately be realized for the periods presented based on our knowledge of our members’ heath care utilization patterns and CMS practices. Based on our knowledge of member health care utilization patterns and expenses we have recorded a net payable of approximately $0.2 million as of March 31, 2013 and a net receivable of approximately $1.7$0.3 million and $5.0 million as of December 31, 2012 for anticipated Medicare risk adjustment premiums as of September 30, 2012, and December 31, 2011, respectively.premiums.

(2) Quality incentives that allow us to recognize incremental revenue if certain quality standards are met.met:These are contract provisions that allow us to earn additional premium revenue in certain states if we achieve certain quality-of-care or administrative measures. We estimate the amount of revenue that will ultimately be realized for the periods presented based on our experience and expertise in meeting the quality and administrative measures as well as our ongoing and current monitoring of our progress in meeting those measures. The amount of the revenue that we will realize under these contractual provisions is determinable based upon that experience. The following contractual provisions fall into this category:

New Mexico Health Plan Quality Incentive Premiums:Under our contract with the state of New Mexico, incremental revenue of up to 0.75% of our total premium is earned if certain performance measures are met. These performance measures are generally linked to various quality-of-care and administrative measures dictated by the state.

Ohio Health Plan Quality Incentive Premiums:Under our contract with the state of Ohio, incremental revenue of up to 1% of our total premium is earned if certain performance measures are met. These performance measures are generally linked to various quality-of-care measures dictated by the state.

Texas Health Plan Quality Incentive Premiums:Effective March 1, 2012, under our contract with the state of Texas, incremental revenue of up to 5% of our total premium may be earned if certain performance measures are met. These performance measures are generally linked to various quality-of-care measures established by the state.

Wisconsin Health Plan Quality Incentive Premiums:Under our contract with the state of Wisconsin, effective beginning in 2011,incremental revenue of up to 3.25% of thetotal premium is withheld by the state. The withheld premiums can be earned by the health plan by meetingif certain performance measures.measures are met. These performance measures are generally linked to various quality-of-care measures dictated by the state.

The following table quantifies the quality incentive premium revenue recognized for the periods presented, including the amounts earned in the period presented and prior periods. Although the reasonably possible effects of a change in estimate related to quality incentive premium revenue as of September 30, 2012March 31, 2013 are not known, we have no reason to believe that the adjustments to prior years noted below are not indicative of the potential future changes in our estimates as of September 30, 2012.

   Three Months Ended September 30, 2012 
   Maximum
Available Quality
Incentive
Premium -
Current Year
   Amount of
Current Year
Quality Incentive
Premium Revenue
Recognized
   Amount of
Quality Incentive
Premium Revenue
Recognized from
Prior Year
   Total Quality
Incentive
Premium Revenue
Recognized
   Total Revenue
Recognized
 
   (In thousands) 

New Mexico

  $560    $532    $—      $532    $84,797  

Ohio

   2,824     1,412     —       1,412     306,314  

Texas

   17,685     10,453     —       10,453     350,810  

Wisconsin

   419     —       246     246     16,279  
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
  $21,488    $12,397    $246    $12,643    $758,200  
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
   Three Months Ended September 30, 2011 
   Maximum
Available Quality
Incentive
Premium -
Current Year
   Amount of
Current Year
Quality Incentive
Premium Revenue
Recognized
   Amount of
Quality Incentive
Premium Revenue
Recognized from
Prior Year
   Total Quality
Incentive
Premium Revenue
Recognized
   Total Revenue
Recognized
 
   (In thousands) 

New Mexico

  $566    $345    $46    $391    $79,644  

Ohio

   2,160     1,719     —       1,719     232,616  

Texas

   400     400     —       400     105,577  

Wisconsin

   420     362     —       362     17,269  
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
  $3,546    $2,826    $46    $2,872    $435,106  
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
   Nine Months Ended September 30, 2012 
   Maximum
Available Quality
Incentive
Premium -
Current Year
   Amount of
Current Year
Quality Incentive
Premium Revenue
Recognized
   Amount of
Quality Incentive
Premium Revenue
Recognized from
Prior Year
   Total Quality
Incentive
Premium Revenue
Recognized
   Total Revenue
Recognized
 
   (In thousands) 

New Mexico

  $1,676    $1,350    $658    $2,008    $253,418  

Ohio

   8,222     6,810     966     7,776     896,908  

Texas

   41,687     30,487     —       30,487     908,532  

Wisconsin

   1,284     —       492     492     52,209  
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
  $52,869    $38,647    $2,116    $40,763    $2,111,067  
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

   Nine Months Ended September 30, 2011 
   Maximum
Available Quality
Incentive
Premium -
Current Year
   Amount of
Current Year
Quality Incentive
Premium Revenue
Recognized
   Amount of
Quality Incentive
Premium Revenue
Recognized from
Prior Year
   Total Quality
Incentive
Premium Revenue
Recognized
   Total Revenue
Recognized
 
   (In thousands) 

New Mexico

  $1,712    $1,219    $364    $1,583    $246,223  

Ohio

   7,472     6,152     3,501     9,653     693,829  

Texas

   1,560     1,560     —       1,560     290,787  

Wisconsin

   1,292     362     —       362     51,526  
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
  $12,036    $9,293    $3,865    $13,158    $1,282,365  
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

March 31, 2013.


9


 Three Months Ended March 31, 2013
 
Maximum
Available Quality
Incentive
Premium -
Current Year
 
Amount of
Current Year
Quality Incentive
Premium Revenue
Recognized
 
Amount of
Quality Incentive
Premium Revenue
Recognized from
Prior Year
 
Total Quality
Incentive
Premium Revenue
Recognized
 
Total Revenue
Recognized
 (In thousands)
New Mexico$585
 $332
 $108
 $440
 $85,798
Ohio3,005
 1,052
 
 1,052
 291,518
Texas16,264
 13,512
 5,995
 19,507
 335,296
Wisconsin761
 
 609
 609
 27,124
 $20,615
 $14,896
 $6,712
 $21,608
 $739,736
          
 Three Months Ended March 31, 2012
 
Maximum
Available Quality
Incentive
Premium -
Current Year
 
Amount of
Current Year
Quality Incentive
Premium Revenue
Recognized
 
Amount of
Quality Incentive
Premium Revenue
Recognized from
Prior Year
 
Total Quality
Incentive
Premium Revenue
Recognized
 
Total Revenue
Recognized
 (In thousands)
New Mexico$555
 $336
 $28
 $364
 $81,226
Ohio2,678
 2,678
 966
 3,644
 293,525
Texas5,750
 5,750
 
 5,750
 198,236
Wisconsin416
 
 
 
 17,142
 $9,399
 $8,764
 $994
 $9,758
 $590,129
Service Revenue and Cost of Service Revenue — Molina Medicaid Solutions Segment

The payments received by our Molina Medicaid Solutions segment under its state contracts are based on the performance of multiple services. The first of these is the design, development and implementation or DDI,(DDI) of a Medicaid Management Information System or MMIS.(MMIS). An additional service, following completion of DDI, is the operation of the MMIS under a business process outsourcing or BPO(BPO) arrangement. While providing BPO services (which include claims payment and eligibility processing), we also provide the state with other services including both hosting and support and maintenance. Our Molina Medicaid Solutions contracts may extend over a number of years, particularly in circumstances where we are delivering extensive and complex DDI services, such as the initial design, development and implementation of a complete MMIS. For example, the terms of our most recently implemented Molina Medicaid Solutions contracts (in Idaho and Maine) were each seven years in total, consisting of two years allocated for the delivery of DDI services, followed by five years for the performance of BPO services. We receive progress payments from the state during the performance of DDI services based upon the attainment of predetermined milestones. We receive a flat monthly payment for BPO services under our Idaho and Maine contracts. The terms of our other Molina Medicaid Solutions contracts – which primarily involve the delivery of BPO services with only minimal DDI activity (consisting of system enhancements) – are shorter in duration than our Idaho and Maine contracts.

We have evaluated our Molina Medicaid Solutions contracts to determine if such arrangements include a software element. Based on this evaluation, we have concluded that these arrangements do not include a software element. As such, we have concluded that our Molina Medicaid Solutions contracts are multiple-element service arrangements under the scope of FASB Accounting Standards Codification Subtopic 605-25,Revenue Recognition –– Multiple–Element Arrangements, and SEC Staff Accounting Bulletin Topic 13,Revenue Recognition.arrangements.

Effective January 1, 2011,

Additionally, we adopted a new accounting standard that amends the guidance on the accounting for multiple-element arrangements. Pursuant to the new standard,evaluate each required deliverable is evaluatedunder our multiple-element service arrangements to determine whether it qualifies as a separate unit of accounting whichaccounting. Such evaluation is generally based on whether the deliverable has standalone value to the customer. In addition to standalone value, previous guidance also required objective and reliable evidence of fair value of a deliverable in order to treat the deliverable as a separate unit of accounting. The arrangement’s consideration that is fixed or determinable is then allocated to each separate unit of accounting based on the relative selling price of each deliverable. In general, the consideration allocated to each unit of accounting is recognized as the related goods or services are delivered, limited to the consideration that is not contingent. We have adopted this guidance on a prospective basis for all new or materially modified revenue arrangements with multiple deliverables entered into on or after January 1, 2011. Our adoption of this guidance has not impacted the timing or pattern of our revenue recognition in 2011 or 2012. Also, there would have been no change in revenue recognized relating to multiple-element arrangements if we had adopted this guidance retrospectively for contracts entered into prior to January 1, 2011.


We have concluded that the various service elements in our Molina Medicaid Solutions contracts represent a single unit of accounting due to the fact that DDI, which is the only service performed in advance of the other services (all other services are performed over an identical period), does not have standalone value because our DDI services are not sold separately by any vendor and the customer could not resell our DDI services. Further, we have no objective and reliable evidence of fair value for any of the individual elements in these contracts, and at no point in the contract will we have objective and reliable

10


evidence of fair value for the undelivered elements in the contracts. For contracts entered into prior to January 1, 2011, objective and reliable evidence of fair value would be required, in addition to DDI standalone value which we do not have, in order to treat DDI as a separate unit of accounting. We lack objective and reliable evidence of the fair value of the individual elements of our Molina Medicaid Solutions contracts for the following reasons:

Each contract calls for the provision of its own specific set of services. While all contracts support the system of record for state MMIS, the actual services we provide vary significantly between contracts; and

The nature of the MMIS installed varies significantly between our older contracts (proprietary mainframe systems) and our new contracts (commercial off-the-shelf technology solutions).

Because we have determined the services provided under our Molina Medicaid Solutions contracts represent a single unit of accounting and because we are unable to determine a pattern of performance of services during the contract period, we recognize all revenue (both the DDI and BPO elements) associated with such contracts on a straight-line basis over the period during which BPO, hosting, and support and maintenance services are delivered. As noted above, the period of performance of BPO services under our Idaho and Maine contracts is five years. Therefore, absent any contingencies as discussed in the following paragraph, we would recognize all revenue associated with those contracts over a period of five years. In cases where there is no DDI element associated with our contracts, BPO revenue is recognized on a monthly basis as specified in the applicable contract or contract extension.

Provisions specific to each contract may, however, lead us to modify this general principle. In those circumstances, the right of the state to refuse acceptance of services, as well as the related obligation to compensate us, may require us to delay recognition of all or part of our revenue until that contingency (the right of the state to refuse acceptance) has been removed. In those circumstances we defer recognition of any contingent revenue (whether DDI, BPO services, hosting, and support and maintenance services) until the contingency has been removed. These types of contingency features are present in our Maine and Idaho contracts. In those states, we deferred recognition of revenue until the contingencies were removed.

Costs associated with our Molina Medicaid Solutions contracts include software related costs and other costs. With respect to software related costs, we apply the guidance for internal-use software and capitalize external direct costs of materials and services consumed in developing or obtaining the software, and payroll and payroll-related costs associated with employees who are directly associated with and who devote time to the computer software project. With respect to all other direct costs, such costs are expensed as incurred, unless corresponding revenue is being deferred. If revenue is being deferred, direct costs relating to delivered service elements are deferred as well and are recognized on a straight-line basis over the period of revenue recognition, in a manner consistent with our recognition of revenue that has been deferred. Such direct costs can include:

Transaction processing costs

;

Employee costs incurred in performing transaction services

;

Vendor costs incurred in performing transaction services

;

Costs incurred in performing required monitoring of and reporting on contract performance

;

Costs incurred in maintaining and processing member and provider eligibility

; and

Costs incurred in communicating with members and providers

.

The recoverability of deferred contract costs associated with a particular contract is analyzed on a periodic basis using the undiscounted estimated cash flows of the whole contract over its remaining contract term. If such undiscounted cash flows are insufficient to recover the long-lived assets and deferred contract costs, the deferred contract costs are written down by the amount of the cash flow deficiency. If a cash flow deficiency remains after reducing the balance of the deferred contract costs to zero, any remaining long-lived assets are evaluated for impairment. Any such impairment recognized would equal the amount by which the carrying value of the long-lived assets exceeds the fair value of those assets.

assetsPremium Deficiency Charges.

We assess the profitability of each contract by state for providing medical care services to our members and identify any contracts where current operating results or forecasts indicate probable future losses. Anticipated future premiums are compared with the sum of anticipated future health care costs and maintenance costs. If the anticipated future costs exceed the premiums, a loss contract accrual is recognized. In the second quarter of 2012, our Texas and Wisconsin health plans recorded premium deficiency charges of $10.0 million and $3.0 million, respectively. Such charges were recorded to medical care costs. As of September 30, 2012, the aggregate premium deficiency reserve balance was $1.5 million.

Income Taxes


The provision for income taxes is determined using an estimated annual effective tax rate, which is generally greater than the U.S. federal statutory rate primarily because of non-deductible compensation and state taxes. The effective tax rate may be subject to fluctuations during the year as new information is obtained. Such information may affect the assumptions used to estimate the annual effective tax rate, including factors such as the mix of pretax earnings in the various tax jurisdictions in which we operate, valuation allowances against deferred tax assets, the recognition or derecognition of tax benefits related to uncertain tax positions, and changes in or the interpretation of tax laws in jurisdictions where we conduct

11


business. We recognize deferred tax assets and liabilities for temporary differences between the financial reporting basis and the tax basis of our assets and liabilities, along with net operating loss and tax credit carryovers.

The total amount of unrecognized tax benefits was $10.3$10.6 million as of September 30, 2012,March 31, 2013 and $10.7 million as of December 31, 2011.2012. Approximately $8.4$8.4 million of the unrecognized tax benefits recorded at September 30,March 31, 2013 and December 31, 2012, relate to a tax position claimed on a state refund claim that will not result in a cash payment for income taxes if our claim is denied. The total amount of unrecognized tax benefits that, if recognized, would affect the effective tax rate was $7.2$7.2 million as of September 30, 2012.March 31, 2013 and December 31, 2012. We expect that during the next 12 months it is reasonably possible that unrecognized tax benefit liabilities may decrease by as much as $8.6$8.6 million due to the expiration of statute of limitations and the resolution to the state refund claim described above.

Our continuing practice is to recognize interest and/or penalties related to unrecognized tax benefits in income tax expense. As of September 30, 2012,March 31, 2013, and December 31, 2011,2012, we had accrued $59,000$60,000 and $65,000,$56,000, respectively, for the payment of interest and penalties.

Recent Accounting Pronouncements
Reclassifications Out of Accumulated Other Comprehensive Income

.  In February 2013, the Financial Accounting Standards Board (FASB) issued guidance for the reporting of amounts reclassified out of accumulated other comprehensive income. The new guidance requires entities to report the effect of significant reclassifications out of accumulated other comprehensive income on the respective line items in net income if the amount being reclassified is required under U.S. generally accepted accounting principles (GAAP) to be reclassified in its entirety to net income. The new guidance does not change the current requirements for reporting net income or other comprehensive income in financial statements and is effective prospectively for reporting periods beginning after December 15, 2012. The adoption of this new guidance in 2013 did not impact our financial position, results of operations or cash flows.

Balance Sheet Offsetting. In December 2011, the Financial Accounting Standards Board (“FASB”)FASB issued guidance for new disclosure requirements related to the nature of an entity’s rights of setoffset-off and related arrangements associated with its financial instruments and derivative instruments. The new guidance is effective for annual reporting periods, and interim periods within those years, beginning on or after January 1, 2013. While we do not expect the adoption of this guidance in 2013 to impact our financial position, results of operations or cash flows, we do expect it to change our disclosure policies relative to certain arrangements with rights of setoff.

Goodwill. In September 2011, the FASB issued guidance related to evaluating goodwill for impairment. The new guidance provides entities with the option to perform a qualitative assessment of whether it is more likely than not that the fair value of a reporting unit is less than its carrying amount before applying the quantitative two-step goodwill impairment test. If an entity concludes that it is not more likely than not that the fair value of a reporting unit is less than its carrying amount, it would not be required to perform the quantitative two-step goodwill impairment test. Entities also have the option to bypass the assessment of qualitative factors for any reporting unit in any period and proceed directly to performing the first step of the quantitative two-step goodwill impairment test, as was required prior to the issuance of this new guidance. An entity may begin or resume performing the qualitative assessment in any subsequent period. The new guidance became effective for annual reporting periods, and interim periods within those years, beginning after December 15, 2011, with early adoption permitted. The adoption of this new guidance in 20122013 did not impact our financial position, results of operations or cash flows.

Federal Premium-Based Assessment. In July 2011, the FASB issued guidance related to accounting for the fees to be paid by health insurers to the federal government under the Patient Protection and Affordable Care Act, as amended by the Health Care and Education Reconciliation Act (the “Affordable Care Act”)(ACA). The Affordable Care ActACA imposes an annual fee on health insurers for each calendar year beginning on or after January 1, 2014. The fee will be imposed beginning in 2014 that is allocated to health insurers based on the ratioa company's share of the amount of an entity’sindustry's net premium revenuespremiums written during the preceding calendar year to the amount of health insurance for any U.S. health risk that is written during the preceding calendar year.
The new guidance specifies that the liability for the fee should be estimated and recorded in full once the entity provides qualifying health insurance in the applicable calendar year in which the fee is payable with a corresponding deferred cost that is amortized to expense using a straight-line method of allocation unless another method better allocates the fee over the calendar year that it is payable. The new guidance is effective for annual reporting periods beginning after December 31, 2013, when the fee initially becomes effective. As enacted, this federal premium-based assessment is non-deductible for income tax purposes, and is anticipated to be significant. It is yet undetermined how this premium-based assessment will be factored into the calculation of our premium rates, if at all. Accordingly, adoption of this guidance and the enactment of this assessment as currently written couldwill have a material impact on our financial position, results of operations, or cash flows in future periods.

Comprehensive Income. In June 2011, We are currently evaluating the FASB issued guidance, as amended in December 2011, relatedimpact of the fee to the presentation of other comprehensive income. The new guidance provides entities with an option to either replace the statement of income with a statement of comprehensive income which would display both the components of net income and comprehensive income in a combined statement, or to present a separate statement of comprehensive income immediately following the statement of income. The new guidance does not affect the components of other comprehensive income or the calculation of earnings per share. To be applied retrospectively with early adoption permitted, the new guidance became effective for annual reporting periods, and interim periods within those years, beginning after December 15, 2011. We have elected to present a separate statement of comprehensive income immediately following the statement of income. The adoption of this new guidance in 2012 did not impact our financial position, results of operations orand cash flows.

Fair Value.In May 2011, the FASB issued guidance related to fair value measurement and disclosure. The new guidance is a result of joint efforts by the FASB and the International Accounting Standards Board to develop a single converged fair value framework. The new guidance expands existing disclosure requirements for fair value measurements and makes other amendments; mostly to eliminate wording differences between U.S. generally accepted accounting principles (“GAAP”) and international financial reporting standards. To be applied prospectively, the new guidance became effective for annual reporting periods, and interim periods within those years, beginning after December 15, 2011. Although the adoption of this new guidance in 2012 did not impact our financial position, results of operations or cash flows, it did change our disclosure policies relative to fair value measurements.

Other recent accounting pronouncements issued by the FASB (including its Emerging Issues Task Force), the American Institute of Certified Public Accountants or AICPA,(AICPA), and the Securities and Exchange Commission or SEC,(SEC) did not have, or are not believed by management to have, a material impact on our present or future consolidated financial statements.

3. Net Income (Loss) per Share

The following table sets forth the calculation of the denominators used to compute basic and diluted net income (loss) per share:

   Three Months Ended  Nine Months Ended 
   September 30,  September 30, 
   2012   2011  2012   2011 
   (In thousands) 

Shares outstanding at the beginning of the period

   46,527     46,062    45,815     45,463  

Weighted-average number of shares repurchased

   —       (235  —       (160

Weighted-average number of shares issued

   19     7    486     390  
  

 

 

   

 

 

  

 

 

   

 

 

 

Denominator for basic income (loss) per share

   46,546     45,834    46,301     45,693  

Dilutive effect of employee stock options and stock grants (1)

   334     462    —       641  
  

 

 

   

 

 

  

 

 

   

 

 

 

Denominator for diluted income (loss) per share (2)

   46,880     46,296    46,301     46,334  
  

 

 

   

 

 

  

 

 

   

 

 

 


12


 Three Months Ended March 31,
 2013 2012
 (In thousands)
Shares outstanding at the beginning of the period46,762
 45,815
Weighted-average number of shares repurchased(867) 
Weighted-average number of shares issued86
 183
Denominator for basic income per share45,981
 45,998
Dilutive effect of employee stock options and stock grants (1)462
 857
Dilutive effect of convertible senior notes
 32
Denominator for diluted income per share (2)46,443
 46,887
(1)
Unvested restricted shares are included in the calculation of diluted income per share when their grant date fair values are below the average fair value of the common shares for each of the periods presented. Options to purchase common shares are included in the calculation of diluted income per share when their exercise prices are below the average fair value of the common shares for each of the periods presented. For the three months ended September 30, 2012March 31, 2013 and 2011,2012, there were approximately 370,000202,500 and 57,000199,700 anti-dilutive weighted restricted shares, respectively. For the three months ended September 30, 2012March 31, 2013 and 20112012 there were approximately 125,00025,500 and 316,0007,900 anti-dilutive weighted options, respectively. Potentially dilutive unvested restricted shares and stock options were not included in the computation of diluted loss per share for the nine months ended September 30, 2012, because to do so would have been anti-dilutive. For the nine months ended September 30, 2011, there were no anti-dilutive weighted restricted shares. For the nine months ended September 30, 2011 there were approximately 126,000 anti-dilutive weighted options.
(2)
Potentially dilutive shares issuable pursuant to our convertible senior notes3.75% Notes and 1.125% Warrants (both defined in Note 10, "Long-Term Debt") were not included in the computation of diluted income (loss) per share for the three month and nine month periodsperiod ended September 30, 2012 and 2011,March 31, 2013, because to do so would have been anti-dilutive.


4. Share-BasedStock-Based Compensation

At September 30, 2012,March 31, 2013, we had employee equity incentives outstanding under threetwo plans: (1) the 2011 Equity Incentive Plan; and (2) the 2002 Equity Incentive Plan (from which equity incentives are no longer awarded); and (3) the 2000 Omnibus Stock and Incentive Plan (from which equity incentives are no longer awarded).
In March 2012,2013, our named executive officers were granted restricted stock awards with performance conditions as follows: our chief executive officer was awarded 186,858 shares, our chief financial officer andwas awarded 93,429 shares, our chief operating officer was awarded 62,286 shares, our chief accounting officer was awarded 28,029 shares, and our general counsel was awarded 21,800 shares. These awards were awarded 94,050 performance units, 53,236 performance units,apportioned into four equal increments, and 30,167 performance units, respectively, that wouldwill vest in accordance with the following four measures: (i) 1/4th will vest in equal 1/3rd increments over three years on March 1, 2014, March 1, 2015, and be settled in shares of the Company’s common stock equal in number to the units grantedMarch 1, 2016; (ii) 1/4th will vest upon theour achievement of certain service and performance conditions. Each ofthree-year Total Stockholder Return as determined by Institutional Shareholder Services Inc. (ISS) calculations for the grants shall vest in 2012, provided that: (i) the Company’s total operating revenue for 2012 isthree-year period ending December 31, 2013 equal to or greater than $5.5the 50th percentile within our ISS peer group; (iii) 1/4th shall vest upon our achievement of total revenue in any of the 2013, 2014, or 2015 fiscal years equal to or greater than $12 billion; and (ii)(iv) 1/4th shall vest upon our achievement of the respective officer continuesthree-year earnings before interest, taxes, depreciation and amortization (EBITDA) margin percentage for the three-year period ending December 31, 2013 equal to be employed by the Company if and when the operating revenue target is met. As of September 30, 2012, we expect such performance awards to vest in full.or greater than 2.5%. In the event the vesting conditions are not achieved, the awards shall lapse. AlsoAs of March 31, 2013, such performance goals have not yet been met, but we do expect the awards to vest in March 2012, our chief executive officer, chief financial officer, chief operating officer, and chief accounting officer were awarded 8,000 shares, 8,000 shares, 8,000 shares, and 3,000 shares, respectively, of performance units that would vest and be settled in shares of the Company’s common stock equal in number to the units granted upon the certification of our Idaho MMIS by CMS. Such awards vested when the Idaho MMIS was certified in July 2012.

full.

Charged to general and administrative expenses, total share-basedstock-based compensation expense was as follows for the three monthmonths ended March 31, 2013 and nine month periods ended September 30, 2012 and 2011:

   Three Months Ended   Nine Months Ended 
   September 30,   September 30, 
   2012   2011   2012   2011 
   (in thousands) 

Restricted share and performance/restricted unit awards

  $5,093    $4,004    $13,943    $11,742  

Stock options (including shares issued under our employee stock purchase plan)

   543     345     1,505     981  
  

 

 

   

 

 

   

 

 

   

 

 

 

Total share-based compensation expense

  $5,636    $4,349    $15,448    $12,723  
  

 

 

   

 

 

   

 

 

   

 

 

 

:

 Three Months Ended March 31,
 2013 2012
 (In thousands)
Restricted stock and performance awards$3,848
 $4,398
Stock options (primarily relating to our employee stock purchase plan)573
 268
 $4,421
 $4,666
As of September 30, 2012,March 31, 2013, there was $19.0$29.2 million of total unrecognized compensation expense related to unvested restricted share awards, which we expect to recognize over a remaining weighted-average period of 2.31.9 years. AsAlso as of September 30, 2012,March 31, 2013, there was $1.9$0.8 million of total unrecognized compensation expense related to performance and restricted units,unvested stock options, which we expect to recognize in the fourth quarterover a weighted-average period of 2012.

2.8 years.


13


Restricted sharestock activity for the ninethree months ended September 30, 2012March 31, 2013 is summarized below:

      Weighted 
      Average 
      Grant Date 
   Shares  Fair Value 

Unvested balance as of December 31, 2011

   1,435,882   $18.97  

Granted

   498,057    31.86  

Vested

   (744,360  20.47  

Forfeited

   (79,999  23.21  
  

 

 

  

Unvested balance as of September 30, 2012

   1,109,580    23.45  
  

 

 

  

 Shares 
Weighted
Average
Grant Date
Fair Value
Unvested balance as of December 31, 2012986,577
 $23.74
Granted601,175
 31.40
Vested(409,484) 22.16
Forfeited(7,750) 22.93
Unvested balance as of March 31, 20131,170,518
 28.23
The total fair value of restricted sharesstock and stock unit awards, including those with performance conditions, granted during the three months ended March 31, 2013 and 2012 was $19.3 million and $19.8 million, respectively. The total fair value of restricted stock and stock unit awards vested during the ninethree months ended September 30, 2012March 31, 2013 and 20112012 was $24.3$13.1 million and $11.5$22.8 million, respectively.

Performance and restricted unit activity for the nine months ended September 30, 2012 is summarized below:

              Weighted 
      Weighted       Average 
      Average   Aggregate   Remaining 
      Grant Date   Intrinsic   Contractual 
   Units  Fair Value   Value   term 
          (In thousands)   (Years) 

Outstanding as of December 31, 2011

   —     $—        

Granted

   213,022    33.59      

Vested

   (31,285  33.73    $823    
  

 

 

    

 

 

   

Outstanding as of September 30, 2012

   181,737    33.56    $4,571     0.3  
  

 

 

    

 

 

   

 

 

 

Performance and restricted units expected to vest as of September 30, 2012

   181,737    33.56    $4,571     0.3  
  

 

 

    

 

 

   

 

 

 

Stock option activity for the ninethree months ended September 30, 2012March 31, 2013 is summarized below:

              Weighted 
      Weighted       Average 
      Average   Aggregate   Remaining 
      Exercise   Intrinsic   Contractual 
   Options  Price   Value   term 
          (In thousands)   (Years) 

Outstanding as of December 31, 2011

   553,049   $20.91      

Granted

   15,000    34.82      

Exercised

   (114,229  19.29    $1,553    
     

 

 

   

Forfeited

   (750  22.37      
  

 

 

      

Outstanding as of September 30, 2012

   453,070    21.78    $1,966     3.4  
  

 

 

    

 

 

   

 

 

 

Stock options exercisable and expected to vest as of September 30, 2012

   453,070    21.78    $1,966     3.4  
  

 

 

    

 

 

   

 

 

 

Exercisable as of September 30, 2012

   438,070    21.33    $1,966     3.2  
  

 

 

    

 

 

   

 

 

 

 Options 
Weighted
Average
Exercise
Price
 
Aggregate
Intrinsic
Value
 
Weighted
Average
Remaining
Contractual
term
     (In thousands) (Years)
Outstanding as of December 31, 2012414,061
 $22.39
 
  
Granted45,000
 33.02
 
  
Exercised(13,001) 17.97
 

  
Forfeited(300) 17.63
 
  
Outstanding as of March 31, 2013445,760
 23.60
 $3,398
 3.8
Stock options exercisable and expected to vest as of March 31, 2013445,760
 23.60
 $3,398
 3.8
Exercisable as of March 31, 2013390,760
 22.23
 $3,398
 3.0
The weighted-average grant date fair value per share of stock options awarded to the new members of our board of directors during the three months ended March 31, 2013 was $14.67. The weighted-average grant date fair value per share of the sole stock option awarded to the director appointed during 2012 was $13.97. To determine the nine months ended September 30, 2012 was $13.97. Nofair values of these stock options were granted in 2011.

we applied risk-free interest rates of 1.1% to 1.4%, expected volatilities of 41.3% to 43.0%, dividend yields of 0%, and expected lives of 6 years to 7 years.

5. Fair Value Measurements

Our consolidated balance sheets include the following financial instruments: cash and cash equivalents, investments, receivables, a derivative asset, trade accounts payable, medical claims and benefits payable, long-term debt, derivative liabilities, and other liabilities. We consider the carrying amounts of cash and cash equivalents, receivables, other current assets and current liabilities to approximate their fair value because of the relatively short period of time between the origination of these instruments and their expected realization or payment. For our financial instruments measured at fair value on a recurring basis, we prioritize the inputs used in measuring fair value according to a three-tier fair value hierarchy as follows:

Level 1 — Observable inputs such as quoted prices in active markets: Our Level 1 financial instruments recorded at fair value consist of investments including government-sponsored enterprise securities (GSEs) and U.S. treasury notes that are classified as current investments in the accompanying consolidated balance sheets. These financial instruments are actively traded and therefore the fair value for these securities is based on quoted market prices on one or more securities exchanges.
Level 2 — Inputs other than quoted prices in active markets that are either directly or indirectly observable: Our Level 2 financial instruments recorded at fair value consist of investments including corporate debt securities, municipal securities, and certificates of deposit that are classified as current investments in the accompanying consolidated balance sheets. Our investments classified as Level 2 are traded frequently though not necessarily

14


daily. Fair value for these investments is determined using a market approach based on quoted prices for similar securities in active markets or quoted prices for identical securities in inactive markets.
Additionally, Level 2 financial instruments include an interest rate swap derivative liability. Fair value for the interest rate swap derivative is based on forward LIBOR rates that are and will be observable at commonly quoted intervals for the full term of the interest rate swap agreement.
Level 3 — Unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions: Our Level 3 financial instruments recorded at fair value include non-current auction rate securities that are designated as available-for-sale, and are reported at fair value of $13.6 million (par value of $14.5 million) as of March 31, 2013. To estimate the fair value of these securities we use valuation data from our primary pricing source, a third party who provides a marketplace for illiquid assets with over 10,000 participants including global financial institutions, hedge funds, private equity funds, mutual funds, corporations and other institutional investors. This valuation data is based on a range of prices that represent indicative bids from potential buyers. To validate the reasonableness of the data, we compare these valuations to data from two other third-party pricing sources, which also provide a range of prices representing indicative bids from potential buyers. We have concluded that these estimates, given the lack of market available pricing, provide a reasonable basis for determining the fair value of the auction rate securities as of March 31, 2013.
Additionally, Level 3 financial instruments include derivative financial instruments comprising the 1.125% Call Option asset, the embedded conversion option liability, and the 1.125% Warrants liability. These derivatives are not actively traded and are valued based on an option pricing model that uses observable and unobservable market data for inputs. Significant market data inputs used to determine fair value as of March 31, 2013 included our common stock price, time to maturity of the derivative instruments, the risk-free interest rate, and the implied volatility of our common stock. See Note 10, “Long-Term Debt,” and Note 11, “Derivative Financial Instruments,” for further information, including defined terms, regarding our derivative financial instruments.
Level 1 — Observable inputs such as quoted prices in active markets: Our Level 1 financial instruments recorded at fair value consist of investments including government-sponsored enterprise securities (GSEs) and U.S. treasury notes that are classified as current investments in the accompanying consolidated balance sheets. These financial instruments are actively traded and therefore the fair value for these securities is based on quoted market prices on one or more securities exchanges.

Level 2 — Inputs other than quoted prices in active markets that are either directly or indirectly observable:Our Level 2 financial instruments recorded at fair value consist of investments including corporate debt securities, municipal securities, and certificates of deposit that are classified as current investments in the accompanying consolidated balance sheets, and an interest rate swap derivative recorded as a noncurrent liability. Our investments classified as Level 2 are traded frequently though not necessarily daily. Fair value for the investments is determined using a market approach based on quoted prices for similar securities in active markets or quoted prices for identical securities in inactive markets. Fair value for the interest rate swap derivative is based on forward LIBOR rates that are and will be observable at commonly quoted intervals for the full term of the interest rate swap agreement. See Note 10, “Long-Term Debt,” for further information regarding the interest rate swap agreement.

Level 3 — Unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions: Our level 3 financial instruments recorded at fair value consist of non-current auction rate securities that are designated as available-for-sale, and are reported at fair value of $13.5 million (par value of $15.0 million) as of September 30, 2012. To estimate the fair value of these securities, we use valuations from third-party pricing models that include factors such as the collateral underlying the securities, the creditworthiness of the counterparty, the timing of expected future cash flows, and the expectation of the next time the security would have a successful auction. To validate the reasonableness of these valuations, we compare such valuations to other third party valuations that provide a range of prices representing indicative bids from potential buyers. We have concluded that these estimates, given the lack of market available pricing, provide a reasonable basis for determining the fair value of the auction rate securities as of September 30, 2012.

Our financial instruments recordedmeasured at fair value on a recurring basis at September 30, 2012,March 31, 2013, were as follows:

   Total   Level 1   Level 2   Level 3 
   (In thousands) 

Corporate debt securities

  $208,862    $—      $208,862    $—    

Government-sponsored enterprise securities (GSEs)

   33,066     33,066     —       —    

Municipal securities

   73,899     —       73,899     —    

U.S. treasury notes

   33,691     33,691     —       —    

Certificates of deposit

   7,377     —       7,377     —    

Auction rate securities

   13,523     —       —       13,523  
  

 

 

   

 

 

   

 

 

   

 

 

 

Total assets at fair value

  $370,418    $66,757    $290,138    $13,523  
  

 

 

   

 

 

   

 

 

   

 

 

 

Interest rate swap liability

  $1,270    $—      $1,270    $—    
  

 

 

   

 

 

   

 

 

   

 

 

 

 Total Level 1 Level 2 Level 3
 (In thousands)
Corporate debt securities$198,567
 $
 $198,567
 $
GSEs27,399
 27,399
 
 
Municipal securities75,411
 
 75,411
 
U.S. treasury notes31,938
 31,938
 
 
Auction rate securities13,600
 
 
 13,600
Certificates of deposit8,631
 
 8,631
 
1.125% Call Option derivative147,385
 
 
 147,385
Total assets measured at fair value on a recurring basis$502,931
 $59,337
 $282,609
 $160,985
        
Embedded conversion option derivative$147,309
 $
 $
 $147,309
1.125% Warrants derivative75,074
 
 
 75,074
Interest rate swap derivative1,264
 
 1,264
 
Total liabilities measured at fair value on a recurring basis$223,647
 $
 $1,264
 $222,383

15

Table of Contents

Our financial instruments recordedmeasured at fair value on a recurring basis at December 31, 2011,2012, were as follows:

   Total   Level 1   Level 2   Level 3 
   (In thousands) 

Corporate debt securities

  $231,634    $—      $231,634    $—    

GSEs

   33,949     33,949     —       —    

Municipal securities

   47,313     —       47,313     —    

U.S. treasury notes

   21,748     21,748     —       —    

Certificates of deposit

   2,272     —       2,272     —    

Auction rate securities

   16,134     —       —       16,134  
  

 

 

   

 

 

   

 

 

   

 

 

 

Total assets at fair value

  $353,050    $55,697    $281,219    $16,134  
  

 

 

   

 

 

   

 

 

   

 

 

 

Interest rate swap liability

  $—      $—      $—      $—    
  

 

 

   

 

 

   

 

 

   

 

 

 

 Total Level 1 Level 2 Level 3
 (In thousands)
Corporate debt securities$191,008
 $
 $191,008
 $
GSEs29,525
 29,525
 
 
Municipal securities75,848
 
 75,848
 
U.S. treasury notes35,740
 35,740
 
 
Auction rate securities13,419
 
 
 13,419
Certificates of deposit10,724
 
 10,724
 
Total assets measured at fair value on a recurring basis$356,264
 $65,265
 $277,580
 $13,419
        
Interest rate swap derivative$1,307
 $
 $1,307
 $
The following table presentstables present activity for the nine months ended September 30, 2012, relating to our assets measured at fair value on a recurring basis using significant unobservable inputs (Level 3):

   (Level 3) 
   (In thousands) 

Balance at December 31, 2011

  $16,134  

Total gains (unrealized only):

  

Included in other comprehensive income

   1,439  

Settlements

   (4,050
  

 

 

 

Balance at September 30, 2012

  $13,523  
  

 

 

 

The amount of total unrealized gains for the period included in other comprehensive income attributable to the change in accumulated other comprehensive losses relating to assets still held at September 30, 2012

  $903  
  

 

 

 

 Changes in Level 3 Instruments for the Three Months Ended March 31, 2013
 TotalAuction Rate SecuritiesDerivatives, Net
  (In thousands) 
Balance at December 31, 2012$13,419
$13,419
$
Net unrealized gains included in other comprehensive income331
331

Net unrealized gains included in earnings76

76
Purchases and issuances of assets (liabilities)(75,074)
(75,074)
Settlements(150)(150)
Balance at March 31, 2013$(61,398)$13,600
$(74,998)
The amount of total unrealized gains for the period included in other comprehensive income attributable to the change in accumulated other comprehensive losses relating to assets still held at March 31, 2013$318
$318
$
 Changes in Level 3 Instruments for the Year Ended December 31, 2012
 TotalAuction Rate SecuritiesDerivatives, Net
 (In thousands)
Balance at December 31, 2011$16,134
$16,134
$
Net unrealized gains included in other comprehensive income1,635
1,635

Settlements(4,350)(4,350)
Balance at December 31, 2012$13,419
$13,419
$
The amount of total unrealized gains for the period included in other comprehensive income attributable to the change in accumulated other comprehensive losses relating to assets still held at December 31, 2012$1,059
$1,059
$
Fair Value Measurements – Disclosure Only

The carrying amounts and estimated fair values of our long-term debt, as well as the applicable fair value hierarchy tier, at September 30, 2012,tiers, are contained in the tabletables below. Our convertible senior notes are classified as Level 2 financial instruments. Fair value for these securities is determined using a market approach based on quoted prices for similar securities in active markets or quoted prices for identical securities in inactive markets. Borrowings under our credit facility and ourOur term loan areis classified as a Level 3 financial instruments,instrument, because certain inputs used to determine the fair value of these agreementsthis financial instrument are unobservable. The carrying value of the credit facility at September 30, 2012 approximates fair value because of the short period of time between the borrowing under the credit facility in 2012, and September 30, 2012. The carrying value of the term loan at September 30, 2012,March 31, 2013, approximates its fair value because there has been no significant change to our credit risk relating to this instrument from the term loan’s origination date in December 2011, to September 30, 2012.

   September 30, 2012 
   Carrying   Total             
   Value   Fair Value   Level 1   Level 2   Level 3 
   (In thousands) 

Convertible senior notes

  $173,940    $209,040    $—      $209,040    $—    

Credit facility

   40,000     40,000     —       —       40,000  

Term loan

   47,754     47,754     —       —       47,754  
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
  $261,694    $296,794    $—      $209,040    $87,754  
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
   December 31, 2011 
   Carrying   Total             
   Value   Fair Value   Level 1   Level 2   Level 3 
   (In thousands) 

Convertible senior notes

  $169,526    $192,049    $—      $192,049    $—    

Credit facility

   —       —       —       —       —    

Term loan

   48,600     48,600     —       —       48,600  
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
  $218,126    $240,649    $—      $192,049    $48,600  
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

through March 31, 2013. As described in Note 14, "Commitments and Contingencies," we recorded a financing obligation in connection with a lease entered into in February


16

Table of Contents

2013. The financing obligation at March 31, 2013, approximates its fair value because of the short period of time between the origination of the obligation in February 2013 and March 31, 2013. The Credit Facility was repaid and terminated effective February 15, 2013.
 March 31, 2013
 
Carrying
Value
 
Total
Fair Value
 Level 1 Level 2 Level 3
 (In thousands)
1.125% Notes$402,836
 $551,271
 $
 $551,271
 $
3.75% Notes177,024
 223,115
 
 223,115
 
Term loan47,179
 47,179
 
 
 47,179
Financing obligation16,133
 16,133
 
 
 16,133
 $643,172
 $837,698
 $
 $774,386
 $63,312
          
 December 31, 2012
 Carrying Total      
 Value Fair Value Level 1 Level 2 Level 3
 (In thousands)
3.75% Notes$175,468
 $208,460
 $
 $208,460
 $
Term loan47,471
 47,471
 
 
 47,471
Credit facility40,000
 40,000
 
 
 40,000
 $262,939
 $295,931
 $
 $208,460
 $87,471

6. Investments

The following tables summarize our investments as of the dates indicated:

   September 30, 2012 
   Amortized   Gross
Unrealized
   Estimated
Fair
 
   Cost   Gains   Losses   Value 
   (In thousands) 

Corporate debt securities

  $208,217    $688    $43    $208,862  

GSEs

   33,015     55     4     33,066  

Municipal securities

   73,750     232     83     73,899  

U.S. treasury notes

   33,640     51     —       33,691  

Certificates of deposit

   7,377     —       —       7,377  

Auction rate securities

   14,950     —       1,427     13,523  
  

 

 

   

 

 

   

 

 

   

 

 

 
  $370,949    $1,026    $1,557    $370,418  
  

 

 

   

 

 

   

 

 

   

 

 

 
   December 31, 2011 
   Amortized   Gross
Unrealized
   Estimated
Fair
 
   Cost   Gains   Losses   Value 
   (In thousands) 

Corporate debt securities

  $231,407    $442    $215    $231,634  

GSEs

   33,912     46     9     33,949  

Municipal securities

   47,099     232     18     47,313  

U.S. treasury notes

   21,627     121     —       21,748  

Certificates of deposit

   2,272     —       —       2,272  

Auction rate securities

   19,000     —       2,866     16,134  
  

 

 

   

 

 

   

 

 

   

 

 

 
  $355,317    $841    $3,108    $353,050  
  

 

 

   

 

 

   

 

 

   

 

 

 


17

Table of Contents

 March 31, 2013
 Amortized 
Gross
Unrealized
 
Estimated
Fair
 Cost Gains Losses Value
 (In thousands)
Corporate debt securities$198,265
 $441
 $139
 $198,567
Government-sponsored enterprise securities (GSEs)27,372
 27
 
 27,399
Municipal securities75,216
 348
 153
 75,411
U.S. treasury notes31,894
 44
 
 31,938
Certificates of deposit8,617
 14
 
 8,631
Subtotal - current investments341,364
 874
 292
 341,946
Auction rate securities14,500
 
 900
 13,600
 $355,864
 $874
 $1,192
 $355,546
        
 December 31, 2012
 Amortized 
Gross
Unrealized
 
Estimated
Fair
 Cost Gains Losses Value
 (In thousands)
Corporate debt securities$190,545
 $528
 $65
 $191,008
GSEs29,481
 45
 1
 29,525
Municipal securities75,909
 185
 246
 75,848
U.S. treasury notes35,700
 42
 2
 35,740
Certificates of deposit10,715
 9
 
 10,724
Subtotal - current investments342,350
 809
 314
 342,845
Auction rate securities14,650
 
 1,231
 13,419
 $357,000
 $809
 $1,545
 $356,264
The contractual maturities of our investments as of September 30, 2012March 31, 2013 are summarized below:

       Estimated 
   Cost   Fair Value 
   (In thousands) 

Due in one year or less

  $210,489    $210,828  

Due one year through five years

   145,510     146,067  

Due after ten years

   14,950     13,523  
  

 

 

   

 

 

 
  $370,949    $370,418  
  

 

 

   

 

 

 

 Cost 
Estimated
Fair Value
 (In thousands)
Due in one year or less$173,871
 $174,145
Due one year through five years167,493
 167,801
Due after ten years14,500
 13,600
 $355,864
 $355,546
Gross realized gains and gross realized losses from sales of available-for-sale securities are calculated under the specific identification method and are included in investment income. Total proceeds from sales and maturities of available-for-sale securities were $76.8 million and $105.0 million for the three months ended September 30, 2012, and 2011, respectively. Total proceeds from sales and maturities of available-for-sale securities were $213.7 million and $226.4 million for the nine months ended September 30, 2012, and 2011, respectively. Net realized investment gains for the three months ended September 30, 2012,March 31, 2013, and 20112012 were $12,000$94,000 and $153,000$64,000 respectively. Net realized investment gains for the nine months ended September 30, 2012, and 2011 were $250,000 and $331,000 respectively.

We monitor our investments for other-than-temporary impairment. For investments other than our auction rate securities, discussed below, we have determined that unrealized gains and losses at September 30, 2012,March 31, 2013, and December 31, 2011,2012, are temporary in nature, because the change in market value for these securities has resulted from fluctuating interest rates, rather than a deterioration of the credit worthiness of the issuers. So long as we hold these securities to maturity, we are unlikely to experience gains or losses. In the event that we dispose of these securities before maturity, we expect that realized gains or losses, if any, will be immaterial.



18

Table of Contents

The following tables segregate those available-for-sale investments that have been in a continuous loss position for less than 12 months, and those that have been in a loss position for 12 months or more as of March 31, 2013.
 
In a Continuous Loss Position
for Less than 12 Months
 
In a Continuous Loss Position
for 12 Months or More
 
Estimated
Fair
Value
 
Unrealized
Losses
 
Total
Number of
Securities
 
Estimated
Fair
Value
 
Unrealized
Losses
 
Total
Number of
Securities
 (Dollars in thousands)
Corporate debt securities$52,264
 $139
 28
 $
 $
 
Municipal securities21,440
 153
 37
 
 
 
Auction rate securities
 
 
 13,600
 900
 19
 $73,704
 $292
 65
 $13,600
 $900
 19
The following table segregates those available-for-sale investments that have been in a continuous loss position for less than 12 months, and those that have been in a loss position for 12 months or more as of December 31, 2012.
 
In a Continuous Loss Position
for Less than 12 Months
 
In a Continuous Loss Position
for 12 Months or More
 
Estimated
Fair
Value
 
Unrealized
Losses
 
Total
Number of
Securities
 
Estimated
Fair
Value
 
Unrealized
Losses
 
Total
Number of
Securities
 (Dollars in thousands)
Corporate debt securities$44,457
 $65
 23
 $
 $
 
Municipal securities35,223
 246
 43
 
 
 
GSEs5,004
 1
 1
 
 
 
U.S. treasury notes4,511
 2
 5
 
 
 
Auction rate securities
 
 
 13,419
 1,231
 21
 $89,195
 $314
 72
 $13,419
 $1,231
 21
Auction Rate Securities

Due to events in the credit markets, the auction rate securities held by us experienced failed auctions beginning in the first quarter of 2008, and such auctions have not resumed. Therefore, quoted prices in active markets have not been available since early 2008. Our investments in auction rate securities are collateralized by student loan portfolios guaranteed by the U.S. government, and the range of maturities for such securities is from 18 years to 3534 years. Considering the relative insignificance of these securities when compared with our liquid assets and other sources of liquidity, we have no current intention of selling these securities nor do we expect to be required to sell these securities before a recovery in their cost basis. For this reason, and because the decline in the fair value of the auction securities was not due to the credit quality of the issuers, we do not consider the auction rate securities to be other-than-temporarily impaired at September 30, 2012.March 31, 2013. At the time of the first failed auctions during first quarter 2008, we held a total of $82.1$82.1 million in auction rate securities at par value; since that time, we have settled $67.1$67.6 million of these instruments at par value.

For the ninethree months ended September 30, 2012,March 31, 2013, and 2011,2012, we recorded pretax unrealized gains of $1.4$0.3 million and $0.9$0.1 million, respectively, to accumulated other comprehensive income for the changes in their fair value. Any future fluctuation in fair value related to these instruments that we deem to be temporary, including any recoveries of previous write-downs, would be recorded to accumulated other comprehensive income. If we determine that any future valuation adjustment was other-than-temporary, we would record a charge to earnings as appropriate.

The following tables segregate those available-for-sale investments that have been in a continuous loss position for less than 12 months, and those that have been in a loss position for 12 months or more as

7. Receivables

19

Table of September 30, 2012.

   In a Continuous Loss Position
for Less than 12 Months
   In a Continuous Loss Position
for 12 Months or More
 
   Estimated
Fair
Value
   Unrealized
Losses
   Total
Number of
Securities
   Estimated
Fair
Value
   Unrealized
Losses
   Total
Number of
Securities
 
   (Dollars in thousands) 

Corporate debt securities

  $23,103    $43     15    $—      $—       —    

GSEs

   8,602     4     3     —       —       —    

Municipal securities

   15,077     81     30     3,693     2     2  

Auction rate securities

   —       —       —       13,523     1,427     22  

U.S. treasury notes

   —       —       —       —       —       —    
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total temporarily impaired securities

  $46,782    $128     48    $17,216    $1,429     24  
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

The following table segregates those available-for-sale investments that have been in a continuous loss position for less than 12 months, and those that have been in a loss position for 12 months or more as of December 31, 2011.

   In a Continuous Loss Position
for Less than 12 Months
   In a Continuous Loss Position
for 12 Months or More
 
   Estimated
Fair
Value
   Unrealized
Losses
   Total
Number of
Securities
   Estimated
Fair
Value
   Unrealized
Losses
   Total
Number of
Securities
 
   (Dollars in thousands) 

Corporate debt securities

  $72,766    $215     47    $—      $—       —    

GSEs

   11,493     9     9     —       —       —    

Municipal securities

   12,033     18     8     —       —       —    

Auction rate securities

   —       —       —       16,134     2,866     27  

U.S. treasury notes

   —       —       —       —       —       —    
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total temporarily impaired securities

  $96,292    $242     64    $16,134    $2,866     27  
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Contents


7. Receivables

Health Plans segment receivables consist primarily of amounts due from the various states in which we operate. Such receivables are subject to potential retroactive adjustment. Because all of our receivable amounts are readily determinable and our creditors are in almost all instances state governments, our allowance for doubtful accounts is immaterial. Any amounts determined to be uncollectible are charged to expense when such determination is made. Accounts receivable were as follows:

   September 30,
2012
   December 31,
2011
 
   (In thousands) 

Health Plans segment:

    

California

  $36,600    $22,175  

Michigan

   9,440     8,864  

Missouri

   1,240     27,092  

New Mexico

   7,908     9,350  

Ohio

   37,971     27,458  

Texas

   5,175     1,608  

Utah

   4,568     2,825  

Washington

   17,024     15,006  

Wisconsin

   2,661     4,909  

Others

   2,121     2,489  
  

 

 

   

 

 

 

Total Health Plans segment

   124,708     121,776  

Molina Medicaid Solutions segment

   32,201     46,122  
  

 

 

   

 

 

 
  $156,909    $167,898  
  

 

 

   

 

 

 

 March 31,
2013
 December 31,
2012
 (In thousands)
Health Plans segment:   
California$45,962
 $28,553
Florida1,468
 953
Michigan9,519
 12,873
New Mexico12,153
 9,059
Ohio33,041
 40,980
Texas8,100
 7,459
Utah4,790
 3,359
Washington13,160
 17,587
Wisconsin4,404
 4,098
Others1,145
 2,177
Total Health Plans segment133,742
 127,098
Molina Medicaid Solutions segment16,509
 22,584
 $150,251
 $149,682

8. Restricted Investments

Pursuant to the regulations governing our Health PlanPlans segment subsidiaries, we maintain statutory deposits and deposits required by state authorities in certificates of deposit and U.S. treasury securities. Additionally, weWe also maintain restricted investments as protection against the insolvency of certain capitated providers. Additionally, in connection with the Molina Medicaid Solutions segment contracts with the states of Maine and Idaho, we maintain restricted investments as collateral for letters of credit. The following table presents the balances of restricted investments.

   September 30,
2012
   December 31,
2011
 
   (In thousands) 

California

  $373    $372  

Florida

   5,733     5,198  

Insurance Company

   —       4,711  

Michigan

   1,000     1,000  

Missouri

   500     504  

New Mexico

   15,911     15,905  

Ohio

   9,079     9,078  

Texas

   3,506     3,518  

Utah

   2,979     2,895  

Washington

   151     151  

Other

   5,256     2,832  
  

 

 

   

 

 

 
  $44,488    $46,164  
  

 

 

   

 

 

 

investments:

 March 31,
2013
 December 31,
2012
 (In thousands)
California$373
 $373
Florida6,840
 5,738
Michigan1,014
 1,014
New Mexico15,917
 15,915
Ohio9,081
 9,082
Texas3,500
 3,503
Utah3,321
 3,126
Washington151
 151
Other4,619
 5,199
Total Health Plans segment44,816
 44,101
Molina Medicaid Solutions segment10,301
 
 $55,117
 $44,101

20

Table of Contents

The contractual maturities of our held-to-maturity restricted investments as of September 30, 2012March 31, 2013 are summarized below.

   Amortized
Cost
   Estimated
Fair Value
 
   (In thousands) 

Due in one year or less

  $44,177    $44,186  

Due one year through five years

   311     311  
  

 

 

   

 

 

 
  $44,488    $44,497  
  

 

 

   

 

 

 

 
Amortized
Cost
 
Estimated
Fair Value
 (In thousands)
Due in one year or less$51,617
 $51,622
Due one year through five years3,500
 3,501
 $55,117
 $55,123

9. Medical Claims and Benefits Payable

The following table presents the components of the change in our medical claims and benefits payable as of and for the periods indicated. The amounts displayed for “Components of medical care costs related to: Prior periods” represent the amount by which our original estimate of claims and benefits payable at the beginning of the period were (more) or less than the actual amount of the liability based on information (principally the payment of claims) developed since that liability was first reported.

   Nine Months
Ended
  Three Months
Ended
  Year Ended 
   September 30,
2012
  September 30,
2012
  Dec. 31, 2011 
   (Dollars in thousands) 

Balances at beginning of period

  $402,476   $525,538   $354,356  

Components of medical care costs related to:

    

Current period

   3,860,825    1,361,539    3,911,803  

Prior periods

   (37,689  (46,968  (51,809
  

 

 

  

 

 

  

 

 

 

Total medical care costs

   3,823,136    1,314,571    3,859,994  
  

 

 

  

 

 

  

 

 

 

Payments for medical care costs related to:

    

Current period

   3,332,896    875,236    3,516,994  

Prior periods

   356,253    428,410    294,880  
  

 

 

  

 

 

  

 

 

 

Total paid

   3,689,149    1,303,646    3,811,874  
  

 

 

  

 

 

  

 

 

 

Balances at end of period

  $536,463   $536,463   $402,476  
  

 

 

  

 

 

  

 

 

 

Benefit from prior period as a percentage of:

    

Balance at beginning of period

   9.4  8.9  14.6

Premium revenue

   0.9  3.2  1.1

Total medical care costs

   1.0  3.6  1.3

 Three Months Ended March 31,
 2013 2012
 (Dollars in thousands)
Balances at beginning of period$494,530
 $402,476
Components of medical care costs related to:   
Current period1,347,181
 1,167,580
Prior periods(58,427) (36,592)
Total medical care costs1,288,754
 1,130,988
Payments for medical care costs related to:   
Current period916,426
 750,994
Prior periods375,713
 326,637
Total paid1,292,139
 1,077,631
Balances at end of period$491,145
 $455,833
Benefit from prior period as a percentage of:   
Balance at beginning of period11.8% 9.1%
Premium revenue3.8% 2.8%
Total medical care costs4.5% 3.2%
Assuming that our initial estimate of claims incurred but not paid (IBNP) is accurate, we believe that amounts ultimately paid out would generally be between 8% and 10% less than the liability recorded at the end of the period as a result of the inclusion in that liability of the allowance for adverse claims development and the accrued cost of settling those claims. Because the amount of our initial liability is merely an estimate (and therefore not perfectly accurate), we will always experience variability in that estimate as new information becomes available with the passage of time. Therefore, there can be no assurance that amounts ultimately paid out will not be higher or lower than this 8% to 10% range. For example, for the three months ended March 31, 2012, the amounts ultimately paid out were less than the amount of the reserves we had established as of December 31, 2011 by9.1%. Furthermore, because our initial estimate of IBNP is derived from many factors, some of which are qualitative in nature rather than quantitative, we are seldom able to assign specific values to the reasons for a change in estimate - we only know when the circumstances for any one or more factors are out of the ordinary.
As indicated above, the amounts ultimately paid out on our liabilities in fiscal years2013 and 2012were less than what we had expected when we had established our reserves. While many related factors working in conjunction with one another determine the accuracy of our estimates, we are seldom able to quantify the impact that any single factor has on a change in estimate. In addition, given the variability inherent in the reserving process, we will only be able to identify specific factors if they represent a significant departure from expectations. As a result, we do not expect to be able to fully quantify the impact of individual factors on changes in estimates.

21

Table of Contents

We recognized favorable prior period claims development in the amount of $37.7$58.4 million for the ninethree months ended September 30, 2012.March 31, 2013. This amount represents our estimate, as of September 30,March 31, 2013, of the extent to which our initial estimate of medical claims and benefits payable at December 31, 2012 was more than the amount that will ultimately be paid out in satisfaction of that liability. We believe the overestimation of our claims liability at December 31, 2012 was due primarily to the following factors:
At our Texas health plan, we saw a reduction in STAR+PLUS (the state’s program for aged and disabled members) membership during mid to late 2012. This caused a reduction in costs per member that we did not fully recognize in our December 31, 2012 reserve estimates.
At our Washington health plan, prior to July 2012, certain high-cost newborns that were approved for SSI coverage by the state were retroactively dis-enrolled from our Healthy Options (TANF) coverage, and the health plan was reimbursed for the claims paid on behalf of these members. Starting July 1, 2012, these newborns, as well as other high-cost disabled members, are now covered by the health plan under the Health Options Blind and Disabled (HOBD) program. At the end of 2012, we did not have enough claims history to accurately estimate the claims liability of the HOBD members, and as a result the liability for these high-cost members was overstated.
For our New Mexico health plan, we overestimated the impact of certain high-dollar outstanding claim payments as of December 31, 2012.
We recognized favorable prior period claims development in the amount of $36.6 million for the three months ended March 31, 2012. This amount represents our estimate as of March 31, 2012, of the extent to which our initial estimate of medical claims and benefits payable at December 31, 2011 was more than the amount that will ultimately be paid out in satisfaction of that liability. TheWe believe the overestimation of our claims liability at December 31, 2011 was due primarily to the following factors:

For

At our Washington health plan, we underestimated the amount of recoveries we would collect for certain high-cost newborn claims, resulting in an overestimation of reserves at year end.

For

At our Texas health plan, we overestimated the cost of new members in STAR+PLUS (the name of our ABD program in Texas), in the Dallas region.

In early 2011, the state of Michigan was delayed in the enrollment of newborns in managed care plans; the delay was resolved by mid-2011. This caused a large number of claims with older dates of service to be paid during late 2011, resulting in an artificial increase in the lag time for claims payment at our Michigan health plan. We adjusted reserves downward for this issue at December 31, 2011, but the adjustment did not capture all of the claims overestimation.

Offsetting some

The overestimation of the overestimation items described above,our liability for medical claims and benefits payable was partially offset by an underestimation of that liability at our Missouri health plan, reserves were underestimated as a result of the costs associated with an unusually large number of premature infants during the fourth quarter of 2011.

We recognized favorable prior period claims development in the amount of $47.0 million for the three months ended September 30, 2012. This amount represents our estimate as of September 30, 2012 of the extent to which our initial estimate of medical claims and benefits payable at June 30, 2012 was more than the amount that will ultimately be paid out in satisfaction of that liability. The overestimation of claims liability at June 30, 2012 was due primarily to the following factors:

For our Texas health plan, we had only four months of paid claims data for the expansion regions that were added March 1, 2012. As a result, we overestimated the medical costs for those regions.

Our contract with the state of Missouri expired without renewal on June 30, 2012; however we continue to be liable for services rendered to members who were admitted to the hospital on or before June 30, 2012, until the earlier of 90 days or their date of discharge. We overestimated the impact of 90 days of run-out claims for these members.

For our Washington health plan, we overpaid certain outpatient claims during 2011 and early 2012, disrupting our payment patterns and leading to an overstatement of our liability at June 30, 2012.

For our Michigan health plan, certain inpatient claims with an unusually long run-out were paid in late 2011 and early 2012, resulting in an artificial increase in the amount of time we typically apply for claims payments when estimating the reserve. In the process of developing the reserves as of June 30, 2012, an adjustment was applied to offset these late claim payments, but the adjustment did not completely remove the effect. As a result, reserves were overstated as of June 30, 2012.

We recognized favorable prior period claims development in the amount of $49.5 million and $51.8 million for the nine months ended September 30, 2011, and the year ended December 31, 2011, respectively. This was primarily caused by the overestimation of our liability for claims and medical benefits payable at December 31, 2010, as a result of the following factors:

We overestimated the impact of a buildup in claims inventory in Ohio.

We overestimated the impact of the settlement of disputed provider claims in California.

We underestimated the reduction in outpatient facility claims costs as a result of a fee schedule reduction in New Mexico effective November 2010.

In estimating our claims liability at September 30, 2012,March 31, 2013, we adjusted our base calculation to take account of the following factors which we believe are reasonably likely to change our final claims liability amount:

Our

In our Texas health plan, although the reduction in STAR+PLUS membership nearly doubled effectivehas leveled off in 2013, we have seen a reduction in per member per month (PMPM) cost for outpatient services and an increase in PMPM costs for inpatient services over the past six to nine months. We have estimated the impact of these shifts in cost in our March 1, 2012. In addition, effective March 1, 2012, we assumed inpatient medical liability for ABD members for which we were not previously responsible. Reserves for new coverage and new regions are now based on the newly developing claims lag patterns and comparisons with similar coverage in other regions with more historical data. The lag patterns are still incomplete and therefore the true reserve liability is more uncertain than usual.

31, 2013 liability.

Our CaliforniaWisconsin health plan has enrolledis experiencing significant membership increases, and is expected to approximately 20,000 new ABD members since September 30, 2011, as a result of the mandatory assignment of ABD members to managed care plans effective July 1, 2011. These new members converted from a fee-for-service environment. Due to the relatively recent transition of these members to managed care, their utilization of medical services is less predictable than it is for many of our other members.

Our claims inventory had increased significantlydouble in size during the first quarterfour months of 2013. This new membership is transitioning to our health plan from a terminated health plan. We enrolled approximately40,000new members in February and March 2013.We have computed a separate reserve analysis for these members and have noted that paid claims are less than what we would expect for newly transitioned members. Therefore, we have increased the reserves for this membership, in anticipation of higher claims costs later than usual for these members.

Our Washington health plan began covering disabled members, including newborns, that were previously covered by the state under a separate state program. Coverage for this segment began in July of 2012, followed by a significant reductionwith gradual growth in claims inventory inmembership. As of March 2013 the second quarterhealth plan covered approximately28,000members under this program. Because of 2012the high costs for these members and a slight drop in the third quarter. Changes in claims inventory can impact historical claims lag patterns.

relative newness of the product category, there is still some uncertainty about the cost and reserve liability for these members as of March 31, 2013.


22

Table of Contents

The use of a consistent methodology in estimating our liability for claims and medical benefits payable minimizes the degree to which the under- or overestimation of that liability at the close of one period may affect consolidated results of operations in subsequent periods. In particular, the use of a consistent methodology should result in the replenishment of reserves during any given period in a manner that generally offsets the benefit of favorable prior period development in that period. Facts and circumstances unique to the estimation process at any single date, however, may still lead to a material impact on consolidated results of operations in subsequent periods. Any absence of adverse claims development (as well as the expensing through general and administrative expense of the costs to settle claims held at the start of the period) will lead to the recognition of a benefit from prior period claims development in the period subsequent to the date of the original estimate. In 20112012 and for the ninethree months ended September 30, 2012,March 31, 2013, the absence of adverse development of the liability for claims and medical benefits payable at the close of the previous period resulted in the recognition of substantial favorable prior period development. In both years, however, the recognition of a benefit from prior period claims development did not have a material impact on our consolidated results of operations because the amountreplenishment of benefit recognized in each year was roughly consistent with that recognizedreserves in the previous year.

respective periods generally offset the benefit from the prior period.

10. Long-Term Debt

Credit Facility

On September 9, 2011, we entered into a credit agreement for a $170 million revolving credit facility (the “Credit Facility”) with various lenders and U.S. Bank National Association, as LC Issuer, Swing Line Lender, and Administrative Agent. The Credit Facility is used for general corporate purposes.

The Credit Facility has a term of five years under which all amounts outstanding will be due and payable on September 9, 2016. Subject to obtaining commitments from existing or new lenders and satisfaction of other specified conditions, we may increase the Credit Facility to up to $195 million.

As of September 30, 2012 there was $40.0March 31, 2013, maturities of long-term debt for the years ending December 31 are as follows (in thousands):
 Total 2013 2014 2015 2016 2017 Thereafter
1.125% Notes$550,000
 $
 $
 $
 $
 $
 $550,000
3.75% Notes187,000
 
 187,000
 
 
 
 
Term loan47,179
 863
 1,206
 1,259
 1,309
 1,372
 41,170
 $784,179
 $863
 $188,206
 $1,259
 $1,309
 $1,372
 $591,170

1.125% Cash Convertible Senior Notes due 2020

On February 15, 2013, we settled the issuance of $550.0 million outstanding under the Credit Facility. Additionally, as of September 30, 2012, our lenders had issued two letters of credit in the aggregate principal amount of $10.31.125% Cash Convertible Senior Notes due 2020 (the 1.125% Notes). This transaction included the initial issuance of $450.0 million on February 11, 2013, plus the exercise of the full amount of the $100.0 million over-allotment option on February 13, 2013. The aggregate net proceeds of the 1.125% Notes were $458.9 million, after payment of the net cost of the Call Spread Overlay described below and in Note 11, “Derivative Financial Instruments,” and transaction costs. Additionally, we used $50.0 million of the net proceeds to purchase shares of our common stock (see Note 12, “Stockholders' Equity”), and $40.0 million to repay the principal owed under our Credit Facility.
Interest on the 1.125% Notes is payable semiannually in arrears on January 15 and July 15 of each year, at a rate of 1.125% per annum commencing on July 15, 2013. The 1.125% Notes will mature on January 15, 2020 unless repurchased or converted in accordance with their terms prior to such date.
The 1.125% Notes are convertible only into cash, and not into shares of our common stock or any other securities. Holders may convert their 1.125% Notes solely into cash at their option at any time prior to the close of business on the business day immediately preceding July 15, 2019 only under the following circumstances: (1) during any calendar quarter commencing after the calendar quarter ending on June 30, 2013 (and only during such calendar quarter), if the last reported sale price of the common stock for at least 20 trading days (whether or not consecutive) during a period of 30 consecutive trading days ending on the last trading day of the immediately preceding calendar quarter is greater than or equal to 130% of the conversion price on each applicable trading day; (2) during the five business day period immediately after any five consecutive trading day period in which the trading price per $1,000 principal amount of 1.125% Notes for each trading day of the measurement period was less than 98% of the product of the last reported sale price of our common stock and the conversion rate on each such trading day; or (3) upon the occurrence of specified corporate events. On or after July 15, 2019 until the close of business on the second scheduled trading day immediately preceding the maturity date, holders may convert their 1.125% Notes solely into cash at any time, regardless of the foregoing circumstances. Upon conversion, in lieu of receiving shares of our common stock, a holder will receive an amount in cash, per $1,000 principal amount of 1.125% Notes, equal to the settlement amount, determined in the manner set forth in the Indenture.
The initial conversion rate will be 24.5277 shares of our common stock per $1,000 principal amount of 1.125% Notes (equivalent to an initial conversion price of approximately $40.77 per share of common stock). The conversion rate will be subject to adjustment in some events but will not be adjusted for any accrued and unpaid interest. In addition, following certain corporate events that occur prior to the maturity date, we will pay a cash make-whole premium by increasing the conversion

23

Table of Contents

rate for a holder who elects to convert its 1.125% Notes in connection with such a corporate event in certain circumstances. We may not redeem the 1.125% Notes prior to the maturity date, and no sinking fund is provided for the 1.125% Notes.
If we undergo a fundamental change (as defined in the indenture to the 1.125% Notes), holders may require us to repurchase for cash all or part of their 1.125% Notes at a repurchase price equal to 100% of the principal amount of the 1.125% Notes to be repurchased, plus accrued and unpaid interest to, but excluding, the fundamental change repurchase date. The indenture provides for customary events of default, including cross acceleration to certain other indebtedness of ours, and our significant subsidiaries.
The 1.125% Notes are senior unsecured obligations, and rank senior in right of payment to any of our indebtedness that is expressly subordinated in right of payment to the 1.125% Notes; equal in right of payment to any of our unsecured indebtedness that is not so subordinated; effectively junior in right of payment to any of our secured indebtedness to the extent of the value of the assets securing such indebtedness; and structurally junior to all indebtedness and other liabilities (including trade payables) of our subsidiaries.

The 1.125% Notes contain an embedded cash conversion option. We have determined that the embedded cash conversion option is a derivative financial instrument, required to be separated from the 1.125% Notes and accounted for separately as a derivative liability, with changes in fair value reported in our consolidated statements of income until the cash conversion option transaction settles or expires. The initial fair value liability of the embedded cash conversion option was $149.3 million, which simultaneously reduced the carrying value of the 1.125% Notes (effectively an original issuance discount). For further discussion of the derivative financial instruments relating to the 1.125% Notes, refer to Note 11, “Derivative Financial Instruments.”

As noted above, the reduced carrying value on the 1.125% Notes resulted in a debt discount that is amortized to the 1.125% Notes' principal amount through the recognition of non-cash interest expense over the expected life of the debt. This has resulted in our recognition of interest expense on the 1.125% Notes at an effective rate approximating what we would have incurred had nonconvertible debt with otherwise similar terms had been issued. The effective interest rate of the 1.125% Notes is 5.9%, which is imputed based on the amortization of the fair value of the embedded cash conversion option over the remaining term of the 1.125% Notes. As of March 31, 2013, we expect the 1.125% Notes to be outstanding until their January 15, 2020 maturity date, for a remaining amortization period of 6.8 years. The 1.125% Notes' if-converted value did not exceed their principal amount as of March 31, 2013.

Also in connection with the Molina Medicaid Solutions contractssettlement of the 1.125% Notes, we paid approximately $16.9 million in transaction costs. Such costs have been allocated to the 1.125% Notes, the 1.125% Call Option (defined below) and the 1.125% Warrants (defined below) according to their relative fair values. The amount allocated to the 1.125% Notes, or $12.0 million, was capitalized and will be amortized over the term of the 1.125% Notes. The aggregate amount allocated to the 1.125% Call Option and 1.125% Warrants, or $4.9 million, was recorded to interest expense in the quarter ended March 31, 2013.

1.125% Notes Call Spread Overlay

Concurrent with the statesissuance of Mainethe 1.125% Notes, we entered into privately negotiated hedge transactions (collectively, the 1.125% Call Option) and Idaho, which reduceswarrant transactions (collectively, the amount available1.125% Warrants), with certain of the initial purchasers of the 1.125% Notes. These transactions represent a Call Spread Overlay, whereby the cost of the 1.125% Call Option we purchased to cover the cash outlay upon conversion of the 1.125% Notes was reduced by the sales price of the 1.125% Warrants. Assuming full performance by the counterparties (and 1.125% Warrants strike prices in excess of the conversion price of the 1.125% Notes), these transactions are intended to offset cash payments due upon any conversion of the 1.125% Notes. We used $149.3 million of the proceeds from the settlement of the 1.125% Notes to pay for the 1.125% Call Option, and simultaneously received $75.1 million for the sale of the 1.125% Warrants, for a net cash outlay of $74.2 million for the Call Spread Overlay. The 1.125% Call Option and the 1.125% Warrants are derivative financial instruments; refer to Note 11, “Derivative Financial Instruments” for further discussion.

Aside from the initial payment of a premium to the counterparties of $149.3 million for the 1.125% Call Option, we will not be required to make any cash payments to the counterparties under the Credit Facility.

Borrowings under1.125% Call Option, and will be entitled to receive from the Credit Facility bear interest based, at our election, on the base rate pluscounterparties an applicable margin or the Eurodollar rate. The base rate is, for any day, a rateamount of interest per annumcash, generally equal to the highestamount by which the market price per share of (i)common stock exceeds the prime rate of interest announced from time to time by U.S. Bank or its parent, (ii) the sumstrike price of the federal funds rate for such day plus 0.50% per annum and (iii)1.125% Call Options during the Eurodollar rate (without giving effectrelevant valuation period. The strike price under the 1.125% Call Option is initially equal to the applicable margin) for a one month interestconversion price of the 1.125% Notes. Additionally, if the market value per share of our common stock exceeds the strike price of the 1.125% Warrants on any trading day during the 160 trading day measurement period on such day (or if such day is not a business day, the immediately preceding business day) plus 1.00%. The Eurodollar rate is a reserve adjusted rate at which Eurodollar deposits are offered in the interbank Eurodollar market plus an applicable margin. The applicable margins range between 0.75% to 1.75% for base rate loans and 1.75% to 2.75% for Eurodollar loans, in each case, based upon our leverage ratio. In addition to interest payable on the principal amount of indebtedness outstanding from time to time under the Credit Facility,1.125% Warrants, we are requiredwill be obligated to payissue to the counterparties a quarterly commitment feenumber of 0.25%shares equal in value to 0.50% (based upon our leverage ratio)the product of the unused amount by which such market value exceeds such strike price and 1/160th of the lenders’ commitments under the Credit Facility.

Our obligations under the Credit Facility are secured by a lien on substantially allaggregate number of shares of our assets,common


24

Table of Contents

stock underlying the 1.125% Warrants transactions and the additional 1.125% Warrants transactions, subject to a share delivery cap. We will not receive any additional proceeds if the 1.125% Warrants are exercised. Pursuant to the 1.125% Warrants transactions, we issued 13,490,236 warrants with strike price of $53.8475 per share. The number of warrants and the exception ofstrike price are subject to adjustment under certain of our real estate assets, and by a pledge of the capital stock or membership interests of our operating subsidiaries and health plans (with the exception of the California health plan).

The Credit Facility includes usual and customary covenants for credit facilities of this type, including covenants limiting liens, mergers, asset sales, other fundamental changes, debt, acquisitions, dividends and other distributions, capital expenditures, and investments. The Credit Facility also requires us to maintain as of the end of any fiscal quarter (calculated for each four consecutive fiscal quarter period) a ratio of total consolidated debt to total consolidated EBITDA, as defined in the Credit Facility, of not more than 2.75 to 1.00, and a fixed charge coverage ratio of not less than 1.75 to 1.00. At September 30, 2012, we were in compliance with all financial covenants under the Credit Facility.

In the event of a default, including cross-defaults relating to specified other debt in excess of $20.0 million, the lenders may terminate the commitments under the Credit Facility and declare the amounts outstanding, including all accrued interest and unpaid fees, payable immediately. In addition, the lenders may enforce any and all rights and remedies created under the Credit Facility or applicable law.

circumstances.


3.75% Convertible Senior Notes due 2014
We had

As$187.0 million of September 30, 2012, $187.0 million in aggregate principal amount of our 3.75% Convertible Senior Notes due 2014 (the “Notes”) remain outstanding.3.75% Notes) outstanding as of March 31, 2013 and December 31, 2012, respectively. The 3.75% Notes rank equally in right of payment with our existing and future senior indebtedness. The 3.75% Notes are convertible into cash and, under certain circumstances, shares of our common stock. The initial conversion rate is 31.9601 shares of our common stock per one thousand dollar principal amount of the 3.75% Notes. This represents aan initial conversion price of approximately $31.29$31.29 per share of our common stock. In addition, if certain corporate transactions that constitute a change of control occur prior to maturity, we will increase the conversion rate in certain circumstances.

The

Because the 3.75% Notes have cash settlement features, accounting guidance required us to allocate the proceeds from thetheir issuance of the Notes have been allocated between a liability component and an equity component. WeThe reduced carrying value on the 3.75% Notes resulted in a debt discount that is amortized back to the 3.75% Notes' principal amount through the recognition of non-cash interest expense over the expected life of the debt. This has resulted in our recognition of interest expense on the 3.75% Notes at an effective rate approximating what we would have determined that theincurred had nonconvertible debt with otherwise similar terms had been issued. The effective interest rate of the 3.75% Notes is 7.5%, principally based on the seven-yearseven-year U.S. treasuryTreasury note rate as of the October 2007 issuance date, plus an appropriate credit spread. The resulting debt discount is being amortized over the period the Notes are expected to be outstanding, as additional non-cash interest expense. As of September 30, 2012,March 31, 2013, we expect the 3.75% Notes to be outstanding until their October 1, 2014 maturity date, for a remaining amortization period of 24 months.18 months. The 3.75% Notes’ if-converted value did not exceed their principal amount as of September 30, 2012.March 31, 2013. At September 30, 2012,March 31, 2013, the equity component of the 3.75% Notes, net of the impact of deferred taxes, was $24.0 million. $24.0 million.

The following table provides the detailsprincipal amounts, unamortized discount and net carrying amounts of the liability amounts recorded:

   As of  As of 
   September 30,  December 31, 
   2012  2011 
   (In thousands) 

Details of the liability component:

   

Principal amount

  $187,000   $187,000  

Unamortized discount

   (13,060  (17,474
  

 

 

  

 

 

 

Net carrying amount

  $173,940   $169,526  
  

 

 

  

 

 

 

   Three Months Ended
September 30,
   Nine Months Ended
September 30,
 
   2012   2011   2012   2011 
   (in thousands) 

Interest cost recognized for the period relating to the:

        

Contractual interest coupon rate of 3.75%

  $1,753    $1,753    $5,259    $5,259  

Amortization of the discount on the liability component

   1,499     1,384     4,414     4,095  
  

 

 

   

 

 

   

 

 

   

 

 

 

Total interest cost recognized

  $3,252    $3,137    $9,673    $9,354  
  

 

 

   

 

 

   

 

 

   

 

 

 

1.125% Notes and 3.75% Notes were as follows:

 Principal Balance Unamortized Discount Net Carrying Amount
 (In thousands)
March 31, 2013:     
1.125% Notes$550,000
 $147,164
 $402,836
3.75% Notes187,000
 9,976
 177,024
 $737,000
 $157,140
 $579,860
December 31, 2012:     
3.75% Notes$187,000
 $11,532
 $175,468
 Three Months Ended March 31,
 2013 2012
 (in thousands)
Interest cost recognized for the period relating to the:   
Contractual interest coupon rate$2,527
 $1,753
Amortization of the discount on the liability component3,723
 1,443
Total interest cost recognized$6,250
 $3,196
Term Loan

On

In December 7, 2011, our wholly owned subsidiary, Molina Center LLC, entered into a Term Loan Agreement with various lenders and East West Bank, as Administrative Agent (the “Administrative Agent”). PursuantAdministrative Agent) to the terms of the Term Loan Agreement, Molina Center LLC borrowed the aggregate principal amount of $48.6borrow $48.6 million to finance a portion of the $81.0 million purchase price for the acquisition of the approximately 460,000 square foot office building, or Molina Center, located in Long Beach, California.

The outstanding principal amount under the Term Loan Agreement bears interest at the Eurodollar rate for each Interest Period (as defined below) commencing January 1, 2012.. The Eurodollar rate is a per annum rate of interest equal to the greater of (a) the rate that is published in the Wall Street Journal as the London interbank offered rate for deposits in United States dollars, for a period of one month,

25


two business days prior to the commencement of an Interest Period, multiplied by a statutory reserve rate established by the Board of Governors of the Federal Reserve System, or (b) 4.25%. “Interest Period”Interest Period means the period commencing on the first day of each calendar month and ending on the last day of sucheach calendar month. The loan matures on November 30, 2018, and is subject to a 25-year25-year amortization schedule that commenced on January 1, 2012.

The Term Loan Agreement contains customary representations, warranties, and financial covenants. In the event of a default as described in the Term Loan Agreement, the outstanding principal amount under the Term Loan Agreement will bear interest at a rate 5.00% per annum higher than the otherwise applicable rate. All amounts due under the Term Loan Agreement and related loan documents are secured by a security interest in the Molina Center in favor of and for the benefit of the Administrative Agent and the other lenders under the Term Loan Agreement.

Credit Facility
On February 15, 2013, we used approximately $40.0 million of the net proceeds from the offering of the 1.125% Notes to repay all of the outstanding indebtedness under our $170 million revolving Credit Facility, with various lenders and U.S. Bank National Association, as Line of Credit Issuer, Swing Line Lender, and Administrative Agent. As of December 31, 2012, there was $40.0 million outstanding under the Credit Facility.
We terminated the Credit Facility in connection with the closing of the offering and sale of the 1.125% Notes. Two letters of credit in the aggregate principal amount of $10.3 million that reduced the amount available for borrowing under the Credit Facility as of December 31, 2012, were transferred to direct issue letters of credit with another financial institution.
11. Derivative Financial Instruments
The following table summarizes the fair values and the presentation of our derivative financial instruments (defined and discussed individually below) in the consolidated balance sheets:
 Balance Sheet Location March 31, 2013
   (In thousands)
Derivative asset:   
1.125% Call OptionNon-current assets: Derivative asset $147,385
 
 

Derivative liabilities:   
Embedded cash conversion optionNon-current liabilities: Derivative liabilities $147,309
1.125% WarrantsNon-current liabilities: Derivative liabilities 75,074
Interest rate swapNon-current liabilities: Derivative liabilities 1,264
   $223,647
Our derivative financial instruments do not qualify for hedge treatment, therefore the change in fair value of these instruments is recognized immediately in our consolidated statements of income, in “Other income (expense).” The following table summarizes the gain (loss) recorded in the period presented (as of March 31, 2012, we did not hold any derivative financial instruments):
 Three Months Ended March 31, 2013
 (In thousands)
Derivative gains (losses): 
1.125% Call Option$(1,946)
Embedded cash conversion option2,022
Interest rate swap43
 $119

1.125% Notes Call Spread Overlay
We entered into the 1.125% Call Option and the 1.125% Warrants transactions with certain of the initial purchasers of the 1.125% Notes (the Option Counterparties). These transactions represent a Call Spread Overlay, whereby the cost of the 1.125% Call Option we purchased to cover the cash outlay upon conversion of the debentures was reduced by the sales price of the 1.125% Warrants. Assuming full performance by the counterparties (and 1.125% Warrants strike prices in excess of the

26


conversion price of the 1.125% Notes), these transactions are intended to offset cash payments due upon any conversion of the 1.125% Notes. We used $149.3 million of the proceeds from the settlement of the 1.125% Notes to pay for the 1.125% Call Option, and simultaneously received $75.1 million for the sale of the 1.125% Warrants, for a net cash outlay of $74.2 million for the Call Spread Overlay.
Aside from the initial payment of a premium to the counterparties of $149.3 million for the 1.125% Call Option, we will not be required to make any cash payments to the counterparties under the 1.125% Call Option, and will be entitled to receive from the counterparties an amount of cash, generally equal to the amount by which the market price per share of common stock exceeds the strike price of the 1.125% Call Options during the relevant valuation period. The strike price under the 1.125% Call Option is initially equal to the conversion price of the 1.125% Notes. Additionally, if the market value per share of our common stock exceeds the strike price of the 1.125% Warrants on any trading day during the 160 trading day measurement period under the 1.125% Warrants, we will be obligated to issue to the counterparties a number of shares equal in value to the product of the amount by which such market value exceeds such strike price and 1/160th of the aggregate number of shares of our common stock underlying the 1.125% Warrants transactions and the additional 1.125% Warrants transactions, subject to a share delivery cap. We will not receive any additional proceeds if the 1.125% Warrants are exercised. Pursuant to the 1.125% Warrants transactions, we issued 13,490,236 warrants with strike price of $53.8475 per share. The number of warrants and the strike price are subject to adjustment under certain circumstances.
The 1.125% Call Option, which is indexed to our common stock, is a derivative asset that requires mark-to-market accounting treatment due to the cash settlement features until such transactions settle or expire. The 1.125% Call Option is measured and reported at fair value on a recurring basis, within Level 3 of the fair value hierarchy. For further discussion of the inputs used to determine the fair value of the 1.125% Call Option, refer to Note 5, “Fair Value Measurements.”
The 1.125% Warrants could separately have a dilutive effect to the extent that the market value per share of our common stock (as measured under the terms of the warrant transactions) exceeds the applicable strike price of the 1.125% Warrants. The 1.125% Warrants are recorded as a derivative liability requiring mark-to-market accounting treatment due to certain terms in the warrant agreements that prevent such instruments being considered to be indexed in our common stock. The 1.125% Warrants are measured and reported at fair value on a recurring basis, within Level 3 of the fair value hierarchy. For further discussion of the inputs used to determine the fair value of the 1.125% Warrants, refer to Note 5, “Fair Value Measurements.”
1.125% Notes Embedded Cash Conversion Option

The embedded cash conversion option within the 1.125% Notes is required to be separated from the 1.125% Notes and accounted for separately as a derivative liability, with changes in fair value reported in our consolidated statements of income until the cash conversion option settles or expires. The initial fair value liability of the embedded cash conversion option was $149.3 million, which simultaneously reduced the carrying value of the 1.125% Notes (effectively an original issuance discount). The embedded cash conversion option is measured and reported at fair value on a recurring basis, within Level 3 of the fair value hierarchy. For further discussion of the inputs used to determine the fair value of the embedded cash conversion option, refer to Note 5, “Fair Value Measurements.”
Interest Rate Swap

In May 2012, we entered into a $42.5$42.5 million notional amount interest rate swap agreement or Swap Agreement,(Swap), with an effective date of March 1, 2013. While not designated as a hedge instrument, the2013. The Swap Agreement is intended to reduce our exposure to fluctuations in the contractual variable interest rates under our Term Loan Agreement, and expires on the maturity date of the Term Loan Agreement, which is November 30, 2018.2018. Since its inception, the Swap has not been designated as a hedge. Under the Swap, Agreement beginning on March 1, 2013, we will receive a variable rate of the one-month LIBOR plus 3.25%, and pay a fixed rate of 5.34%. The Swap Agreement is measured and reported at fair value on a recurring basis, within Level 2 of the fair value hierarchy. Gains and losses relating to changes in its fair value are reported in earnings in the current period. For the three months and nine months ended September 30, 2012, we have recorded losses of $0.2 million and $1.3 million, respectively, to general and administrative expense. As of September 30, 2012, the fair value of the Swap Agreement is a liability of $1.3 million, recorded to other noncurrent liabilities. We do not use derivatives for trading or speculative purposes. We believe that we are not exposed to more than a nominal amount of credit risk relating to the Swap Agreement because the counterparty is an established and well-capitalized financial institution.


11.12. Stockholders’ Equity

Securities Repurchases and Repurchase Program. In connection with the issuance and settlement of the 1.125% Notes, we used a portion of the net proceeds from the offering to repurchase $50 million of our common stock in negotiated transactions with institutional investors in the offering, concurrently with the pricing of the offering. On February 12, 2013, we repurchased a total of 1,624,959 shares at $30.77 per share, which was our closing stock price on that date. As of March 31, 2013, additional paid-in capital decreased primarily due to this repurchase.

27

Table of Contents

Effective as of October 26, 2011,February 13, 2013, our board of directors authorized the repurchase of $75$75 million in aggregate of either our common stock or our convertible senior notes due 2014 (see Note 10, “Long-Term Debt”).the 3.75% Notes, in addition to the $50.0 million repurchase discussed above. The repurchase program expired October 25, 2012. Noextends through December 31, 2014.

Shelf Registration Statement.In May 2012, we filed an automatic shelf registration statement on Form S-3 with the Securities and Exchange Commission covering the issuance of an indeterminate number of our securities, were purchased under this program inincluding common stock, warrants, or debt securities. We may publicly offer securities from time to time at prices and terms to be determined at the nine months ended September 30, 2012.time of the offering.

Stock Plans. In connection with the plans described in Note 4 “Share-Based, “Stock-Based Compensation,” we issued approximately 755,000279,000 shares of common stock, net of shares used to settle employees’ income tax obligations, for the ninethree months ended September 30, 2012. Stock plan activity resulted in a $14.7 million increase to additional paid-in capital for the same period.March 31, 2013

12..

13. Segment Reporting

We report our financial performance based on two reportable segments: Health Plans and Molina Medicaid Solutions. Our reportable segments are consistent with how we manage the business and view the markets we serve. Our Health Plans segment consists of our state health plans which serve Medicaid populations in nine states (subsequent to the termination of our Medicaid contract in Missouri effective June 30, 2012), and also includes our smaller direct delivery line of business. Our state health plans represent operating segments that have been aggregated for reporting purposes because they share similar economic characteristics.

Our Molina Medicaid Solutions segment provides design, development, implementation; business processingprocess outsourcing solutions; hosting services; and information technology development and administrativesupport services to state Medicaid agencies in an additional five states.

agencies.

We rely on an internal management reporting process that provides segment information to the operating income level for purposes of making financial decisions and allocating resources. The accounting policies of the segments are the same as those described in Note 2, “Significant Accounting Policies.” The cost of services shared between the Health Plans and Molina Medicaid Solutions segments is charged to the Health Plans segment.

   Three Months Ended September 30,  Nine Months Ended September 30, 
   2012  2011  2012  2011 
   (In thousands)  (In thousands) 

Revenue:

     

Health Plans:

     

Premium revenue

  $1,488,718   $1,138,230   $4,308,439   $3,348,438  

Investment income

   1,171    764    3,996    3,804  

Rental income

   1,879    —      5,408    —    

Molina Medicaid Solutions:

     

Service revenue

   48,422    37,728    132,351    111,290  
  

 

 

  

 

 

  

 

 

  

 

 

 
  $1,540,190   $1,176,722   $4,450,194   $3,463,532  
  

 

 

  

 

 

  

 

 

  

 

 

 

Depreciation and amortization:

     

Health Plans

  $14,753   $12,207   $43,600   $34,915  

Molina Medicaid Solutions

   5,526    5,605    14,689    17,499  
  

 

 

  

 

 

  

 

 

  

 

 

 
  $20,279   $17,812   $58,289   $52,414  
  

 

 

  

 

 

  

 

 

  

 

 

 

Operating Income (Loss):

     

Health Plans

  $(969 $33,773   $(41,867 $100,273  

Molina Medicaid Solutions

   8,156    (207  23,207    (3,997
  

 

 

  

 

 

  

 

 

  

 

 

 

Total operating income (loss)

   7,187    33,566    (18,660  96,276  

Interest expense

   4,315    4,380    12,421    11,666  
  

 

 

  

 

 

  

 

 

  

 

 

 

Income (loss) before income taxes

  $2,872   $29,186   $(31,081 $84,610  
  

 

 

  

 

 

  

 

 

  

 

 

 

   September 30,   December 31, 
   2012   2011 

Goodwill and intangible assets, net:

    

Health Plans

  $145,021    $159,963  

Molina Medicaid Solutions

   91,100     95,787  
  

 

 

   

 

 

 
  $236,121    $255,750  
  

 

 

   

 

 

 

Total assets:

    

Health Plans

  $1,672,149    $1,425,764  

Molina Medicaid Solutions

   234,918     226,382  
  

 

 

   

 

 

 
  $1,907,067    $1,652,146  
  

 

 

   

 

 

 

13.

 Three Months Ended March 31,
 2013 2012
 (In thousands)
Revenue:   
Health Plans:   
Premium revenue$1,534,608
 $1,325,406
Investment income1,529
 1,717
Rental and other income4,694
 4,259
Molina Medicaid Solutions:   
Service revenue49,756
 42,205
 $1,590,587
 $1,373,587
Depreciation and amortization:   
Health Plans$15,238
 $13,743
Molina Medicaid Solutions6,561
 4,596
 $21,799
 $18,339
Operating Income:   
Health Plans$60,738
 $25,011
Molina Medicaid Solutions6,353
 8,409
Total operating income67,091
 33,420
Interest expense(13,037) (4,298)
Other income131
 
Income before income taxes$54,185
 $29,122

28


 March 31,
2013
 December 31,
2012
 (In thousands)
Goodwill and intangible assets, net:   
Health Plans$136,874
 $139,710
Molina Medicaid Solutions87,078
 89,089
 $223,952
 $228,799
Total assets:   
Health Plans$2,280,460
 $1,702,212
Molina Medicaid Solutions207,629
 232,610
 $2,488,089
 $1,934,822

14. Commitments and Contingencies
Leases
We lease administrative and clinic facilities, and certain equipment, under non-cancelable operating leases expiring on various dates through 2024. Facility lease terms generally range from five to ten years with one-to-two renewal options for extended terms. In most cases, we are required to make additional payments under facility operating leases for taxes, insurance and other operating expenses incurred during the lease period. Certain of our leases contain rent escalation clauses or lease incentives, including rent abatements and tenant improvement allowances. Rent escalation clauses and lease incentives are taken into account in determining total rent expense to be recognized during the lease term.
As described and defined in further detail in Note 15, "Related Party Transactions," we entered into a Lease for office space in February 2013 consisting of two office buildings under construction. Because of our involvement in the properties, we are treated as the in-substance owner of the properties. As such, we have recorded

$16.1 million to construction in progress, included in property, equipment and capitalized software, net, in the accompanying consolidated balance sheet as of March 31, 2013. This amount represents costs, including construction costs, incurred to date by the Landlord on the properties. We have recorded a corresponding financing obligation of $16.1 million to long-term debt, and will capitalize construction costs as incurred, including imputed interest, until the properties are available for occupancy. In addition to the capitalization of the costs incurred by the Landlord, we have imputed and recorded rent expense relating to the ground leases for the property sites. Such rent expense is computed based on the fair value of the land and our incremental borrowing rate, and was immaterial for the three months ended March 31, 2013.

As of March 31, 2013, our expectation is that Building A will be available for occupancy in June 2013, and Building B will be available for occupancy in November 2014. At the time of occupancy for each property, we will evaluate the accounting guidance applicable to sale-leasebacks of real estate to determine our continuing involvement in the properties, and whether we can remove the assets from our balance sheet.
Legal Proceedings

The health care and business process outsourcing industries are subject to numerous laws and regulations of federal, state, and local governments. Compliance with these laws and regulations can be subject to government review and interpretation, as well as regulatory actions unknown and unasserted at this time. Penalties associated with violations of these laws and regulations include significant fines and penalties, exclusion from participating in publicly funded programs, and the repayment of previously billed and collected revenues.

We are involved in legal actions in the ordinary course of business, some of which seek monetary damages, including claims for punitive damages, which are not covered by insurance. We have accrued liabilities for certain matters for which we deem the loss to be both probable and estimable. Although we believe that our estimates of such losses are reasonable, these estimates could change as a result of further developments of these matters. The outcome of legal actions is inherently uncertain and such pending matters for which accruals have not been established have not progressed sufficiently through discovery and/or development of important factual information and legal issues to enable us to estimate a range of possible loss, if any. While it is not possible to accurately predict or determine the eventual outcomes of these items, an adverse determination in one or more of these pending matters could have a material adverse effect on our consolidated financial position, results of operations, or cash flows.

Molina Medicaid Solutions

On April 6, 2012, Molina Medicaid Solutions received a schedule from the state


29

Table of Maine purporting to represent approximately $32.6 million in unspecified damages suffered by the state related to the state’s MMIS that was designed, developed, and implemented by Molina Medicaid Solutions. The level of detail provided in the schedule is not adequate for us to determine the specific nature of the damages claimed by the state. No formal claim has been asserted against us by the state, nor has any legal basis been asserted for any potential claims against us. To the extent that the state decides at some point in the future to pursue its alleged claims against us, Unisys Corporation, or Unisys, the former owner of the MMIS, has agreed to assume the defense of that portion of the claim related to the delay in the MMIS “go live” date from March 1, 2010 to August 1, 2010, since that delay had been agreed upon with the state prior to our May 1, 2010 acquisition of Molina Medicaid Solutions from Unisys. The amount of our potential liability related to this matter, if any, cannot be reasonably estimated at this time, nor can a range of such possible liability be established.

Contents


Provider Claims

Many of our medical contracts are complex in nature and may be subject to differing interpretations regarding amounts due for the provision of various services. Such differing interpretations have led certain medical providers to pursue us for additional compensation. The claims made by providers in such circumstances often involve issues of contract compliance, interpretation, payment methodology, and intent. These claims often extend to services provided by the providers over a number of years.

Various providers have contacted us seeking additional compensation for claims that we believe to have been settled. These matters, when finally concluded and determined, will not, in our opinion, have a material adverse effect on our business, consolidated financial position, results of operations, or cash flows.

Regulatory Capital and Dividend Restrictions

Our health plans, which are operated by our respective wholly owned subsidiaries in those states, are subject to state laws and regulations that, among other things, require the maintenance of minimum levels of statutory capital, as defined by each state. Such state laws and regulations also restrict the timing, payment, and amount of dividends and other distributions that may be paid to us as the sole stockholder. To the extent theour subsidiaries must comply with these regulations, they may not have the financial flexibility to transfer funds to us. The net assets in these subsidiaries (after intercompany eliminations) which may not be transferable to us in the form of loans, advances, or cash dividends was $519.2$572.9 million at September 30, 2012,March 31, 2013, and $492.4$549.7 million at December 31, 2011.

2012. Because of the statutory restrictions that inhibit the ability of our health plans to transfer net assets to us, the amount of retained earnings readily available to pay dividends to our stockholders is generally limited to cash, cash equivalents and investments held by the parent company – Molina Healthcare, Inc. Such cash, cash equivalents and investments amounted to$450.5 million and $46.9 million as of March 31, 2013, and December 31, 2012, respectively.

The National Association of Insurance Commissioners, or NAIC, adopted rules effective December 31, 1998, which, if implemented by the states, set minimum capitalization requirements for insurance companies, HMOs, and other entities bearing risk for health care coverage. The requirements take the form of risk-based capital (RBC) rules. Michigan, New Mexico, Ohio, Texas, Utah, Washington, and Wisconsin have adopted these rules, which may vary from state to state. California and Florida have not yet adopted NAIC risk-based capital requirements for HMOs and have not formally given notice of their intention to do so. Such requirements, if adopted by California and Florida, may increase the minimum capital required for those states.

As of September 30, 2012,March 31, 2013, our health plans had aggregate statutory capital and surplus of approximately $525.4$585.5 millioncompared with the required minimum aggregate statutory capital and surplus of approximately $270.0 million. $341.7 million. All of our health plans were in compliance with the minimum capital requirements at September 30, 2012.March 31, 2013. We have the ability and commitment to provide additional capital to each of our health plans when necessary to ensure that statutory capital and surplus continue to meet regulatory requirements.

Receivable/Liability

As described in Note 2, "Significant Accounting Policies," the ACA imposes an annual fee on health insurers for Ceded Lifeeach calendar year beginning on or after January 1, 2014. The fee will be imposed beginning in 2014 based on a company's share of the industry's net premiums written during the preceding calendar year. If the fee assessment is enacted as written, our minimum capitalization requirements will increase significantly on January 1, 2014; we are currently evaluating the impact of the fee assessment to our financial position, results of operations and Annuity Contractscash flows.
15. Related Party Transactions
Lease
On

PriorFebruary 27, 2013, we entered into a lease (the Lease) with 6th & Pine Development, LLC (the Landlord) for office space located in Long Beach, California. The Lease consists of two office buildings under construction, including a building which comprises approximately 70,000 square feet of office space (Building A); and a building which is expected to February 17, 2012, we reportedcomprise approximately 120,000 square feet of office space (Building B).

The term of the Lease with respect to Building A is expected to commence on June 1, 2013, and the term of the Lease with respect to Building B is expected to commence on November 1, 2014. The initial term of the Lease with respect to both buildings expires on December 31, 2024, subject to two options to extend the term for a 100% ceded reinsurance arrangementperiod of five years each. Initial annual rent for life insurance policies writtenBuilding A is expected to be approximately $2.5 million, and held byinitial annual rent for Building B is expected to be approximately $4.0 million. Rent will increase 3.75% per year through the initial term. Rent during the extension terms will be the greater of then-current rent or fair market rent.
The principal members of the Landlord are John C. Molina, our wholly owned insurance subsidiary, Molina Healthcare Insurancechief financial officer and a director of the Company, by recording a non-current receivable fromand his wife. In addition, in connection with the reinsurer with a corresponding non-current liability for ceded life and annuity contracts. Effective February 17, 2012, we sold Molina Healthcare Insurance Company. The transaction resulteddevelopment of the buildings being leased, the Landlord has pledged shares of

30


common stock in the elimination of both the noncurrent receivableCompany he holds as trustee. Dr. J. Mario Molina, our chief executive officer and liability for ceded life and annuity contracts, each amounting to $23.4 million as of December 31, 2011. Additionally, a gain of approximately $2.4 million was recorded upon closingchairman of the transaction, recorded to general and administrative expensesboard of directors, holds a partial interest in the accompanying consolidated income statement.

We remain liable for benefits payable under the life insurance policies that were held by Molina Healthcare Insurance Company, in the event that both the reinsurer and the buyer of Molina Healthcare Insurance Company are unable to pay those benefits. We believe the possibility of our having to pay such benefits is remote, and no provision for the payment of such benefits is included in our consolidated financial statements.

shares as trust beneficiary.

Medical Services
14. Related Party Transactions

We have an equity investment in a medical service provider that provides certain vision services to our members. Wemembers; we account for this investment under the equity method of accounting because we have an ownership interest in the investee that confers significant influence over operating and financial policies of the investee.accounting. For the three months ended September 30, 2012March 31, 2013 and 2011,2012, we paid $7.0$7.7 million, and $5.0$6.6 million, respectively, for medical service fees to this provider. For

16. Variable Interest Entities
Joseph M. Molina M.D., Professional Corporations

TheJoseph M. Molina, M.D. Professional Corporations (JMMPC) were created in 2012 to further advance our direct delivery business. JMMPC's sole shareholder is Dr. J. Mario Molina, our Chairman of the nineBoard, President and Chief Executive Officer. Dr. Molina is paid no salary and receives no dividends in connection with his work for, or ownership of, JMMPC. JMMPC provides outpatient professional medical services to the general public for routine non-life threatening, outpatient health care needs. Substantially all of the individuals served by JMMPC are members of our health plans. JMMPC does not have agreements to provide professional medical services with any other entities.
Our wholly owned subsidiary, American Family Care, Inc. (AFC), has entered into services agreements with JMMPC to provide clinic facilities, clinic administrative support staff, patient scheduling services and medical supplies to JMMPC. The services agreements were designed such that JMMPC will not operate at a loss, ensuring the availability of quality care and access for our health plan members. The services agreements provide that the administrative fees charged to JMMPC by AFC are reviewed annually to assure the achievement of this goal.
Our California, Florida, New Mexico and Washington health plans have entered into primary care capitation agreements with JMMPC. These agreements also direct our health plans to fund JMMPC's operating deficits, or receive JMMPC's operating surpluses, based on a monthly reconciliation. Because the AFC services agreements described above mitigate the likelihood of significant operating deficits or surpluses, such monthly reconciliation amounts are insignificant. There were no amounts recorded under this reconciliation arrangement for the three months ended September 30,March 31,2013 and March 31, 2012.
We have determined that JMMPC is a variable interest entity, or VIE, and that we are its primary beneficiary. We have reached this conclusion under the power and benefits criterion model according to GAAP. Specifically, we have the power to direct the activities that most significantly affect JMMPC's economic performance, and the obligation to absorb losses or right to receive benefits that are potentially significant to the VIE, under the agreements described above. Because we are its primary beneficiary, we have consolidated JMMPC. JMMPC's assets may be used to settle only JMMPC's obligations, and JMMPC's creditors have no recourse to the general credit of Molina Healthcare, Inc. As of March 31, 2013, JMMPC had total assets of $1.3 million, comprising primarily cash and equivalents, and total liabilities of $1.1 million, comprising primarily accrued payroll and employee benefits.
Our maximum exposure to loss as a result of our involvement with JMMPC is equal to the amounts needed to fund JMMPC's ongoing payroll and employee benefits. We believe that such loss exposure will be immaterial to our consolidated operating results and cash flows for the foreseeable future. We provided an initial cash infusion of $0.3 million to JMMPC in the first quarter of 2012 to fund its start-up operations.
New Markets Tax Credit
During the fourth quarter of 2011 our New Mexico data center subsidiary entered into a financing transaction with Wells Fargo Community Investment Holdings, LLC, or Wells Fargo, its wholly owned subsidiary New Mexico Healthcare Data Center Investment Fund, LLC, or Investment Fund, and certain of Wells Fargo's affiliated Community Development Entities, or CDEs, in connection with our participation in the federal government's New Markets Tax Credit Program, or NMTC. The NMTC was established by Congress in 2000 to facilitate new or increased investments in businesses and real estate projects in low-income communities. The NMTC attracts investment capital to low-income communities by permitting investors to receive a tax credit against their federal income tax return in exchange for equity investments in specialized financial institutions, called CDEs, which provide financing to qualified active businesses operating in low-income communities. The credit amounts to 39% of the original investment amount and is claimed over a period of seven years (five percent for each of the first three years, and six percent for each of the remaining four years). The investment in the CDE cannot be redeemed before the end of the seven-year period.

31

Table of Contents

In the fourth quarter of 2011, as a result of a series of simultaneous financing transactions, Wells Fargo contributed capital of $5.9 million to the Investment Fund, and Molina Healthcare, Inc. loaned the principal amount of $15.5 million to the Investment Fund. The Investment Fund then contributed the proceeds to certain CDEs, which, in turn, loaned the proceeds of $20.9 million to our New Mexico data center subsidiary. Wells Fargo will be entitled to claim the NMTC while we effectively received net loan proceeds equal to Wells Fargo's contribution to the Investment Fund, or approximately $5.9 million. Additionally, financing costs incurred in structuring the arrangement amounting to $1.2 million were deferred and will be recognized as expense over the term of the loans. This transaction also includes a put/call feature that becomes enforceable at the end of the seven-year compliance period. Wells Fargo may exercise its put option or we can exercise the call, both of which will serve to transfer the debt obligation to us. Incremental costs to maintain the structure during the compliance period will be recognized as incurred.

We have determined that the financing arrangement with Investment Fund and CDEs is a VIE, and that we are the primary beneficiary of the VIE. We reached this conclusion based on the following:
The ongoing activities of the VIE-collecting and remitting interest and fees and NMTC compliance-were all considered in the initial design and are not expected to significantly affect economic performance throughout the life of the VIE;
Contractual arrangements obligate us to comply with NMTC rules and regulations and provide various other guarantees to Investment Fund and CDEs;
Wells Fargo lacks a material interest in the underling economics of the project; and
We are obligated to absorb losses of the VIE.
Because we are the primary beneficiary of the VIE, we have included it in our consolidated financial statements. Wells Fargo's contribution of $5.9 million is included in cash at December 31, 2012 and 2011,the offsetting Wells Fargo's interest in the financing arrangement is included in other liabilities in the accompanying consolidated balance sheets.
As described above, this transaction also includes a put/call provision whereby we paid $20.6 million,may be obligated or entitled to repurchase Wells Fargo's interest in the Investment Fund. The value attributed to the put/call is nominal. The NMTC is subject to 100% recapture for a period of seven years as provided in the Internal Revenue Code and $16.8 million, respectively,applicable U.S. Treasury regulations. We are required to be in compliance with various regulations and contractual provisions that apply to the NMTC arrangement. Non-compliance with applicable requirements could result in Wells Fargo's projected tax benefits not being realized and, therefore, require us to indemnify Wells Fargo for medical service feesany loss or recapture of NMTCs related to the financing until such time as the recapture provisions have expired under the applicable statute of limitations. We do not anticipate any credit recaptures will be required in connection with this provider.

Item 2.Management’s Discussion and Analysis of Financial Condition and Results of Operations.

arrangement.



32

Table of Contents

Item 2.    Management's Discussion and Analysis of Financial Condition and Results of Operations.
Forward Looking Statements

This quarterly report on Form 10-Q contains forward-looking statements regarding our business, financial condition, and results of operations within the meaning of Section 27A of the Securities Act of 1933, or Securities Act, and Section 21E of the Securities Exchange Act of 1934, or Securities Exchange Act. We intend such forward-looking statements to be covered by the safe harbor provisions for forward-looking statements contained in the Private Securities Litigation reform Act of 1995, and we are including this statement for purposes of complying with these safe harbor provisions. All statements, other than statements of historical facts, included in this quarterly report may be deemed to be forward-looking statements for purposes of the Securities Act and the Securities Exchange Act. Without limiting the foregoing, we use the words “anticipate(s),” “believe(s),” “estimate(s),” “expect(s),” “intend(s),” “may,” “plan(s),” “project(s),” “will,” “would,” “could,” “should” and similar expressions to identify forward-looking statements, although not all forward-looking statements contain these identifying words. We cannot guarantee that we will actually achieve the plans, intentions, or expectations disclosed in our forward-looking statements and, accordingly, you should not place undue reliance on our forward-looking statements. There are a number of important factors that could cause actual results or events to differ materially from the forward-looking statements that we make. You should read these factors and the other cautionary statements as being applicable to all related forward-looking statements wherever they appear in this quarterly report. We caution you that we do not undertake any obligation to update forward-looking statements made by us. Forward-looking statements involve known and unknown risks and uncertainties that may cause our actual results in future periods to differ materially from those projected, estimated, expected, or contemplated as a result of, but not limited to, risk factors related to the following:

uncertainties associated with the effectivenessimplementation of the Affordable Care Act, including the impact of the health insurance industry excise tax, the expansion of Medicaid eligibility in participating states to previously uninsured populations unfamiliar with managed care, the implementation of state insurance exchanges currently expected to become operational by October 1, 2013, the effect of various implementing regulations, and uncertainties regarding the impact of other federal or state health care and insurance reform measures, including the duals demonstration programs in California, Illinois, Ohio, Michigan, Texas, and Washington;

the success of our medical cost containment initiatives in Texas;

Texas, and other risks associated with the expansion of our Texas health plan's service areas in 2012;

significant budget pressures on state governments and their potential inability to maintain current rates, to implement expected rate increases, or to maintain existing benefit packages or membership eligibility thresholds or criteria;

uncertainties regarding the implementation of the Patient Protection and Affordable Care Act, including the potential refusal of a state to expand Medicaid eligibility to its uninsured population, issues surrounding state insurance exchanges, the impact of the health insurance industry excise tax, the effect of various implementing regulations, and uncertainties regarding the impact of other federal or state health care and insurance reform measures;

management of the Company’sour medical costs, including seasonal flu patterns and rates of utilization that are consistent with the Company’sour expectations and the reduction over time of the highour accruals for incurred but not reported medical costs associated with new populations;

costs;

the success of the Company’sour efforts to retain existing government contracts and to obtain new government contracts in connection with state requests for proposals (RFPs) in both existing and new states, including the pending RFP in New Mexico, and the Company’sour ability to grow the Company’sincrease our revenues consistent with the Company’sour expectations;

the accurate estimation of incurred but not reported medical costs across the Company’sour health plans;

risks associated with the continued growth in new Medicaid and Medicare enrollees, and the development of actuarially sound rates with respect to such new enrollees, including dually eligible enrollees;

duals;

retroactive adjustments to premium revenue or accounting estimates which require adjustment based upon subsequent developments, including Medicaid pharmaceutical rebates;

the continuation and renewal of the government contracts of both the Company’sour health plans and Molina Medicaid Solutions and the terms under which such contracts are renewed;

the timing of receipt and recognition of revenue and the amortization of expense under the state contracts of Molina Medicaid Solutions in Maine or Idaho;

additional administrative costs and the potential payment of additional amounts to providers and/or the state by Molina Medicaid Solutions as a result of MMIS implementation issues in Maine or Idaho;

government audits and reviews, and any enrollment freeze or monitoring program that may result therefrom;

changes with respect to the Company’sour provider contracts and the loss of providers;

the establishment of a federal or state medical cost expenditure floor as a percentage of the premiums we receive, and the interpretation and implementation of medical cost expenditure floors, administrative cost and profit ceilings, and profit sharing arrangements;

the interpretation and implementation of at-risk premium rules regarding the achievement of certain quality measures;

approval by state regulators of dividends and distributions by the Company’sour health plan subsidiaries;

changes in funding under the Company’sour contracts as a result of regulatory changes, programmatic adjustments, or other reforms;

high dollar claims related to catastrophic illness;

the favorable resolution of litigation, arbitration, or administrative proceedings;

proceedings, including our pending litigation against the state of California related to rates paid to our California plan in earlier years that were not actuarially sound;

restrictions and covenants in the Company’sany future credit facility;

the relatively small number of states in which we operate health plans;

the availability of adequate financing to fund and capitalize the Company’s acquisitionsour expansion and start-upgrowth activities and to meet our liquidity needs, including the Company’s liquidity needs;

interest expense and other costs associated with such financing;


33

Table of Contents

a state’sstate's failure to renew its federal Medicaid waiver;

an inadvertent unauthorized disclosure of protected health information;

changes generally affecting the managed care or Medicaid management information systems industries;

increases in government surcharges, taxes, and assessments;

changes in general economic conditions, including unemployment rates; and

increasing consolidation in the Medicaid industry.

Investors should refer to Part I, Item 1A of our Annual Report on Form 10-K for the year ended December 31, 2011, as updated in Part II, Item 1A—Risk Factors, in our Quarterly Report on Form 10-Q for the quarterly period ended June 30, 2012, for a discussion of certain risk factors that could materially affect our business, financial condition, cash flows, or results of operations. Given these risks and uncertainties, we can give no assurance that any results or events projected or contemplated by our forward-looking statements will in fact occur.

This document and the following discussion of our financial condition and results of operations should be read in conjunction with the accompanying consolidated financial statements and the notes to those statements appearing elsewhere in this report and the audited financial statements and Management’s Discussion and Analysis appearing in our Annual Report on Form 10-K for the year ended December 31, 2011.

2012.



34

Table of Contents

Overview
Overview

Molina Healthcare, Inc. provides quality and cost-effective Medicaid-related solutions to meet the health care needs of low-income families and individuals and to assist state agencies in their administration of the Medicaid program. We report our financial performance based on two reportable segments: Health Plans;Plans and Molina Medicaid Solutions.

Our Health Plans segment comprises health plans in California, Florida, Michigan, New Mexico, Ohio, Texas, Utah, Washington, and Wisconsin, and includes our direct delivery business. As of September 30, 2012,March 31, 2013, these health plans served approximately1.8 millionmembers eligible for Medicaid, Medicare, and other government-sponsored health care programs for low-income families and individuals. The health plans are operated by our respective wholly owned subsidiaries in those states, each of which is licensed as a health maintenance organization, or HMO. Our direct delivery business consists of primary care community clinics in California, Florida, New Mexico, and Washington; additionally, we manage three county-owned primary care clinics under a contract with Fairfax County, Virginia.

Washington.

Our health plans’ state Medicaid contracts generally have terms of three to four years with annual adjustments to premium rates. These contracts are renewable at the discretion of the state. In general, either the state Medicaid agency or the health plan may terminate the state contract with or without cause upon 30 days to nine months with prior written notice. cause.Most of these contracts contain renewal options that are exercisable by the state. Our health plan subsidiaries have generally been successful in obtaining the renewal of their contracts in each state prior to the actual expiration ofretaining their contracts. Our state contracts are generally at greatest risk of loss when a state issues a new request for proposals, or RFP, subject to competitive bidding by other health plans. If one of our health plans is not a successful responsive bidder to a state RFP, its contract may be subject to non-renewal. For instance, on February 17, 2012, the Division of Purchasing of the Missouri Office of Administration notified us that our Missouri health plan was not awarded a contract under the Missouri HealthNet Managed Care Request for Proposal; therefore, our Missouri health plan’s prior contract with the state expired without renewal on June 30, 2012 subject to certain transition obligations. For the six months ended June 30, 2012, our Missouri health plan contributed premium revenue of $113.8 million, or 4.1% of total premium revenue, and comprised 79,000 members, or 4.3% of total Health Plans segment membership as of June 30, 2012.


Our state Medicaid contracts may be periodically adjusted to include or exclude certain health benefits (such as pharmacy services, behavioral health services, or long-term care services); populations (such as the aged, blind or disabled, or ABD); and regions or service areas. For example, our Texas health plan added significant membership effective March 1, 2012, in service areas we had not previously served (the Hidalgo and El Paso service areas); and among populations we had not previously served within existing service areas, such as the Temporary Assistance for Needy Families, or TANF, population in the Dallas service area. Additionally, the health benefits provided to our TANF and ABD members in Texas under our contracts with the state were expanded to include inpatient facility and pharmacy services.

With regard to our Ohio health plan, as a result of a lawsuit challenging the selection of several plans including our health plan for the new Medicaid managed care program in Ohio, the Ohio Office of Medical Assistance (OMA)services effective March 1, 2012.

On February 14, 2013, we announced on October 5, 2012 that the operation of the program is being delayed from the previously scheduled January 1, 2013 start date and will now commence on July 1, 2013. Following the trial court’s dismissal of the lawsuit, the court of appeals has permitted the state of Ohio to move forward with working on implementing the new program and finalizing the provider agreements with our Ohio plan and the other selected managed care plans.

During fiscal year 2012, we expect to respond to several RFPs and invitations to negotiate with respect to new business, including proposals to serve dual eligible populations and applications to participate in CMS’ Capitated Financial Alignment Demonstration project. On August 27, 2012, our Ohio health plan was chosen to participate in the Southwest, West Central, and Central markets under the Ohio Integrated Care Delivery System (ICDS). The Ohio ICDS is intended to improve care coordination for individuals enrolled in both Medicaid and Medicare. The selection of Molina of Ohio was made by the Ohio Department of Jobs and Family Services (ODJFS) pursuant to the request for applications for qualified health plans to serve in the ICDS issued in April 2012. The commencement of the ICDS is subject to the readiness review of the selected health plans, and the execution of three-way provider agreements between the health plans, ODJFS, and CMS. Enrollment of dual eligible members in the ICDS is expected to begin on April 1, 2013. Furthermore, on June 29, 2012, the Florida Agency for Health Care Administration (AHCA) issued invitations to negotiate for the Long-term Care Managed Care component ofawarded our Florida health plan contracts in three regions under the Statewide Medicaid Managed Care Long-Term Care program. We submittedAs a bid for eightresult of eleven regionsthe awards, we will now enter into a comprehensive pre-contracting assessment, with the program currently scheduled to commence on August 27, 2012, representing approximately thirty countiesDecember 1, 2013. Under the program, we will provide long-term care benefits, including institutional and 90,000 beneficiaries. We expecthome and community-based services.

On February 11, 2013, we announced that our New Mexico health plan was selected by the stateNew Mexico Human Services Department, or HSD, to announce contract awardsparticipate in January 2013 with phased-in enrollment beginning August 2013 and extending through March 2014.

the new Centennial Care program. In addition with regard to existing business, on August 31, 2012,continuing to provide physical and acute health care services, under the state ofnew program our New Mexico issued an RFP for all covered Medicaidhealth plan will expand its services (physical health,to provide behavioral health and long-term care), with such services expectedcare services. The selection of our New Mexico health plan was made by HSD pursuant to commence onits request for proposals issued in August 2012. The operational start date for the program is currently scheduled for January 1, 2014 under the new Medicaid contract. The awards are expected to be announced in January 2013.

2014.

Our Molina Medicaid Solutions segment provides design,business processing and information technology development implementation, and business process outsourcing solutionsadministrative services to state governments for their Medicaid Management Information Systems, or MMIS. MMIS is a core tool used to support the administration of state Medicaid and other health care entitlement programs. Molina Medicaid Solutions currently holds MMIS contracts with the states ofagencies in Idaho, Louisiana, Maine, New Jersey, and West Virginia, as well as a contract to provideand drug rebate administration services for the Florida Medicaid program.

On October 12, 2012, the Governor of the U.S. Virgin Islands announced a partnership in which the Company will provide MMIS to the U.S. Virgin Islands through our West Virginia fiscal agent operation. The contract outlining the sharing of the Company’s platform went through several rounds of review at the federal level and has been approved by CMS. The partnership will benefit both the Virgin Islands and taxpayers by circumventing the costs associated with establishing an independent system while gaining leverage from operating under a common platform. This partnership can serve as a model for the country by demonstrating that state and territorial governments can reduce local and federal costs by sharing such technologies for their Medicaid populations.

On July 13, 2012, our Molina Medicaid Solutions segment received full federal certification of its MMIS in the state of Idaho from the Centers for Medicare and Medicaid Services, or CMS. As a result of the CMS certification, the state of Idaho is entitled to receive federal reimbursement of 75% of its MMIS operations costs retroactive to June 1, 2010, the date that the system first began processing claims.

Florida.

On June 9, 2011, Molina Medicaid Solutions received notice from the state of Louisiana that the state intendsintended to award the contract for a replacement MMISMedicaid Management Information System (MMIS) to another company.a different vendor, CNSI. However, in March 2013, the state of Louisiana cancelled its contract award to CNSI. CNSI is currently challenging the contract cancellation. The state has informed us that we will continue to perform under our current contract until a successor is named. Subject to the pending challenge, it is currently uncertain whether a new RFP will be issued, and if so, when it will be issued. At such time as a new RFP may be issued, we intend to respond to the state's RFP. For the ninethree months ended September 30, 2012, March 31, 2013, our revenue under the Louisiana MMIS contract was $38.8approximately $10.1 million, or 29.3% 20.3% of total service revenue. We expect that we will continue to perform under this contract through implementation and acceptance of the successor MMIS. Based uponSo long as our past experience and our knowledge of the Louisiana MMIS bid process, we believe that implementation and acceptance of the successor MMIS will not occur until 2014 at the earliest. Through implementation and acceptance of the successor MMIScontract continues, we expect to recognize approximately $40 million inof service revenue annually under our Louisiana MMISthis contract.

Composition of Revenue and Membership

Health Plans Segment


35

Table of Contents

Our Health Plans segment derives its revenue, in the form of premiums, chiefly from Medicaid contracts with the states in which our health plans operate. Premium revenue is fixed in advance of the periods covered and, except as described in “Critical Accounting Policies” below, is not generally subject to significant accounting estimates. For the ninethree months ended September 30, 2012,March 31, 2013, we received approximately 96% of our premium revenue as a fixed amount per member per month, or PMPM, pursuant to our Medicaid contracts with state agencies, our Medicare contracts with CMS, and our contracts with other managed care organizations for which we operate as a subcontractor. These premium revenues are recognized in the month that members are entitled to receive health care services. The state Medicaid programs and the federal Medicare program periodically adjust premium rates.

For the ninethree months ended September 30, 2012,March 31, 2013, we recognized approximately 4% of our premium revenue in the form of “birth income” — a one-time payment for the delivery of a child — from the Medicaid programs in all of our state health plans except New Mexico. Such payments are recognized as revenue in the month the birth occurs.

The amount of the premiums paid to us may vary substantially between states and among various government programs. PMPM premiums for the Children’s Health Insurance Program, or CHIP, members are generally among our lowest, with rates as low as approximately $75$70 PMPM in California. Premium revenues for Medicaid members are generally higher. Among the TANF Medicaid population — the Medicaid group that includes mostly mothers and children — PMPM premiums range between approximately $110$100 in California to $260 in Ohio. Among our ABD membership, PMPM premiums range from approximately $330$400 in Utah to $1,400 in Ohio. Contributing to the variability in Medicaid rates among the states is the practice of some states to exclude certain benefits from the managed care contract (most often pharmacy, inpatient, behavioral health and catastrophic case benefits) and retain responsibility for those benefits at the state level. Medicare membership generates the highest PMPM premiums in the aggregate, at approximately $1,200 PMPM.


36

Table of Contents

The following table sets forth the approximate total number of members by state health plan as of the dates indicated:

   September 30,   June 30,   December 31,   September 30, 
   2012   2012   2011   2011 

Total Ending Membership by Health Plan:

        

California

   346,000     350,000     355,000     350,000  

Florida

   71,000     70,000     69,000     67,000  

Michigan

   219,000     220,000     222,000     217,000  

Missouri (1)

   —       79,000     79,000     78,000  

New Mexico

   90,000     89,000     88,000     89,000  

Ohio

   272,000     260,000     248,000     256,000  

Texas

   291,000     301,000     155,000     148,000  

Utah

   85,000     86,000     84,000     82,000  

Washington

   411,000     356,000     355,000     350,000  

Wisconsin

   41,000     42,000     42,000     41,000  
  

 

 

   

 

 

   

 

 

   

 

 

 

Total

   1,826,000     1,853,000     1,697,000     1,678,000  
  

 

 

   

 

 

   

 

 

   

 

 

 

Total Ending Membership by State for our Medicare Advantage Plans:

        

California

   7,300     7,000     6,900     6,500  

Florida

   900     900     800     700  

Michigan

   9,300     8,900     8,200     7,600  

New Mexico

   900     900     800     800  

Ohio

   200     200     200     100  

Texas

   1,100     800     700     600  

Utah

   8,300     8,300     8,400     7,400  

Washington

   6,100     5,700     5,000     4,500  
  

 

 

   

 

 

   

 

 

   

 

 

 

Total

   34,100     32,700     31,000     28,200  
  

 

 

   

 

 

   

 

 

   

 

 

 

Total Ending Membership by State for our Aged, Blind or Disabled Population:

        

California

   44,100     41,100     31,500     23,700  

Florida

   10,300     10,400     10,400     10,400  

Michigan

   40,700     40,000     37,500     31,600  

New Mexico

   5,600     5,600     5,600     5,600  

Ohio

   29,000     29,600     29,100     29,900  

Texas

   101,300     111,000     63,700     61,800  

Utah

   8,900     8,800     8,500     8,300  

Washington

   23,400     4,400     4,800     4,700  

Wisconsin

   1,600     1,700     1,700     1,700  
  

 

 

   

 

 

   

 

 

   

 

 

 

Total

   264,900     252,600     192,800     177,700  
  

 

 

   

 

 

   

 

 

   

 

 

 

 March 31,
2013
 December 31,
2012
 March 31,
2012
Total Ending Membership by Health Plan:     
California332,000
 336,000
 351,000
Florida75,000
 73,000
 69,000
Michigan217,000
 220,000
 222,000
Missouri (1)
 
 81,000
New Mexico91,000
 91,000
 89,000
Ohio242,000
 244,000
 249,000
Texas274,000
 282,000
 280,000
Utah87,000
 87,000
 86,000
Washington416,000
 418,000
 356,000
Wisconsin86,000
 46,000
 42,000
Total1,820,000
 1,797,000
 1,825,000
Total Ending Membership for our Medicare Advantage Plans:     
California7,700
 7,700
 6,900
Florida600
 900
 800
Michigan9,200
 9,700
 8,500
New Mexico900
 900
 900
Ohio300
 300
 200
Texas1,900
 1,500
 800
Utah7,600
 8,200
 8,100
Washington6,100
 6,500
 5,200
Total34,300
 35,700
 31,400
Total Ending Membership for our Aged, Blind or Disabled Population:     
California44,600
 44,700
 37,300
Florida10,400
 10,300
 10,500
Michigan44,000
 41,900
 38,800
New Mexico5,800
 5,700
 5,600
Ohio28,200
 28,200
 29,700
Texas94,200
 95,900
 109,000
Utah9,200
 9,000
 8,700
Washington31,300
 30,000
 4,700
Wisconsin1,600
 1,700
 1,700
Total269,300
 267,400
 246,000
(1)Our contract with the state of Missouri expired without renewal on June 30, 2012.

Molina Medicaid Solutions Segment

The payments received by our Molina Medicaid Solutions segment under its state contracts are based on the performance of multiple services. The first of these is the design, development and implementation, or DDI, of a Medicaid Management Information System, or MMIS. An additional service, following completion of DDI, is the operation of the MMIS under a business process outsourcing, or BPO arrangement. While providing BPO services (which include claims payment and eligibility processing) we also provide the state with other services including both hosting and support and maintenance. Because we have determined the services provided under our Molina Medicaid Solutions contracts represent a single unit of accounting, we recognize revenue associated with such contracts on a straight-line basis over the period during which BPO, hosting, and support and maintenance services are delivered.

Composition of Expenses

Health Plans Segment


37

Table of Contents

Operating expenses for the Health Plans segment include expenses related to the provision of medical care services, G&A expenses, and premium tax expenses. Our results of operations are impacted by our ability to effectively manage expenses related to medical care services and to accurately estimate medical costs incurred. Expenses related to medical care services are captured in the following four categories:

Fee-for-service — Expenses paid for specific encounters or episodes of care according to a fee schedule or other basis established by the state or by contract with the provider.

Capitation — Expenses for PMPM payments to the provider without regard to the frequency, extent, or nature of the medical services actually furnished.

Pharmacy — Expenses for all drug, injectible, and immunization costs paid through our pharmacy benefit manager.

Other — Expenses for medically related administrative costs of approximately $94.6 million, and $76.3 million, for the nine months ended September 30, 2012 and 2011, respectively, as well as certain provider incentive costs, reinsurance, costs to operate our medical clinics, and other medical expenses.

Fee-for-service — Expenses paid for specific encounters or episodes of care according to a fee schedule or other basis established by the state or by contract with the provider.
Capitation — Expenses for PMPM payments to the provider without regard to the frequency, extent, or nature of the medical services actually furnished.
Pharmacy — Expenses for all drug, injectible, and immunization costs paid through our pharmacy benefit manager.
Other — Expenses for medically related administrative costs of approximately $33.9 million, and $32.1 million, for the three months endedMarch 31, 2013 and 2012, respectively, as well as certain provider incentive costs, reinsurance, costs to operate our medical clinics, and other medical expenses.
Our medical care costs include amounts that have been paid by us through the reporting date as well as estimated liabilities for medical care costs incurred but not paid by us as of the reporting date. See “Critical Accounting Policies” below for a comprehensive discussion of how we estimate such liabilities.

Molina Medicaid Solutions Segment

Cost of service revenue consists primarily of the costs incurred to provide business process outsourcing and technology outsourcing services under our MMIS contracts. General and administrative costs consist primarily of indirect administrative costs and business development costs.

In some circumstances we may defer recognition of incremental direct costs (such as direct labor, hardware, and software) associated with a contract if revenue recognition is also deferred. Such deferred contract costs are amortized on a straight-line basis over the remaining original contract term, consistent with the revenue recognition period.

Third

First Quarter Financial Performance Summary

The following table and narrative briefly summarizessummarize our financial and operating performance for the three and nine months ended September 30, 2012. Comparable metrics for the third quarter of 2011 are also shown.March 31, 2013 and 2012. All ratios, with the exception of the medical care ratio and the premium tax ratio, are shown as a percentage of total revenue. The medical care ratio and the premium tax ratio are computed as a percentage of premium revenue because there are direct relationships between premium revenue earned, and the cost of health care and premium taxes.

   Three Months Ended  Nine Months Ended 
   September 30,  September 30, 
   2012  2011  2012  2011 
   (Dollar amounts in thousands, except per share data) 

Net income (loss) per diluted share

  $0.07   $0.41   $(0.34 $1.16  

Premium revenue

  $1,488,718   $1,138,230   $4,308,439   $3,348,438  

Service revenue

  $48,422   $37,728   $132,351   $111,290  

Operating income (loss)

  $7,187   $33,566   $(18,660 $96,276  

Net income (loss)

  $3,364   $18,950   $(15,853 $53,778  

Total ending membership

   1,826,000    1,678,000    1,826,000    1,678,000  

Premium revenue

   96.7  96.7  96.8  96.7

Service revenue

   3.1    3.2    3.0    3.2  

Investment income

   0.1    0.1    0.1    0.1  

Rental income

   0.1    —      0.1    —    
  

 

 

  

 

 

  

 

 

  

 

 

 

Total revenue

   100.0  100.0  100.0  100.0
  

 

 

  

 

 

  

 

 

  

 

 

 

Medical care ratio

   88.3  84.3  88.7  84.3

General and administrative expense ratio

   8.3  8.5  8.5  8.4

Premium tax ratio

   2.5  3.2  2.8  3.3

Operating income (loss)

   0.5  2.9  (0.4)%   2.8

Net income (loss)

   0.2  1.6  (0.4)%   1.6

Effective tax rate

   (17.1)%   35.1  49.0  36.4


38

Table of Contents

 Three Months Ended March 31,
 2013 2012
 (Dollar amounts in thousands, except per share data)
Net income per diluted share$0.64
 $0.39
Premium revenue$1,534,608
 $1,325,406
Service revenue$49,756
 $42,205
Operating income$67,091
 $33,420
Net income$29,915
 $18,089
Total ending membership1,820,000
 1,825,000
Premium revenue96.5% 96.5%
Service revenue3.1% 3.1%
Investment income0.1% 0.1%
Rental and other income0.3% 0.3%
Total revenue100.0% 100.0%
    
Medical care ratio86.1% 88.1%
General and administrative expense ratio8.9% 8.8%
Premium tax ratio2.4% 3.2%
Operating income4.2% 2.4%
Net income1.9% 1.3%
Effective tax rate44.8% 37.9%
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
ThirdWe calculate a non-GAAP measure, EBITDA, which management uses as a supplemental metric in evaluating our financial performance, in evaluating financing and business development decisions, and in forecasting and analyzing future periods. For these reasons, management believes that EBITDA is a useful supplemental measure to investors in evaluating our performance and the performance of other companies in our industry. The reconciliation of this non-GAAP to GAAP financial measure is as follows (GAAP stands for U.S. generally accepted accounting principles):
 Three Months Ended March 31,
 2013 2012
 (In thousands)
Net income$29,915
 $18,089
Add back:   
Depreciation and amortization reported in the consolidated statements of cash flows21,799
 18,339
Interest expense13,037
 4,298
Income tax expense24,270
 11,033
EBITDA (1)$89,021
 $51,759
(1)EBITDA is not prepared in conformity with GAAP because it excludes depreciation and amortization, as well as interest expense, and the provision for income taxes. This non-GAAP financial measure should not be considered as an alternative to the GAAP measures of net income, operating income, operating margin, or cash provided by operating activities; nor should EBITDA be considered in isolation from these GAAP measures of operating performance.
First Quarter 20122013 Overview

For the thirdfirst quarter of 2012,2013, net income was $3.4$29.9 million, or $0.07$0.64 per diluted share, compared with net income of $19.0$18.1 million, or $0.41$0.39 per diluted share, for the thirdfirst quarter of 2011.

2012.

Our financial performance in the thirdfirst quarter of 20122013 improved substantially over the secondfirst quarter of 2012. Among the key developments affecting first quarter2013 performance were the following:


39

Table of Contents

The recognition of approximately $21 million of premium rate changes at the California health plan. Approximately $19 million of the premium revenue related to 2012 dueand 2011. Net of related expenses, the rate increases resulted in an increase of approximately $19 million to pretax income; $18 million (approximately $0.24 per diluted share) of which related to 2012 and 2011. The adjustment to premium rates resulted from the receipt of new rate sheets from the state of California that restored the rates that had existed prior to the cuts that had been taken effective July 1, 2011, and a significant improvement inmodest increase to rates for our ABD membership retroactive to July 1, 2011. The new premium rates are expected to increase premium revenue at the profitabilityCalifornia health plan going forward by approximately $400,000 per month;
The recognition of approximately $6 million (approximately $0.08 per diluted share) of performance revenue at the Texas health plan. Revenue was consistent betweenplan related to 2012. The Texas health plan recently received notice from the secondTexas Department of Health and third quartersHuman Services that a specific measure is being removed from the calculation of performance revenue for all contracted health plans for 2012. As of December 31, 2012, as a 30% increase inthe Texas health plan had not recognized approximately $6 million of revenue related to this performance measure;
Flat inpatient utilization compared to the first quarter of 2012;
Improved performance at the WashingtonFlorida, Texas, Ohio and Wisconsin health plan offsetplans; and
The immediate recognition in interest expense of approximately $6 million (approximately $0.08 per diluted share) of debt issuance fees related to our issuance of $550 million of 1.125% cash convertible senior notes (the 1.125% Notes) in February 2013. The remainder of the terminationfees associated with that issuance will be expensed over the seven-year life of our Missouri enrollment and a slight decline in Texas enrollment.

the 1.125% Notes.

Results of Operations

Three Months Ended September 30, 2012March 31, 2013 Compared with the Three Months Ended September 30, 2011

March 31, 2012

Health Plans Segment

Premium Revenue

Premium revenue for the thirdfirst quarter of 20122013 increased 30.8%16% (or 17%, net of premium taxes) over the thirdfirst quarter of 2011,2012, primarily due primarily to an increase in membership, a shift in member mix to populations generating higher premium revenue per member per month (PMPM), and benefit expansions.. Medicare premium revenue was $116.1$118.4 million for the thirdfirst quarter of 20122013 compared with $101.5$109.8 million for the thirdfirst quarter of 2011.

Membership at the Texas health plan nearly doubled year over year, while also growing significantly in Ohio and Washington. 2012.

Growth in our ABD membership in Washington and California led to higher premium revenue PMPM in 2012.2013. ABD membership, as a percent of total membership, has increased approximately 37%10% year over year. Premium revenue PMPM also increased in the thirdfirst quarter of 2012 2013as a result of the inclusion of revenue fromfor pharmacy benefits for the pharmacy benefit for our OhioUtah health plan effective OctoberJanuary 1, 2011,2013, and as a result of the inclusion of revenue from thefor inpatient facility and pharmacy benefits across all of ourthe Texas health planplan’s membership effective March 1, 2012.

Medical Care Costs

The following table provides the details of consolidated medical care costs for the periods indicated (dollars in thousands except PMPM amounts):

   Three Months Ended September 30, 
   2012  2011 
           % of          % of 
   Amount   PMPM   Total  Amount   PMPM   Total 

Fee for service

  $908,201    $165.97     69.1 $698,995    $140.55     72.9

Pharmacy

   219,823     40.17     16.7    89,191     17.93     9.3  

Capitation

   142,714     26.08     10.9    129,315     26.00     13.5  

Other

   43,833     8.03     3.3    41,657     8.39     4.3  
  

 

 

   

 

 

   

 

 

  

 

 

   

 

 

   

 

 

 

Total

  $1,314,571    $240.25     100.0 $959,158    $192.87     100.0
  

 

 

   

 

 

   

 

 

  

 

 

   

 

 

   

 

 

 

 Three Months Ended March 31,
 2013 2012
 Amount PMPM 
% of
Total
 Amount PMPM 
% of
Total
Fee for service$867,648
 $160.18
 67.3% $777,267
 $148.81
 68.7%
Pharmacy231,838
 42.80
 18.0% 173,237
 33.17
 15.3%
Capitation140,324
 25.91
 10.9% 136,038
 26.04
 12.0%
Other48,944
 9.04
 3.8% 44,446
 8.51
 4.0%
Total$1,288,754
 $237.93
 100.0% $1,130,988
 $216.53
 100.0%

Medical care costs increased in the thirdfirst quarter of 2012 2013primarily due to the same shifts in member mix and the benefit expansions that led to increased premium revenue. Medical care costs as a percentage of premium revenue, (theparticularly in California, Texas and Washington. Our consolidated medical care ratio) also increasedratio, however, decreased to 86.1% in the thirdfirst quarter of 2012 when compared with2013, from 88.1% in the thirdfirst quarter of 2011 because2012. Retroactive rate increases for the California health plan and increased margins at the Texas health plan were the primary drivers of the lower medical care ratio in premium rates have not kept pace with increasesthe first quarter of 2013. Stable inpatient utilization and lower pharmacy unit costs also contributed to the lower medical care ratio in medical costs.

the first quarter of 2013.


40


Individual Health Plan Analysis


The Texasmedical care ratio at the California health plan’s financial performance improved dramaticallyplan decreased to 85.1% in the thirdfirst quarter of 2013 from 88.7% in the secondfirst quarter of 2012. The lower medical care ratio was primarily the result of the recognition of retroactive premium rate changes that contributed approximately $19 million to pretax income for the first quarter of 2012. 2013, of which approximately $18 million (after related expenses) related to 2012 and 2011.
The medical care ratio of the Florida health plan decreased to 84.9% in the first quarter of 2013, from 88.2% in the first quarter of 2012 due to improved hospital provider contracts, inpatient utilization reductions and lower pharmacy costs.
The medical care ratio of the Michigan health plan increased to 88.1% in the first quarter of 2013, from 84.0% in the first quarter of 2012, primarily as a result of higher pharmacy and fee-for-service costs.
The medical care ratio of the New Mexico health plan increased to 85.9% in the first quarter of 2013, from 84.7% in the first quarter of 2012, primarily as a result of higher pharmacy and fee-for-service costs.
The medical care ratio of the Ohio health plan decreased to 84.6% for the first quarter of 2013, from 87.4% for the first quarter of 2012, primarily as a result of a 4% premium rate increase effective January 1, 2013.
The medical care ratio of the Texas health plan was 90.3%80.9% in the thirdfirst quarter of 2013 compared with 92.3% in the first quarter of 2012. We previously reported on the financial challenges faced by the Texas health plan. Although first quarter results show considerable improvement over the results reported for the first quarter of 2012, compared with 109.4% inmanagement cautions investors regarding the secondfollowing points:

The first quarters of 2013 and 2012 are not meaningfully comparable. The state of Texas expanded Medicaid managed care into new regions effective March 1, 2012. Additionally, the state extended inpatient facility and pharmacy benefits into Medicaid managed care on that date. The result of these actions was to dramatically increase the Texas health plan's revenue and medical costs between the first quarter of 2012 and 93.7% in2013.

The Texas health plan received a 4% rate increase (adding about $4 million to monthly revenue) effective September 1, 2012.

Certain out-of-period adjustments artificially lowered the third quarter of 2011. The medical care ratio for the Texas health plan’s ABD membership declined to 94%plan in the thirdfirst quarter of 2013. Absent the previously described $6 million out-of-period benefit related to 2012 performance revenue, and a $13.5 million benefit from 119% infavorable development of the second quarter. We received a blended rate increase in Texas of approximately 4%, or $4.5 million per month, effective September 1, 2012. The loss before taxesclaims liability established for the health plan at December 31, 2012, the Texas health plan was approximately $5 million for the third quarter of 2012, compared with approximately $68 million for the second quarter of 2012 (which included a premium deficiency reserve charge of $10 million). In our Quarterly Report on Form 10-Q for the period ended June 30, 2012, we discussed the steps we are taking to return the Texas health plan to profitability. We confirm the previously disclosed expectation that the Texas health plan will be operating at financial break even on a go forward basis by December 2012.

The medical care ratio at the California health plan increased to 96.1% in the third quarter of 2012 from 88.8% in the third quarter of 2011. The higher medical care ratio was primarily the result of a shift in member mix to include more ABD members. Theplan's medical care ratio for the California health plan’s ABD membership was 110% in the thirdfirst quarter of 2012, 100% for2013 would have been approximately 86.6% rather than the nine months ended September 30, 2012, and 84% for the third quarter of 2011. The California Department of Health Care Services has recently solicited health plan input as to whether to conduct a review of the adequacy of ABD premium rates in California. The California health plan, which believes the ABD premium rates to be inadequate, has provided input supporting such a review. During the fourth quarter of 2012, we intend to exit an unprofitable service area in California, reducing enrollment by approximately 6,000 members.

The California health plan’s medical care ratio also increased by 1.4% in the third quarter of 2012 due to reductions to premium revenue of $2.4 million related to the expected reduction in premium rates of 2.35% for the elimination of the gross premium tax effective July 1, 2012. The reduction in premium was offset by an equivalent decrease in premium tax of $2.4 million. Although the state has not yet reduced the premium rates, we believe that both premium taxes and premium rates will be reduced equivalently retroactive to July 1, 2012.

Thereported medical care ratio of 80.9%.


While management continues to work to improve the Floridafinancial performance of the Texas health plan, decreasedmanagement also believes that increased payments to 84.0%certain providers are necessary. Specifically, the health plan intends to increase provider reimbursement for personal attendant services and day activity and health services effective July 1, 2013. We anticipate that this increase in provider payments alone will add approximately $10 million to medical expense in the third quartersecond half of 2012, from 89.2% in the third quarter of 2011 due to a premium rate increase effective September 1, 2011, the re-contracting of portions of the health plan’s specialty care network, lower inpatient utilization and lower pharmacy costs.

The medical care ratio of the Michigan health plan increased to 89.3% in the third quarter of 2012, from 82.0% in the third quarter of 2011. The primary reason for the increase in the medical care ratio in 2012 was a reduction to premium rates linked to a decrease in premium taxes, in which both premium taxes and premium revenue were reduced equivalently effective April 1, 2012. The result was a higher medical care ratio in 2012, but there was no impact on profitability as premium tax expense was reduced by the same amount as premium revenue. The remainder of the deterioration in the Michigan plan’s medical care ratio was the result of higher pharmacy and fee for service costs. We expect to receive a blended rate increase in Michigan of approximately 2%, effective October 1, 2012.

The medical care ratio of the New Mexico health plan increased to 86.9% in the third quarter of 2012, from 84.2% in the third quarter of 2011, primarily as a result of higher inpatient facility costs.

The medical care ratio of the Ohio health plan increased to 82.7% for the third quarter of 2012 from 78.4% for the third quarter of 2011. The increase in the Ohio health plan’s medical care ratio was primarily the result of a 2% rate reduction effective January 1, 2012, together with the assumption of the lower margin pharmacy benefit effective October 1, 2011. Although the Ohio health plan’s medical care ratio increased in 2012, the medical margin (measured as total premium revenue less total medical care costs) increased to $52.9 million in the third quarter of 2012, from $50.2 million in the third quarter of 2011.

2013.

The medical care ratio of the Utah health plan increased to 85.2%86.8% in the thirdfirst quarter of 20122013, from 79.3%77.0% in the thirdfirst quarter of 2011. The Utah health plan received2012 primarily due to a Medicaid premium rate reduction of approximately 2%16% (exclusive of the pharmacy benefit added) effective January 1, 2013.
The medical care ratio of the Washington health plan increased to 87.6% in the first quarter of 2013, compared with 85.7% in the first quarter of 2012 primarily due to the addition of ABD members effective July 1, 2012.

The addition of ABD members to the Washington health plan effective July 1, 2012 increased its medical care ratio to 86.4% in the third quarter of 2012 compared with 82.8% in the third quarter of 2011. The higher premium revenue PMPM associated with the ABD membership, however, offset the increased medical care ratio, so that income from operations was consistent between the third quartersexcess of 2012 and 2011. Thepremium revenue over medical care ratiocosts increased to $42.3 million for the Washington health plan’s new ABD membership was 93% in the thirdfirst quarter of 2012.

The Wisconsin health plan reported a medical care ratio of 93.5%2013, compared with $34.2 million for the thirdfirst quarter of 2012 compared with 79.1% for the third quarter of 2011. We believe that the state’s premium rates in effect through December 31, 2012 are not adequate to cover the costs of servicing that contract. Accordingly, we recorded a premium deficiency reserve for the Wisconsin health plan at June 30, 2012 of $3.0 million. One-half of that reserve was reversed during the third quarter corresponding with the reduction in the number of months remaining in the rating period. Absent the $1.5 million partial reversal of the premium deficiency reserve, the2012.

The medical care ratio of the Wisconsin health plan would have been approximately 102.6% for the third quarter of 2012. Inpatient costsdecreased to 87.2% in the TANF program are the primary driverfirst quarter of the increased costs2013, compared with 98.5% in the thirdfirst quarter of 2012 when compared with the third quarter 2011.. The Wisconsin health plan will receive new premium rates effective January 1, 2013. Company management believes that premiums remain too low to cover medical costs and is working with the state and CMS to achieve actuarially sound rates. Additionally, our Wisconsin plan has implemented provider contracting initiatives and new utilization management techniques as a part of its efforts to improve profitability. If we are unable to achieve rates that are actuarially sound, it may no longer be feasible for us to continue as aprofitability, including in-sourcing the management of behavioral health services. The health plan received a 3% premium rate increase effective January 1, 2013. Additionally, the health plan gained 40,000 members in February and March due to another health plan's recent exit from the state.

market. We are closely monitoring the utilization patterns and loss reserves for these new members.


41


Health Plans Segment Operating Data

The following table summarizes member months, premium revenue, medical care costs, medical care ratio, and premium taxes by health plan for the periods indicated (PMPM amounts are in whole dollars; member months and other dollar amounts are in thousands):

   Three Months Ended September 30, 2012 
       Premium Revenue   Medical Care Costs         MCR
Excluding
 
   Member
Months (1)
   Total   PMPM   Total   Expense   Medical
Care Ratio
  Premium Tax
Expense
  Premium Tax
Expense (4)
 

California

   1,041    $162,389    $156.00    $156,106    $149.96     96.1 $—      96.1

Florida

   214     57,429     268.56     48,250     225.64     84.0    (5  84.0  

Michigan

   656     160,637     244.91     143,513     218.80     89.3    1,046    89.9  

Missouri (2)

   —       —       —       —       —       —      —      —    

New Mexico

   269     84,797     315.49     73,721     274.28     86.9    1,761    88.8  

Ohio

   805     306,314     380.20     253,447     314.58     82.7    23,824    89.7  

Texas

   890     350,810     394.10     316,716     355.80     90.3    6,289    91.9  

Utah

   256     73,484     287.21     62,630     244.79     85.2    —      85.2  

Washington

   1,217   �� 274,079     225.29     236,928     194.76     86.4    4,888    88.0  

Wisconsin

   124     16,279     131.21     15,217     122.65     93.5    —      93.5  

Other (3)

   —       2,500     —       8,043     —       —      91    —    
  

 

 

   

 

 

     

 

 

      

 

 

  
   5,472    $1,488,718    $272.08    $1,314,571    $240.25     88.3 $37,894    90.6
  

 

 

   

 

 

     

 

 

      

 

 

  
   Three Months Ended September 30, 2011 
       Premium Revenue   Medical Care Costs         MCR
Excluding
 
   Member
Months (1)
   Total   PMPM   Total   Expense   Medical
Care Ratio
  Premium Tax
Expense
  Premium Tax
Expense (4)
 

California

   1,049    $144,888    $138.11    $128,596    $122.58     88.8 $1,114    89.4

Florida

   199     51,569     258.96     46,009     231.04     89.2    (17  89.2  

Michigan

   656     165,636     252.46     135,899     207.13     82.0    9,644    87.1  

Missouri (2)

   234     58,196     248.80     45,428     194.22     78.1    —      78.1  

New Mexico

   267     79,644     297.82     67,043     250.70     84.2    2,084    86.4  

Ohio

   745     232,616     312.55     182,363     245.02     78.4    18,072    85.0  

Texas

   414     105,577     255.25     98,954     239.24     93.7    1,613    95.2  

Utah

   243     69,763     286.47     55,293     227.05     79.3    —      79.3  

Washington

   1,043     211,131     202.49     174,912     167.76     82.8    3,776    84.4  

Wisconsin

   123     17,269     139.95     13,656     110.67     79.1    —      79.1  

Other (3)

   —       1,941     —       11,005     —       —      88    —    
  

 

 

   

 

 

     

 

 

      

 

 

  
   4,973    $1,138,230    $228.88    $959,158    $192.87     84.3 $36,374    87.0
  

 

 

   

 

 

     

 

 

      

 

 

  

 Three Months Ended March 31, 2013
   Premium Revenue Medical Care Costs   MCR (2)
 
Member
Months (1)
 Total PMPM Total PMPM 
Premium Tax
Expense
 
California1,001
 $187,880
 $187.64
 $159,763
 $159.56
 $92
 85.1%
Florida223
 58,167
 260.15
 49,404
 220.95
 3
 84.9
Michigan652
 167,676
 257.24
 146,748
 225.13
 1,119
 88.1
New Mexico274
 85,798
 313.54
 72,149
 263.66
 1,798
 85.9
Ohio726
 291,518
 401.73
 227,454
 313.45
 22,710
 84.6
Texas832
 335,296
 402.99
 266,449
 320.24
 5,845
 80.9
Utah259
 74,956
 289.59
 65,029
 251.24
 
 86.8
Washington1,250
 303,719
 243.05
 261,397
 209.18
 5,433
 87.6
Wisconsin200
 27,124
 135.53
 23,664
 118.24
 
 87.2
Other (3) (4)

 2,474
 
 16,697
 
 
 
 5,417
 $1,534,608
 $283.32
 $1,288,754
 $237.93
 $37,000
 86.1%
              
 Three Months Ended March 31, 2012
   Premium Revenue Medical Care Costs   MCR (2)
 
Member
Months (1)
 Total PMPM Total PMPM 
Premium Tax
Expense
 
California1,059
 $161,685
 $152.65
 $141,349
 $133.45
 $2,309
 88.7%
Florida208
 56,190
 269.87
 49,569
 238.07
 7
 88.2
Michigan665
 167,906
 252.49
 134,211
 201.82
 8,040
 84.0
Missouri (4)
243
 56,613
 233.32
 53,120
 218.93
 
 93.8
New Mexico266
 81,226
 305.63
 67,111
 252.52
 1,953
 84.7
Ohio746
 293,525
 393.73
 236,701
 317.51
 22,853
 87.4
Texas592
 198,236
 334.61
 180,089
 303.97
 3,197
 92.3
Utah252
 75,138
 297.59
 57,881
 229.24
 
 77.0
Washington1,067
 215,610
 202.08
 181,425
 170.04
 3,816
 85.7
Wisconsin125
 17,142
 136.97
 16,886
 134.92
 
 98.5
Other (3)

 2,135
 
 12,646
 
 11
 
 5,223
 $1,325,406
 $253.75
 $1,130,988
 $216.53
 $42,186
 88.1%
(1)A member month is defined as the aggregate of each month’s ending membership for the period presented.
(2)Our contract with the stateThe MCR represents medical costs as a percentage of Missouri expired without renewal on June 30, 2012. The Missouri health plan’s claims run-out activity subsequent to June 30, 2012,premium revenues, where premium revenue is reported in “Other.”reduced by premium tax expense.
(3)“Other” medical care costs also include medically related administrative costs at the parent company.
(4)The MCR Excluding Premium Tax Expense represents medical costs as a percentage of premium revenues, where premium revenue is reduced by premium tax expense.

Molina Medicaid Solutions Segment

Performance of the Molina Medicaid Solutions segment was as follows:

   Three Months Ended September 30, 
   2012  2011 
   (In thousands) 

Service revenue before amortization

  $48,958   $39,273  

Amortization recorded as reduction of service revenue

   (536  (1,545
  

 

 

  

 

 

 

Service revenue

   48,422    37,728  

Cost of service revenue

   37,004    34,584  

General and administrative costs

   1,980    2,069  

Amortization of customer relationship intangibles recorded as amortization

   1,282    1,282  
  

 

 

  

 

 

 

Operating income (loss)

  $8,156   $(207
  

 

 

  

 

 

 

Operating income for our Molina Medicaid Solutions segment improved $8.4 million for the three months ended September 30, 2012, compared with the same prior year period. This improvement was primarily the result of stabilization of our newest Medicaid Management Information Systems, or MMIS, in Idaho and Maine. As discussed earlier, our Idaho MMIS has received full federal certification. Among the reasons cited by the Company for purchasing Molina Medicaid Solutions effective May 1, 2010, was the benefit of reducing our reliance on health plan operations. For the quarter ended September 30, 2012, the Molina Medicaid Solutions segment gross margin rate was 23.6%, compared with 11.7% for the Health Plans segment.

Nine Months Ended September 30, 2012 Compared with the Nine Months Ended September 30, 2011

Health Plans Segment

Premium Revenue

In the nine months ended September 30, 2012, compared with the nine months ended September 30, 2011, premium revenue grew 28.7% primarily due to an increase in membership, a shift in member mix to populations generating higher premium revenue per member per month (PMPM), and benefit expansions. Medicare premium revenue was $346.6 million for the nine months ended September 30, 2012, compared with $282.3 million for the nine months ended September 30, 2011.

Growth in our ABD membership led to higher premium revenue PMPM in 2012. ABD membership, as a percent of total membership, has increased approximately 37% year over year. Premium revenue PMPM also increased in the nine months ended September 30, 2012, as a result of the inclusion of revenue from the pharmacy benefit for our Ohio health plan effective October 1, 2011, and as a result of the inclusion of revenue from the inpatient facility and pharmacy benefits across all of our Texas health plan membership effective March 1, 2012.

Medical Care Costs

The following table provides the details of consolidated medical care costs for the periods indicated (dollars in thousands except PMPM amounts):

   Nine Months Ended September 30, 
   2012  2011 
   Amount   PMPM   % of
Total
  Amount   PMPM   % of
Total
 

Fee for service

  $2,666,470    $164.09     69.8 $2,050,430    $138.40     72.7

Pharmacy

   606,004     37.29     15.9    268,637     18.13     9.5  

Capitation

   417,643     25.70     10.9    383,955     25.92     13.6  

Other

   133,019     8.19     3.4    119,027     8.03     4.2  
  

 

 

   

 

 

   

 

 

  

 

 

   

 

 

   

 

 

 

Total

  $3,823,136    $235.27     100.0 $2,822,049    $190.48     100.0
  

 

 

   

 

 

   

 

 

  

 

 

   

 

 

   

 

 

 

Our medical care ratio and medical margin deteriorated in the nine months ended September 30, 2012, when compared with the nine months ended September 30, 2011, for the same reasons described above in the “Three Months Ended September 30, 2012 Compared with the Three Months Ended September 30, 2011.”

Health Plans Segment Operating Data

The following table summarizes member months, premium revenue, medical care costs, medical care ratio, and premium taxes by health plan for the periods indicated (PMPM amounts are in whole dollars; member months and other dollar amounts are in thousands):

   Nine Months Ended September 30, 2012  

MCR
Excluding

Premium

 
   Member   Premium Revenue   Medical Care Costs   Medical Care  Premium Tax  Tax 
   Months (1)   Total   PMPM   Total   PMPM   Ratio  Expense  Expense(4) 

California

   3,156    $491,718    $155.80    $446,694    $141.53     90.8 $5,004    91.8

Florida

   632     170,922     270.47     146,261     231.44     85.6    (18  85.6  

Michigan

   1,983     491,301     247.78     419,406     211.52     85.4    11,203    87.4  

Missouri (2)

   483     113,818     235.63     113,101     234.15     99.4    —      99.4  

New Mexico

   801     253,418     316.56     208,668     260.66     82.3    5,971    84.3  

Ohio

   2,313     896,908     387.74     735,432     317.93     82.0    69,689    88.9  

Texas

   2,389     908,532     380.30     890,042     372.57     98.0    16,155    99.7  

Utah

   767     225,533     293.93     183,930     239.71     81.6    —      81.6  

Washington

   3,352     697,065     207.97     592,398     176.75     85.0    12,599    86.5  

Wisconsin

   374     52,209     139.46     54,861     146.54     105.1    —      105.1  

Other (3)

   —       7,015     —       32,343     —       —      350    —    
  

 

 

   

 

 

     

 

 

      

 

 

  
   16,250    $4,308,439    $265.14    $3,823,136    $235.27     88.7 $120,953    91.3
  

 

 

   

 

 

     

 

 

      

 

 

  
   Nine Months Ended September 30, 2011  

MCR
Excluding

Premium

 
   Member   Premium Revenue   Medical Care Costs   Medical Care  Premium Tax  Tax 
   Months (1)   Total   PMPM   Total   PMPM   Ratio  Expense  Expense(4) 

California

   3,133    $418,961    $133.71    $359,844    $114.84     85.9 $4,937    86.9

Florida

   588     150,561     256.13     141,872     241.35     94.2    34    94.3  

Michigan

   2,002     495,971     247.70     399,952     199.75     80.6    29,219    85.7  

Missouri (2)

   722     169,988     235.45     148,135     205.18     87.1    —      87.1  

New Mexico

   808     246,223     304.71     205,659     254.51     83.5    6,472    85.8  

Ohio

   2,218     693,829     312.86     533,216     240.44     76.9    53,629    83.3  

Texas

   1,154     290,787     252.06     271,723     235.54     93.4    5,016    95.1  

Utah

   723     215,205     297.62     167,605     231.79     77.9    —      77.9  

Washington

   3,104     608,998     196.25     515,769     166.20     84.7    11,099    86.3  

Wisconsin

   364     51,526     141.42     47,450     130.23     92.1    44    92.2  

Other (3)

   —       6,389     —       30,824     —       —      183    —    
  

 

 

   

 

 

     

 

 

      

 

 

  
   14,816    $3,348,438    $226.01    $2,822,049    $190.48     84.3 $110,633    87.2
  

 

 

   

 

 

     

 

 

      

 

 

  

(1)A member month is defined as the aggregate of each month’s ending membership for the period presented.
(2)(4)Our contract with the state of Missouri expired without renewal on June 30, 2012. The Missouri health plan’splan's claims run-out activity subsequent to June 30, 2012, is reported in “Other.”"Other."
(3)“Other” medical care costs also include medically related administrative costs of the parent company.
(4)The MCR Excluding Premium Tax Expense represents medical costs as a percentage of premium revenues, where premium revenue is reduced by premium tax expense.

Molina Medicaid Solutions Segment


42

Table of Contents

Performance of the Molina Medicaid Solutions segment was as follows:

   Nine Months Ended September 30, 
   2012  2011 
   (In thousands) 

Service revenue before amortization

  $133,193   $116,567  

Amortization recorded as reduction of service revenue

   (842  (5,277
  

 

 

  

 

 

 

Service revenue

   132,351    111,290  

Cost of service revenue

   98,111    105,020  

General and administrative costs

   7,187    6,421  

Amortization of customer relationship intangibles recorded as amortization

   3,846    3,846  
  

 

 

  

 

 

 

Operating income (loss)

  $23,207   $(3,997
  

 

 

  

 

 

 

 Three Months Ended March 31,
 2013 2012
 (In thousands)
Service revenue before amortization$50,485
 $42,358
Amortization recorded as reduction of service revenue(729) (153)
Service revenue49,756
 42,205
Cost of service revenue39,770
 30,494
General and administrative costs2,351
 2,020
Amortization of customer relationship intangibles recorded as amortization1,282
 1,282
Operating income$6,353
 $8,409

Operating income for our Molina Medicaid Solutions segment improved $27.2decreased $2.1 million for the ninethree months ended September 30, 2012,March 31, 2013, compared with the same prior year periodperiod. The decrease in operating income was primarily the result of a change in the mix of transactions processed from fee-for-service claims to managed care encounters (processing fees are lower for the reasons discussed above in “Three Months Ended September 30, 2012 Compared with the Three Months Ended September 30, 2011.”

encounters than for fee-for-service claims) and changes to state contracts implemented during 2012.


Consolidated Expenses


General and Administrative Expenses

General and administrative expenses decreased to 8.3% of total revenue for the three months ended September 30, 2012, compared with 8.5% of total revenue for the three months ended September 30, 2011.


General and administrative expenses increased to 8.5%8.9% of total revenue for the ninethree months ended September 30, 2012,March 31, 2013, compared with 8.4%8.8% of total revenue for the ninethree months ended September 30, 2011.March 31, 2012. The increased ratio of general and administrative expenses to total revenue for the ninethree months ended September 30, 2012,March 31, 2013, was primarily due to continuing investments in administrative infrastructure relating to our membership growth in Texas, and in anticipation of opportunities among the dual-eligible population.


Premium Tax Expense


Premium tax expense decreased to 2.5%2.4% of premium revenue for the three months ended September 30, 2012,March 31, 2013, from 3.2% in the three months ended September 30, 2011, and decreased to 2.8% of premium revenue,March 31, 2012. The decrease in the nine months ended September 30, 2012, from 3.3% in the nine months ended September 30, 2011. The quarter and year-to-date decreases were2013 was primarily due to the reduction of premium taxes at the Michigan and California health plans effective in 2012, as discussed in “Three Months Ended September 30, 2012 Compared with the Three Months Ended September 30, 2011,” above, and the growth in revenue at our Texas health plan, which is subject to a lower premium tax rate (measured as a percentage of premium revenue) than our consolidated average.

2012.


Depreciation and Amortization


Depreciation and amortization related to our Health Plans segment is all recorded in “Depreciation and Amortization” in the consolidated statements of income. Amortization related to our Molina Medicaid Solutions segment is recorded within three different headings in the consolidated statements of income as follows:

Amortization of purchased intangibles relating to customer relationships is reported as amortization within the heading “Depreciation and Amortization;”

Amortization of purchased intangibles relating to contract backlog is recorded as a reduction of “Service Revenue;” and

Amortization of capitalized software is recorded within the heading “Cost of Service Revenue.”


43

Table of Contents

The following table presents all depreciation and amortization recorded in our consolidated statements of income, regardless of whether the item appears as depreciation and amortization, a reduction of service revenue, or as cost of service revenue.

   Three Months Ended September 30, 
   2012  2011 
   Amount   % of  Total
Revenue
  Amount   % of  Total
Revenue
 
   (Dollar amounts in thousands) 

Depreciation, and amortization of capitalized software

  $11,201     0.7 $8,234     0.7

Amortization of intangible assets

   4,833     0.3    5,196     0.4  
  

 

 

   

 

 

  

 

 

   

 

 

 

Depreciation and amortization reported as such in the consolidated statements of income

   16,034     1.0    13,430     1.1  

Amortization recorded as reduction of service revenue

   536     0.1    1,545     0.1  

Amortization of capitalized software recorded as cost of service revenue

   3,709     0.2    2,837     0.2  
  

 

 

   

 

 

  

 

 

   

 

 

 

Total

  $20,279     1.3 $17,812     1.4
  

 

 

   

 

 

  

 

 

   

 

 

 

   Nine Months Ended September 30, 
   2012  2011 
   Amount   % of  Total
Revenue
  Amount   % of  Total
Revenue
 
   (Dollar amounts in thousands) 

Depreciation, and amortization of capitalized software

  $31,524     0.7 $22,859     0.7

Amortization of intangible assets

   15,922     0.4    15,728     0.5  
  

 

 

   

 

 

  

 

 

   

 

 

 

Depreciation and amortization reported as such in the consolidated statements of income

   47,446     1.1    38,587     1.2  

Amortization recorded as reduction of service revenue

   842     —      5,277     0.1  

Amortization of capitalized software recorded as cost of service revenue

   10,001     0.2    8,550     0.2  
  

 

 

   

 

 

  

 

 

   

 

 

 

Total

  $58,289     1.3 $52,414     1.5
  

 

 

   

 

 

  

 

 

   

 

 

 

 Three Months Ended March 31,
 2013 2012
 Amount % of Total Revenue Amount % of Total Revenue
 (Dollar amounts in thousands)
Depreciation, and amortization of capitalized software$12,447
 0.8% $9,472
 0.7%
Amortization of intangible assets4,118
 0.3
 5,553
 0.4
Depreciation and amortization reported as such in the consolidated statements of income16,565
 1.1
 15,025
 1.1
Amortization recorded as reduction of service revenue729
 
 153
 
Amortization of capitalized software recorded as cost of service revenue4,505
 0.3
 3,161
 0.2
Total$21,799
 1.4% $18,339
 1.3%
Other Expenses (Income)
Interest Expense

Interest expense decreasedincreased to $4.3$13.0 million for the three months ended September 30, 2012,March 31, 2013, from $4.4$4.3 million for the three months ended September 30, 2011, and increased to $12.4 million for the nine months ended September 30,March 31, 2012 from $11.7 million for the nine months ended September 30, 2011, primarily due to interest expense associated with the long-term debt we incurred to purchase our corporate headquarters buildingissuance of the 1.125% Notes in December 2011.February 2013. Interest expense includes non-cash interest expense relating to our convertible senior notes, which amounted to $1.5$3.7 million and $1.4$1.4 million for the three months ended September 30, 2012,March 31, 2013, and 2011, respectively, and $4.42012, respectively. Interest expense in 2013 also included the immediate recognition of approximately $6 million and $4.1of interest expense relating to debt issuance costs. The remainder of the fees associated with that issuance, amounting to approximately $12 million, forwill be expensed over the nine months ended September 30, 2012, and 2011, respectively

seven-year life of the 1.125% Notes.

Income Taxes

The provision for income taxes is recorded at an effective rate of (17.1%)44.8% for the three months ended September 30, 2012March 31, 2013 compared with 35.1%37.9% for the three months ended September 30, 2011, and 49.0% for the nine months ended September 30,March 31, 2012 compared with 36.4% for the nine months ended September 30, 2011.. The higher rate in 20122013 is primarily due to the greater proportional impact of non-deductible compensation under a provision of the Affordable Care Act that limits deductions claimed by health insurers on compensation earned after December 31, 2009 that is paid after December 31, 2012.
Other Transactions
As described above, our Missouri health plan, Alliance for Community Health, L.L.C. (ACH), was not awarded a contract under the effective tax rate as earnings before taxes decrease. We recorded a tax benefitMissouri HealthNet Managed Care Request for Proposal; therefore, our Missouri health plan's prior contract with the three months ended Septemberstate (the MC+ Contract) expired without renewal on June 30, 2012, primarily duesubject to certain transition obligations which terminate on June 30, 2013. On April 5, 2013, ACH entered into an assignment and assumption agreement with an affiliated company, Molina Healthcare of Illinois, Inc., another one of our wholly owned subsidiaries (Molina Illinois), pursuant to which ACH assigned to Molina Illinois substantially all of its assets and liabilities, including its surviving rights, duties and obligations, including all of the post-expiration duties and services under the MC+ Contract. Such assignment was approved by the Missouri Department of Insurance, Financial Institutions and Professional Registration, and the Illinois Department of Insurance. The state of Missouri's Medicaid agency also consented to the incremental impactassignment. Subsequent to the effectiveness of the increaseassignment and assumption agreement, ACH surrendered its Missouri certificate of authority as a health maintenance organization. We intend to abandon our equity interests in our estimated annual tax rate relatingACH to an unrelated entity. Pursuant to such transaction, ACH will retain certain assets and investments to which we will no longer have access after the year-to-date net loss.

abandonment transaction is effected, and which amounts we intend to write off.


Liquidity and Capital Resources


Introduction
We manage our cash, investments, and capital structure to meet the short- and long-term obligations of our business while maintaining liquidity and financial flexibility. We forecast, analyze, and monitor our cash flows to enable prudent investment management and financing within the confines of our financial strategy.


44

Table of Contents

Our regulated subsidiaries generate significant cash flows from premium revenue. Such cash flows are our primary source of liquidity. Thus, any future decline in our profitability may have a negative impact on our liquidity. We generally receive premium revenue in advance of the payment of claims for the related health care services. A majority of the assets held by our regulated subsidiaries are in the form of cash, cash equivalents, and investments. After considering expected cash flows from operating activities, we generally invest cash of regulated subsidiaries that exceeds our expected short-term obligations in longer term, investment-grade, and marketable debt securities to improve our overall investment return. These investments are made pursuant to board approved investment policies which conform to applicable state laws and regulations. Our investment policies are designed to provide liquidity, preserve capital, and maximize total return on invested assets, all in a manner consistent with state requirements that prescribe the types of instruments in which our subsidiaries may invest. These investment policies require that our investments have final maturities of five years or less (excluding auction rate securities and variable rate securities, for which interest rates are periodically reset) and that the average maturity be two years or less. Professional portfolio managers operating under documented guidelines manage our investments. As of September 30, 2012,March 31, 2013, a substantial portion of our cash was invested in a portfolio of highly liquid money market securities, and our investments consisted solely of investment-grade debt securities. All of our investments are classified as current assets, except for our restricted investments, and our investments in auction rate securities, which are classified as non-current assets. Our restricted investments are invested principally in certificates of deposit and U.S. treasury securities.

Investment income increased to $4.0was $1.5 million for the ninethree months ended September 30, 2012,March 31, 2013, compared with $3.8$1.7 million for the ninethree months ended September 30, 2011.March 31, 2012. Our annualized portfolio yield for the ninethree months ended September 30, 2012March 31, 2013 was 0.5%0.4% compared with 0.6% for the ninethree months ended September 30, 2011.

March 31, 2012.

Investments and restricted investments are subject to interest rate risk and will decrease in value if market rates increase. We have the ability to hold our restricted investments until maturity. Declines in interest rates over time will reduce our investment income.

Cash in excess of the capital needs of our regulated health plans is generally paid to our non-regulated parent company in the form of dividends, when and as permitted by applicable regulations, for general corporate use.

Liquidity
Cash provided by operating activities for the ninethree months ended September 30, 2012March 31, 2013 was $264.0$20.1 million compared with $155.2$50.6 million for the ninethree months ended September 30, 2011, an increaseMarch 31, 2012, a decrease of $108.8 million. Higher$30.5 million. The decrease in cash provided by operating activities was primarily due to the changes in deferred revenue and medical claims and benefits payable, at our Texas health plan waspartially offset by the primary reason for the increasechange in cash flow provided by operating activities, followed by an increase in deferred revenue. Medicalaccounts receivable. Deferred revenue and medical claims and benefits payable were a use of operating cash amounting to $9.4 million in the aggregate in the three months ended March 31, 2013, compared with a source of operating cash of $134.0$97.9 million in the nine months ended September 30, 2012 compared with $6.7 millionaggregate in the nine months ended September 30, 2011. Deferred revenuesame period in 2012. Accounts receivable was a sourceuse of operating cash amounting to $92.4$0.6 million in the ninethree months ended September 30, 2012,March 31, 2013, compared with $25.4$54.4 million in the ninesame period in 2012.
Cash used in investing activities for the three months ended September 30, 2011.

Reconciliation of Non-GAAP(1)March 31, 2013 to GAAP Financial Measures

EBITDA(2)

   Three Months Ended
September 30,
   Nine Months Ended
September 30,
 
   2012  2011   2012  2011 
   (In thousands) 

Net income (loss)

  $3,364   $18,950    $(15,853 $53,778  

Add back:

      

Depreciation and amortization reported in the consolidated statements of cash flows

   20,279    17,812     58,289    52,414  

Interest expense

   4,315    4,380     12,421    11,666  

Income tax (benefit) expense

   (492  10,236     (15,228  30,832  
  

 

 

  

 

 

   

 

 

  

 

 

 

EBITDA

  $27,466   $51,378    $39,629   $148,690  
  

 

 

  

 

 

   

 

 

  

 

 

 

(1)GAAP stands for U.S. generally accepted accounting principles.
(2)EBITDA is not prepared in conformity with GAAP because it excludes depreciation and amortization, as well as interest expense, and the provision for income taxes. This non-GAAP financial measure should not be considered as an alternative to the GAAP measures of net income, operating income, operating margin, or cash provided by operating activities, nor should EBITDA be considered in isolation from these GAAP measures of operating performance. Management uses EBITDA as a supplemental metric in evaluating our financial performance, in evaluating financing and business development decisions, and in forecasting and analyzing future periods. For these reasons, management believes that EBITDA is a useful supplemental measure to investors in evaluating our performance and the performance of other companies in our industry.

Capital Resources

At September 30, 2012, the parent company — Molina Healthcare, Inc. — held cash and investments of approximately $41.0was $21.2 million compared with approximately $23.6$42.7 million for the three months ended March 31, 2012, a decrease of cash$21.5 million. This decrease was primarily due to reduced purchases of investments in 2013.

Cash provided by financing activities for the three months ended March 31, 2013 was $374.8 million compared with $16.0 million for the three months ended March 31, 2012, an increase of $358.8 million. The significant increase was primarily due to $538.0 million in proceeds we received from our offering of 1.125% Notes and investments at December 31, 2011.

$75.1 million from the sale of warrants, partially offset by $149.3 million paid for the purchased call option relating to the 1.125% Notes, $50.0 million paid for repurchases of our common stock, and $40.0 million used to repay our Credit Facility.


Financial Condition

On a consolidated basis, at September 30, 2012,March 31, 2013, we had working capital of $482.4$924.0 million compared with $446.2$521.1 million at December 31, 2011.2012. At September 30, 2012,March 31, 2013, and December 31, 2011,2012, we had cash and investments, including restricted investments, of $1,130.4$1,580.2 million, and $893.0$1,196.1 million, respectively.

Effective as of October 26, 2011, our board of directors authorized the repurchase of $75 million in aggregate of either our common stock or our convertible senior notes due 2014 (see discussion of “Convertible Senior Notes” below). This repurchase program expired October 25, 2012. No securities were purchased under this program in the nine months ended September 30, 2012.

We believe that our cash resources Credit Facility (as defined below) and internally generated funds will be sufficient to support our operations, regulatory requirements, and capital expenditures for at least the next 12 months.


Regulatory Capital and Dividend Restrictions

Our health plans, which are operated by our respective wholly owned subsidiaries in those states, are subject to state laws and regulations that, among other things, require the maintenance of minimum levels of statutory capital, as defined by each

45

Table of Contents

Credit Facilitystate. Such state laws and regulations also restrict the timing, payment, and amount of dividends and other distributions that may be paid to us as the sole stockholder. To the extent our subsidiaries must comply with these regulations, they may not have the financial flexibility to transfer funds to us. The net assets in these subsidiaries (after intercompany eliminations) which may not be transferable to us in the form of loans, advances, or cash dividends was

On September 9, 2011, we entered into a credit agreement for a $170 $572.9 million revolving credit facility (the “Credit Facility”) with various lendersat March 31, 2013, and U.S. Bank$549.7 million at December 31, 2012. Because of the statutory restrictions that inhibit the ability of our health plans to transfer net assets to us, the amount of retained earnings readily available to pay dividends to our stockholders is generally limited to cash, cash equivalents and investments held by the parent company – Molina Healthcare, Inc. Such cash, cash equivalents and investments amounted to $450.5 million and $46.9 million as of March 31, 2013, and December 31, 2012, respectively.


The National Association as LC Issuer, Swing Line Lender,of Insurance Commissioners, or NAIC, adopted rules effective December 31, 1998, which, if implemented by the states, set minimum capitalization requirements for insurance companies, HMOs, and Administrative Agent.other entities bearing risk for health care coverage. The Credit Facility is usedrequirements take the form of risk-based capital (RBC) rules. Michigan, New Mexico, Ohio, Texas, Utah, Washington, and Wisconsin have adopted these rules, which may vary from state to state. California and Florida have not adopted NAIC risk-based capital requirements for general corporate purposes.

The Credit Facility has a termHMOs and have not formally given notice of five years under which all amounts outstanding will be duetheir intention to do so. Such requirements, if adopted by California and payable on September 9, 2016. Subject to obtaining commitments from existing or new lenders and satisfaction of other specified conditions, weFlorida, may increase the Credit Facility to up to $195 million. minimum capital required for those states.


As of September 30, 2012 there was $40.0March 31, 2013, our health plans had aggregate statutory capital and surplus of approximately $585.5 million outstanding undercompared with the Credit Facility. Additionally,required minimum aggregate statutory capital and surplus of approximately $341.7 million. All of our health plans were in compliance with the minimum capital requirements atMarch 31, 2013. We have the ability and commitment to provide additional capital to each of our health plans when necessary to ensure that statutory capital and surplus continue to meet regulatory requirements.
As described in Note 2 to the accompanying Notes to the Consolidated Financial Statements, the ACA imposes an annual fee on health insurers for each calendar year beginning on or after January 1, 2014. The fee will be imposed beginning in 2014 based on a company's share of the industry's net premiums written during the preceding calendar year. If the fee assessment is enacted as written, our minimum capitalization requirements will increase significantly on January 1, 2014; we are currently evaluating the impact of September 30, 2012,the fee assessment to our lenders had issued two lettersfinancial position, results of credit inoperations and cash flows.

Future Sources and Uses of Liquidity
As of March 31, 2013, maturities of long-term debt for the years ending December 31 are as follows (in thousands):
 Total 2013 2014 2015 2016 2017 Thereafter
1.125% Notes$550,000
 $
 $
 $
 $
 $
 $550,000
3.75% Notes187,000
 
 187,000
 
 
 
 
Term loan47,179
 863
 1,206
 1,259
 1,309
 1,372
 41,170
 $784,179
 $863
 $188,206
 $1,259
 $1,309
 $1,372
 $591,170

1.125% Cash Convertible Senior Notes due 2020

On February 15, 2013, we settled the issuance of $550.0 million aggregate principal amount of $10.31.125% Cash Convertible Senior Notes due 2020 (the 1.125% Notes). This transaction included the initial issuance of $450.0 million on February 11, 2013, plus the exercise of the full amount of the $100.0 million over-allotment option on February 13, 2013. The aggregate net proceeds of the 1.125% Notes were $458.9 million, after payment of the net cost of the Call Spread Overlay described below. Additionally, we used $50.0 million of the net proceeds to purchase shares of our common stock, and $40.0 million to repay principal and accrued interest owed under our Credit Facility.

Interest on the 1.125% Notes is payable semiannually in arrears on January 15 and July 15 of each year, at a rate of 1.125% per annum commencing on July 15, 2013. The 1.125% Notes will mature on January 15, 2020 unless repurchased or converted in accordance with their terms prior to such date.

The 1.125% Notes are convertible only into cash, and not into shares of our common stock or any other securities. Holders may convert their 1.125% Notes solely into cash at their option at any time prior to the close of business on the business day immediately preceding July 15, 2019 only under the following circumstances: (1) during any calendar quarter commencing after the calendar quarter ending on June 30, 2013 (and only during such calendar quarter), if the last reported sale price of the common stock for at least 20 trading days (whether or not consecutive) during a period of 30 consecutive trading days ending on the last trading day of the immediately preceding calendar quarter is greater than or equal to 130% of the conversion price on each applicable trading day; (2) during the five business day period immediately after any five consecutive

46

Table of Contents

trading day period in which the trading price per $1,000 principal amount of 1.125% Notes for each trading day of the measurement period was less than 98% of the product of the last reported sale price of our common stock and the conversion rate on each such trading day; or (3) upon the occurrence of specified corporate events. On or after July 15, 2019 until the close of business on the second scheduled trading day immediately preceding the maturity date, holders may convert their 1.125% Notes solely into cash at any time, regardless of the foregoing circumstances. Upon conversion, in lieu of receiving shares of our common stock, a holder will receive an amount in cash, per $1,000 principal amount of 1.125% Notes, equal to the settlement amount, determined in the manner set forth in the Indenture.

The initial conversion rate will be 24.5277 shares of our common stock per $1,000 principal amount of 1.125% Notes (equivalent to an initial conversion price of approximately $40.77 per share of common stock). The conversion rate will be subject to adjustment in some events but will not be adjusted for any accrued and unpaid interest. In addition, following certain corporate events that occur prior to the maturity date, we will pay a cash make-whole premium by increasing the conversion rate for a holder who elects to convert its 1.125% Notes in connection with such a corporate event in certain circumstances. We may not redeem the 1.125% Notes prior to the maturity date, and no sinking fund is provided for the 1.125% Notes.

If we undergo a fundamental change (as defined in the indenture to the 1.125% Notes), holders may require us to repurchase for cash all or part of their 1.125% Notes at a repurchase price equal to 100% of the principal amount of the 1.125% Notes to be repurchased, plus accrued and unpaid interest to, but excluding, the fundamental change repurchase date. The indenture provides for customary events of default, including cross acceleration to certain other indebtedness of ours, and our significant subsidiaries.

The 1.125% Notes are senior unsecured obligations, and rank senior in right of payment to any of our indebtedness that is expressly subordinated in right of payment to the 1.125% Notes; equal in right of payment to any of our unsecured indebtedness that is not so subordinated; effectively junior in right of payment to any of our secured indebtedness to the extent of the value of the assets securing such indebtedness; and structurally junior to all indebtedness and other liabilities (including trade payables) of our subsidiaries.

The 1.125% Notes contain an embedded cash conversion option. We have determined that the embedded cash conversion option is a derivative financial instrument, required to be separated from the 1.125% Notes and accounted for separately as a derivative liability, with changes in fair value reported in our consolidated statements of income until the cash conversion option transaction settles or expires. The initial fair value liability of the embedded cash conversion option was $149.3 million, which simultaneously reduced the carrying value of the 1.125% Notes (effectively an original issuance discount). As of March 31, 2013, the fair value of embedded cash conversion option derivative liability was $147.3 million.

As noted above, the reduced carrying value on the 1.125% Notes resulted in a debt discount that is amortized to the 1.125% Notes' principal amount through the recognition of non-cash interest expense over the expected life of the debt. This has resulted in our recognition of interest expense on the 1.125% Notes at an effective rate approximating what we would have incurred had nonconvertible debt with otherwise similar terms had been issued. The effective interest rate of the 1.125% Notes is 5.9% which is imputed based on the amortization of the fair value of the embedded cash conversion option over the remaining term of the 1.125% Notes. As of March 31, 2013, we expect the 1.125% Notes to be outstanding until their January 15, 2020 maturity date, for a remaining amortization period of 6.8 years.

Also in connection with the Molina Medicaid Solutions contractssettlement of the 1.125% Notes, we paid approximately $16.9 million in transaction costs. Such costs have been allocated to the 1.125% Notes, the 1.125% Call Option (defined below), and the 1.125% Warrants (defined below) according to their relative fair values. The amount allocated to the 1.125% Notes, or $12.0 million, was capitalized and will be amortized over the term of the 1.125% Notes. The aggregate amount allocated to the 1.125% Call Option and 1.125% Warrants, or $4.9 million, was recorded to interest expense in the quarter ended March 31, 2013.

1.125% Notes Call Spread Overlay

Concurrent with the statesissuance of Mainethe 1.125% Notes, we entered into privately negotiated hedge transactions (collectively, the 1.125% Call Option) and Idaho, which reduceswarrant transactions (collectively, the amount available1.125% Warrants), with certain of the initial purchasers of the 1.125% Notes. These transactions represent a Call Spread Overlay, whereby the cost of the 1.125% Call Option we purchased to cover the cash outlay upon conversion of the 1.125% Notes was reduced by the sales price of the 1.125% Warrants. Assuming full performance by the counterparties (and 1.125% Warrants strike prices in excess of the conversion price of the 1.125% Notes), these transactions are intended to offset cash payments due upon any conversion of the 1.125% Notes. We used $149.3 million of the proceeds from the settlement of the 1.125% Notes to pay for the 1.125% Call Option, and simultaneously received $75.1 million for the sale of the 1.125% Warrants, for a net cash outlay of $74.2 million for the Call

47

Table of Contents

Spread Overlay. The 1.125% Call Option and 1.125% Warrants are derivative financial instruments; refer to Note 11 of the accompanying Notes to Consolidated Financial Statements for further discussion.

Aside from the initial payment of a premium to the counterparties of $149.3 million for the 1.125% Call Option, we will not be required to make any cash payments to the counterparties under the Credit Facility.

Borrowings under1.125% Call Option, and will be entitled to receive from the Credit Facility bear interest based, at our election, on the base rate pluscounterparties an applicable margin or the Eurodollar rate. The base rate is, for any day, a rateamount of interest per annumcash, generally equal to the highestamount by which the market price per share of (i)common stock exceeds the prime rate of interest announced from time to time by U.S. Bank or its parent, (ii) the sumstrike price of the federal funds rate for such day plus 0.50% per annum and (iii)1.125% Call Options during the Eurodollar rate (without giving effectrelevant valuation period. The strike price under the 1.125% Call Option is initially equal to the applicable margin) for a one month interestconversion price of the 1.125% Notes. Additionally, if the market value per share of our common stock exceeds the strike price of the 1.125% Warrants on any trading day during the 160 trading day measurement period on such day (or if such day is not a business day, the immediately preceding business day) plus 1.00%. The Eurodollar rate is a reserve adjusted rate at which Eurodollar deposits are offered in the interbank Eurodollar market plus an applicable margin. The applicable margins range between 0.75% to 1.75% for base rate loans and 1.75% to 2.75% for Eurodollar loans, in each case, based upon our leverage ratio. In addition to interest payable on the principal amount of indebtedness outstanding from time to time under the Credit Facility,1.125% Warrants, we are requiredwill be obligated to payissue to the counterparties a quarterly commitment feenumber of 0.25%shares equal in value to 0.50% (based upon our leverage ratio)the product of the unused amount by which such market value exceeds such strike price and 1/160th of the lenders’ commitments under the Credit Facility.

Our obligations under the Credit Facility are secured by a lien on substantially allaggregate number of shares of our assets,common stock underlying the 1.125% Warrants transactions and the additional 1.125% Warrants transactions, subject to a share delivery cap. We will not receive any additional proceeds if the 1.125% Warrants are exercised. Pursuant to the 1.125% Warrants transactions, we issued 13,490,236 warrants with strike price of $53.8475 per share. The number of warrants and the exceptionstrike price are subject to adjustment under certain circumstances. On April 22, 2013, in order to clarify certain accounting matters with respect to the 1.125% Warrants, we entered into amended and restated warrant confirmations with JPMorgan Chase Bank and Bank of certainAmerica, copies of our real estate assets, and by a pledge of the capital stock or membership interests of our operating subsidiaries and health plans (with the exception of the California health plan).

The Credit Facility includes usual and customary covenants for credit facilities ofwhich are filed as Exhibits 10.1 through 10.4 to this type, including covenants limiting liens, mergers, asset sales, other fundamental changes, debt, acquisitions, dividends and other distributions, capital expenditures, and investments. The Credit Facility also requires us to maintain as of the end of any fiscal quarter (calculated for each four consecutive fiscal quarter period) a ratio of total consolidated debt to total consolidated EBITDA, as defined in the Credit Facility, of not more than 2.75 to 1.00, and a fixed charge coverage ratio of not less than 1.75 to 1.00. At September 30, 2012, we were in compliance with all financial covenants under the Credit Facility.

In the event of a default, including cross-defaults relating to specified other debt in excess of $20.0 million, the lenders may terminate the commitments under the Credit Facility and declare the amounts outstanding, including all accrued interest and unpaid fees, payable immediately. In addition, the lenders may enforce any and all rights and remedies created under the Credit Facility or applicable law.

Quarterly Report.


3.75% Convertible Senior Notes due 2014
We had

As$187.0 million of September 30, 2012, $187.0 million in aggregate principal amount of our 3.75% Convertible Senior Notes due 2014 (the “Notes”) remain outstanding.3.75% Notes) outstanding as of March 31, 2013 and December 31, 2012, respectively. The 3.75% Notes rank equally in right of payment with our existing and future senior indebtedness. The 3.75% Notes are convertible into cash and, under certain circumstances, shares of our common stock. The initial conversion rate is 31.9601 shares of our common stock per $1,000one thousand dollar principal amount of the 3.75% Notes. This represents aan initial conversion price of approximately $31.29$31.29 per share of our common stock. In addition, if certain corporate transactions that constitute a change of control occur prior to maturity, we will increase the conversion rate in certain circumstances.


Because the 3.75% Notes have cash settlement features, accounting guidance required us to allocate the proceeds from their issuance between a liability component and an equity component. The reduced carrying value on the 3.75% Notes resulted in a debt discount that is amortized back to the 3.75% Notes' principal amount through the recognition of non-cash interest expense over the expected life of the debt. This has resulted in our recognition of interest expense on the 3.75% Notes at an effective rate approximating what we would have incurred had nonconvertible debt with otherwise similar terms had been issued. The effective interest rate of the 3.75% Notes is 7.5%, principally based on the seven-year U.S. Treasury note rate as of the October 2007 issuance date, plus an appropriate credit spread. As of March 31, 2013, we expect the 3.75% Notes to be outstanding until their October 1, 2014 maturity date, for a remaining amortization period of 18 months. The 3.75% Notes’ if-converted value did not exceed their principal amount as of March 31, 2013. At March 31, 2013, the equity component of the 3.75% Notes, net of the impact of deferred taxes, was $24.0 million.

Term Loan

On


In December 7, 2011, our wholly owned subsidiary, Molina Center LLC, entered into a Term Loan Agreement with various lenders and East West Bank, as Administrative Agent (the “Administrative Agent”). PursuantAdministrative Agent) to the terms of the Term Loan Agreement, Molina Center LLC borrowed the aggregate principal amount of $48.6borrow $48.6 million to finance a portion of the $81.0 million purchase price for the acquisition of the approximately 460,000 square foot office building, or Molina Center, located in Long Beach, California.


The outstanding principal amount under the Term Loan Agreement bears interest at the Eurodollar rate for each Interest Period (as defined below) commencing January 1, 2012.. The Eurodollar rate is a per annum rate of interest equal to the greater of (a) the rate that is published in the Wall Street Journal as the London interbank offered rate for deposits in United States dollars, for a period of one month, two business days prior to the commencement of an Interest Period, multiplied by a statutory reserve rate established by the Board of Governors of the Federal Reserve System, or (b) 4.25%. “Interest Period”Interest Period means the period commencing on the first day of each calendar month and ending on the last day of sucheach calendar month. The loan matures on November 30, 2018, and is subject to a 25-year25-year amortization schedule that commenced on January 1, 2012.


The Term Loan Agreement contains customary representations, warranties, and financial covenants. In the event of a default as described in the Term Loan Agreement, the outstanding principal amount under the Term Loan Agreement will bear interest at a rate 5.00% per annum higher than the otherwise applicable rate. All amounts due under the Term Loan Agreement and related loan documents are secured by a security interest in the Molina Center in favor of and for the benefit of the Administrative Agent and the other lenders under the Term Loan Agreement.



48

Table of Contents

Credit Facility

Interest Rate SwapOn February 15, 2013, we used approximately

In May$40.0 million of the net proceeds from the offering of the 1.125% Notes to repay all of the outstanding indebtedness under our $170 million revolving Credit Facility, with various lenders and U.S. Bank National Association, as Line of Credit Issuer, Swing Line Lender, and Administrative Agent. As of December 31, 2012, we entered into a $42.5there was $40.0 million notional amount interest rate swap agreement, or Swap Agreement, outstanding under the Credit Facility.


We terminated the Credit Facility in connection with an effective datethe closing of March 1, 2013. While not designated as a hedge instrument, the Swap Agreement is intended to reduce our exposure to fluctuationsoffering and sale of the 1.125% Notes. Two letters of credit in the contractual variable interest rates under our Term Loan Agreement, and expires on the maturity date of the Term Loan Agreement, which is November 30, 2018. Under the Swap Agreement beginning on March 1, 2013, we will receive a variable rate of the one-month LIBOR plus 3.25%, and pay a fixed rate of 5.34%. The Swap Agreement is measured and reported at fair value on a recurring basis, within Level 2 of the fair value hierarchy. Gains and losses relating to changes in its fair value are reported in earnings in the current period. For the three months and nine months ended September 30, 2012, we have recorded losses of $0.2 million and $1.3 million, respectively, to general and administrative expense. As of September 30, 2012, the fair value of the Swap Agreement is a liability of $1.3 million, recorded to other noncurrent liabilities. We do not use derivatives for trading or speculative purposes. We believe that we are not exposed to more than a nominalaggregate principal amount of $10.3 million that reduced the amount available for borrowing under the Credit Facility as of December 31, 2012, were transferred to direct issue letters of credit risk relating to the Swap Agreement because the counterparty is an established and well-capitalizedwith another financial institution.


Shelf Registration Statement


In the second quarter of 2012, we filed a shelf registration statement on Form S-3 with the Securities and Exchange Commission covering the registration, issuance, and sale of an indeterminate amount of our securities, including common stock, preferred stock, senior or subordinated debt securities, or warrants. We may publicly offer securities from time to time at prices and terms to be determined at the time of the offering.

Regulatory Capital and Dividend Restrictions

Our health plans are subject to state laws and regulations that, among other things, require


Securities Repurchase Program

Effective as of February 13, 2013, our board of directors authorized the maintenancerepurchase of minimum levels of statutory capital, as defined by each state, and restrict the timing, payment, and amount of dividends and other distributions that may be paid to us as the sole stockholder. To the extent the subsidiaries must comply with these regulations, they may not have the financial flexibility to transfer funds to us. The net assets in these subsidiaries (after intercompany eliminations) which may not be transferable to us$75 million in the formaggregate of loans, advances,either our common stock or cash dividends was $519.2our 3.75% Notes, in addition to the $50.0 million at September 30, 2012, and $492.4 million atof our common stock that we repurchased on February 12, 2013. The repurchase program extends through December 31, 2011.

The National Association2014.


Contractual Obligations
A summary of Insurance Commissioners, or NAIC, adopted rules effective future obligations under our various contractual obligations and commitments as of December 31, 1998, which, if implemented by2012, was disclosed in our 2012 Form 10-K. Other than the states, set minimum capitalization requirements for insurance companies, HMOs, and other entities bearing risk for health care coverage. The requirements taketransactions relating to our February 2013 offering of the form of risk-based capital (RBC) rules. Michigan, New Mexico, Ohio, Texas, Utah, Washington, and Wisconsin have adopted these rules, which may vary from state to state. California and Florida have not yet adopted NAIC risk-based capital requirements for HMOs and have not formally given notice of their intention to do so. Such requirements, if adopted by California and Florida, may increase the minimum capital required for those states.

As of September 30, 2012, our health plans had aggregate statutory capital and surplus of approximately $525.4 million compared with the required minimum aggregate statutory capital and surplus of approximately $270.0 million. All of our health plans1.125% Notes, there were in compliance with the minimum capital requirements at September 30, 2012. We have the ability and commitment to provide additional capital to each of our health plans when necessary to ensure that statutory capital and surplus continue to meet regulatory requirements.

Contractual Obligations

In our Annual Report on Form 10-K for the year ended December 31, 2011, we reported on our contractual obligations as of that date. There have been no material changes to this previously filed information outside the ordinary course of business during the three months ended March 31, 2013. For further discussion and maturities of our contractual obligations since that report.

long-term debt, see Note 10 of Notes to the Consolidated Financial Statements.

Critical Accounting Policies

When we prepare our consolidated financial statements, we use estimates and assumptions that may affect reported amounts and disclosures. Actual results could differ from these estimates. Our most significant accounting policies relate to:

Health plan contractual provisions that may limit revenue based upon the costs incurred or the profits realized under a specific contract;

Health plan quality incentives that allow us to recognize incremental revenue if certain quality standards are met;

The recognition of revenue and costs associated with contracts held by our Molina Medicaid Solutions segment; and

The determination of medical claims and benefits payable.

Premium Revenue – Health Plans Segment

Premium revenue is fixed in advance of the periods covered and, except as described below, is not generally subject to significant accounting estimates. Premium revenues are recognized in the month that members are entitled to receive health care services.

Certain components of premium revenue are subject to accounting estimates. The components of premium revenue subject to estimation fall into two categories:

(1)Contractual provisions that may limit revenue based upon the costs incurred or the profits realized under a specific contract.contract:These are contractual provisions that require the health plan to return premiums to the extent that certain thresholds are not met. In some instances premiums are returned when medical costs fall below a certain percentage of gross premiums; or when administrative costs or profits exceed a certain percentage of gross premiums. In other instances, premiums are partially determined by the acuity of care provided to members (risk adjustment). To the extent that our expenses and profits change from the amounts previously reported (due to changes in estimates), our revenue earned for those periods will

49

Table of Contents

also change. In all of these instances, our revenue is only subject to estimate due to the fact that the thresholds themselves contain elements (expense or profit) that are subject to estimate. While we have adequate experience and data to make sound estimates of our expenses or profits, changes to those estimates may be necessary, which in turn willwould lead to changes in our estimates of revenue. In general, a change in estimate relating to expense or profit would offset any related change in estimate to premium, resulting in no or small impact to net income. The following contractual provisions fall into this category:

California Health Plan Medical Cost Floors (Minimums):A portion of certain premiums received by our California health plan may be returned to the state if certain minimum amounts are not spent on defined medical care costs. We recorded a liability under the terms of these contract provisions of $0.5 million and $1.0$0.3 million at September 30, 2012,both March 31, 2013, and December 31, 2011, respectively.2012

.

Florida Health Plan Medical Cost Floor (Minimum) for Behavioral Health:A portion of premiums received by our Florida health plan may be returned to the state if certain minimum amounts are not spent on defined behavioral health care costs. At both September 30, 2012,March 31, 2013, and December 31, 2011,2012, we had not recorded any liability under the terms of this contract provision since behavioral health expenses are not less than the contractual floor.

New Mexico Health Plan Medical Cost Floors (Minimums) and Administrative Cost and Profit Ceilings (Maximums):Our contract with the state of New Mexico directs that a portion of premiums received may be returned to the state if certain minimum amounts are not spent on defined medical care costs, or if administrative costs or profit (as defined) exceed certain amounts. At both September 30, 2012,March 31, 2013, and December 31, 2011,2012, we had not recorded any liability under the terms of these contract provisions.

Texas Health Plan Profit Sharing:Under our contract with the state of Texas, there is a profit-sharing agreement under which we pay a rebate to the state of Texas if our Texas health plan generates pretax income, as defined in the contract, above a certain specified percentage, as determined in accordance with a tiered rebate schedule. We are limited in the amount of administrative costs that we may deduct in calculating the rebate, if any. As a result of profits in excess of the amount we are allowed to fully retain, we had accrued an aggregate liability of approximately $3.2$3.1 million and $0.7$3.2 million pursuant to our profit-sharing agreement with the state of Texas at September 30, 2012,March 31, 2013, and December 31, 2011,2012, respectively.

Washington Health Plan Medical Cost Floors (Minimums):A portion of certain premiums received by our Washington health plan may be returned to the state if certain minimum amounts are not spent on defined medical care costs. We recorded a liability under the terms of these contract provisions of approximately $1.0 million at March 31, 2013. At both September 30, 2012, and December 31, 2011,2012, we had not recorded any liability under the terms of this contract provision since medical expenses arewere not less than the contractual floor.

Medicare Revenue Risk Adjustment:Based on member encounter data that we submit to CMS, our Medicare premiums are subject to retroactive adjustment for both member risk scores and member pharmacy cost experience for up to two years after the original year of service. This adjustment takes into account the acuity of each member’s medical needs relative to what was anticipated when premiums were originally set for that member. In the event that a member requires less acute medical care than was anticipated by the original premium amount, CMS may recover premium from us. In the event that a member requires more acute medical care than was anticipated by the original premium amount, CMS may pay us additional retroactive premium. A similar retroactive reconciliation is undertaken by CMS for our Medicare members’ pharmacy utilization. We estimate the amount of Medicare revenue that will ultimately be realized for the periods presented based on our knowledge of our members’ heath care utilization patterns and CMS practices. Based on our knowledge of member health care utilization patterns and expenses we have recorded a net payable of approximately $0.2 million as of March 31, 2013 and a net receivable of approximately $1.7$0.3 million and $5.0 millionas of December 31, 2012 for anticipated Medicare risk adjustment premiums as of September 30, 2012, and December 31, 2011, respectively.premiums.

(2) Quality incentives that allow us to recognize incremental revenue if certain quality standards are met.met:These are contract provisions that allow us to earn additional premium revenue in certain states if we achieve certain quality-of-care or administrative measures. We estimate the amount of revenue that will ultimately be realized for the periods presented based on our experience and expertise in meeting the quality and administrative measures as well as our ongoing and current monitoring of our progress in meeting those measures. The amount of the revenue that we will realize under these contractual provisions is determinable based upon that experience. The following contractual provisions fall into this category:

New Mexico Health Plan Quality Incentive Premiums:Under our contract with the state of New Mexico, incremental revenue of up to 0.75% of our total premium is earned if certain performance measures are met. These performance measures are generally linked to various quality-of-care and administrative measures dictated by the state.

Ohio Health Plan Quality Incentive Premiums:Under our contract with the state of Ohio, incremental revenue of up to 1% of our total premium is earned if certain performance measures are met. These performance measures are generally linked to various quality-of-care measures dictated by the state.


50

Table of Contents

Texas Health Plan Quality Incentive Premiums:Effective March 1, 2012, under our contract with the state of Texas, incremental revenue of up to 5% of our total premium may beis earned if certain performance measures are met. These performance measures are generally linked to various quality-of-care measures established by the state.

Wisconsin Health Plan Quality Incentive Premiums:Under our contract with the state of Wisconsin, effective beginning in 2011,incremental revenue of up to 3.25% of thetotal premium is withheld by the state. The withheld premiums canmay be earned by the health plan by meetingif certain performance measures.measures are met. These performance measures are generally linked to various quality-of-care measures dictated by the state.

The following table quantifies the quality incentive premium revenue recognized for the periods presented, including the amounts earned in the period presented and prior periods. Although the reasonably possible effects of a change in estimate related to quality incentive premium revenue as of September 30, 2012March 31, 2013 are not known, we have no reason to believe that the adjustments to prior years noted below are not indicative of the potential future changes in our estimates as of September 30, 2012.

   Three Months Ended September 30, 2012 
   Maximum
Available Quality
Incentive
Premium -
Current Year
   Amount of
Current Year
Quality Incentive
Premium Revenue
Recognized
   Amount of
Quality Incentive
Premium Revenue
Recognized from
Prior Year
   Total Quality
Incentive
Premium Revenue
Recognized
   Total Revenue
Recognized
 
   (In thousands) 

New Mexico

  $560    $532    $—      $532    $84,797  

Ohio

   2,824     1,412     —       1,412     306,314  

Texas

   17,685     10,453     —       10,453     350,810  

Wisconsin

   419     —       246     246     16,279  
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
  $21,488    $12,397    $246    $12,643    $758,200  
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
   Three Months Ended September 30, 2011 
   Maximum
Available Quality
Incentive
Premium -
Current Year
   Amount of
Current Year
Quality Incentive
Premium Revenue
Recognized
   Amount of
Quality Incentive
Premium Revenue
Recognized from
Prior Year
   Total Quality
Incentive
Premium Revenue
Recognized
   Total Revenue
Recognized
 
   (In thousands) 

New Mexico

  $566    $345    $46    $391    $79,644  

Ohio

   2,160     1,719     —       1,719     232,616  

Texas

   400     400     —       400     105,577  

Wisconsin

   420     362     —       362     17,269  
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
  $3,546    $2,826    $46    $2,872    $435,106  
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
   Nine Months Ended September 30, 2012 
   Maximum
Available Quality
Incentive
Premium -
Current Year
   Amount of
Current Year
Quality Incentive
Premium Revenue
Recognized
   Amount of
Quality Incentive
Premium Revenue
Recognized from
Prior Year
   Total Quality
Incentive
Premium Revenue
Recognized
   Total Revenue
Recognized
 
   (In thousands) 

New Mexico

  $1,676    $1,350    $658    $2,008    $253,418  

Ohio

   8,222     6,810     966     7,776     896,908  

Texas

   41,687     30,487     —       30,487     908,532  

Wisconsin

   1,284     —       492     492     52,209  
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
  $52,869    $38,647    $2,116    $40,763    $2,111,067  
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
   Nine Months Ended September 30, 2011 
   Maximum
Available Quality
Incentive
Premium -
Current Year
   Amount of
Current Year
Quality Incentive
Premium Revenue
Recognized
   Amount of
Quality Incentive
Premium Revenue
Recognized from
Prior Year
   Total Quality
Incentive
Premium Revenue
Recognized
   Total Revenue
Recognized
 
   (In thousands) 

New Mexico

  $1,712    $1,219    $364    $1,583    $246,223  

Ohio

   7,472     6,152     3,501     9,653     693,829  

Texas

   1,560     1,560     —       1,560     290,787  

Wisconsin

   1,292     362     —       362     51,526  
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
  $12,036    $9,293    $3,865    $13,158    $1,282,365  
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

March 31, 2013.

 Three Months Ended March 31, 2013
 
Maximum
Available Quality
Incentive
Premium -
Current Year
 
Amount of
Current Year
Quality Incentive
Premium Revenue
Recognized
 
Amount of
Quality Incentive
Premium Revenue
Recognized from
Prior Year
 
Total Quality
Incentive
Premium Revenue
Recognized
 
Total Revenue
Recognized
 (In thousands)
New Mexico$585
 $332
 $108
 $440
 $85,798
Ohio3,005
 1,052
 
 1,052
 291,518
Texas16,264
 13,512
 5,995
 19,507
 335,296
Wisconsin761
 
 609
 609
 27,124
 $20,615
 $14,896
 $6,712
 $21,608
 $739,736
          
 Three Months Ended March 31, 2012
 
Maximum
Available Quality
Incentive
Premium -
Current Year
 
Amount of
Current Year
Quality Incentive
Premium Revenue
Recognized
 
Amount of
Quality Incentive
Premium Revenue
Recognized from
Prior Year
 
Total Quality
Incentive
Premium Revenue
Recognized
 
Total Revenue
Recognized
 (In thousands)
New Mexico$555
 $336
 $28
 $364
 $81,226
Ohio2,678
 2,678
 966
 3,644
 293,525
Texas5,750
 5,750
 
 5,750
 198,236
Wisconsin416
 
 
 
 17,142
 $9,399
 $8,764
 $994
 $9,758
 $590,129
Service Revenue and Cost of Service Revenue — Molina Medicaid Solutions Segment

The payments received by our Molina Medicaid Solutions segment under its state contracts are based on the performance of multiple services. The first of these is the design, development and implementation or DDI,(DDI) of a Medicaid Management Information System or MMIS.(MMIS). An additional service, following completion of DDI, is the operation of the MMIS under a business process outsourcing or BPO(BPO) arrangement. While providing BPO services (which include claims payment and eligibility processing), we also provide the state with other services including both hosting and support and maintenance. Our Molina Medicaid Solutions contracts may extend over a number of years, particularly in circumstances where we are delivering extensive and complex DDI services, such as the initial design, development and implementation of a complete MMIS. For example, the terms of our most recently implemented Molina Medicaid Solutions contracts (in Idaho and Maine) were each seven years in total, consisting of two years allocated for the delivery of DDI services, followed by five years for the performance of BPO services. We receive progress payments from the state during the performance of DDI services based upon the attainment of predetermined milestones. We receive a flat monthly payment for BPO services under our Idaho and Maine contracts. The terms of our other Molina Medicaid Solutions contracts – which primarily involve the delivery of BPO services with only minimal DDI activity (consisting of system enhancements) – are shorter in duration than our Idaho and Maine contracts.


We have evaluated our Molina Medicaid Solutions contracts to determine if such arrangements include a software element. Based on this evaluation, we have concluded that these arrangements do not include a software element. As such, we have concluded that our Molina Medicaid Solutions contracts are multiple-element service arrangements under the scopearrangements.

51

Table of FASB Accounting Standards Codification Subtopic 605-25,Revenue Recognition –– Multiple–Element Arrangements, and SEC Staff Accounting Bulletin Topic 13,Revenue Recognition.

Effective January 1, 2011,Contents


Additionally, we adopted a new accounting standard that amends the guidance on the accounting for multiple-element arrangements. Pursuant to the new standard,evaluate each required deliverable is evaluatedunder our multiple-element service arrangements to determine whether it qualifies as a separate unit of accounting whichaccounting. Such evaluation is generally based on whether the deliverable has standalone value to the customer. In addition to standalone value, previous guidance also required objective and reliable evidence of fair value of a deliverable in order to treat the deliverable as a separate unit of accounting. The arrangement’s consideration that is fixed or determinable is then allocated to each separate unit of accounting based on the relative selling price of each deliverable. In general, the consideration allocated to each unit of accounting is recognized as the related goods or services are delivered, limited to the consideration that is not contingent. We have adopted this guidance on a prospective basis for all new or materially modified revenue arrangements with multiple deliverables entered into on or after January 1, 2011. Our adoption of this guidance has not impacted the timing or pattern of our revenue recognition in 2011 or 2012. Also, there would have been no change in revenue recognized relating to multiple-element arrangements if we had adopted this guidance retrospectively for contracts entered into prior to January 1, 2011.


We have concluded that the various service elements in our Molina Medicaid Solutions contracts represent a single unit of accounting due to the fact that DDI, which is the only service performed in advance of the other services (all other services are performed over an identical period), does not have standalone value because our DDI services are not sold separately by any vendor and the customer could not resell our DDI services. Further, we have no objective and reliable evidence of fair value for any of the individual elements in these contracts, and at no point in the contract will we have objective and reliable evidence of fair value for the undelivered elements in the contracts. For contracts entered into prior to January 1, 2011, objective and reliable evidence of fair value would be required, in addition to DDI standalone value which we do not have, in order to treat DDI as a separate unit of accounting. We lack objective and reliable evidence of the fair value of the individual elements of our Molina Medicaid Solutions contracts for the following reasons:


Each contract calls for the provision of its own specific set of services. While all contracts support the system of record for state MMIS, the actual services we provide vary significantly between contracts; and

The nature of the MMIS installed varies significantly between our older contracts (proprietary mainframe systems) and our new contracts (commercial off-the-shelf technology solutions).

Because we have determined the services provided under our Molina Medicaid Solutions contracts represent a single unit of accounting and because we are unable to determine a pattern of performance of services during the contract period, we recognize all revenue (both the DDI and BPO elements) associated with such contracts on a straight-line basis over the period during which BPO, hosting, and support and maintenance services are delivered. As noted above, the period of performance of BPO services under our Idaho and Maine contracts is five years. Therefore, absent any contingencies as discussed in the following paragraph, we would recognize all revenue associated with those contracts over a period of five years. In cases where there is no DDI element associated with our contracts, BPO revenue is recognized on a monthly basis as specified in the applicable contract or contract extension.


Provisions specific to each contract may, however, lead us to modify this general principle. In those circumstances, the right of the state to refuse acceptance of services, as well as the related obligation to compensate us, may require us to delay recognition of all or part of our revenue until that contingency (the right of the state to refuse acceptance) has been removed. In those circumstances we defer recognition of any contingent revenue (whether DDI, BPO services, hosting, and support and maintenance services) until the contingency has been removed. These types of contingency features are present in our Maine and Idaho contracts. In those states, we deferred recognition of revenue until the contingencies were removed.


Costs associated with our Molina Medicaid Solutions contracts include software related costs and other costs. With respect to software related costs, we apply the guidance for internal-use software and capitalize external direct costs of materials and services consumed in developing or obtaining the software, and payroll and payroll-related costs associated with employees who are directly associated with and who devote time to the computer software project. With respect to all other direct costs, such costs are expensed as incurred, unless corresponding revenue is being deferred. If revenue is being deferred, direct costs relating to delivered service elements are deferred as well and are recognized on a straight-line basis over the period of revenue recognition, in a manner consistent with our recognition of revenue that has been deferred. Such direct costs can include:


Transaction processing costs

Employee costs incurred in performing transaction services

Vendor costs incurred in performing transaction services

Costs incurred in performing required monitoring of and reporting on contract performance

Costs incurred in maintaining and processing member and provider eligibility

Costs incurred in communicating with members and providers

The recoverability of deferred contract costs associated with a particular contract is analyzed on a periodic basis using the undiscounted estimated cash flows of the whole contract over its remaining contract term. If such undiscounted cash flows are insufficient to recover the long-lived assets and deferred contract costs, the deferred contract costs are written down by the amount of the cash flow deficiency. If a cash flow deficiency remains after reducing the balance of the deferred contract costs

52

Table of Contents

to zero, any remaining long-lived assets are evaluated for impairment. Any such impairment recognized would equal the amount by which the carrying value of the long-lived assets exceeds the fair value of those assets.

assets

Medical Claims and Benefits Payable — Health Plans Segment

The following table provides the details of our medical claims and benefits payable as of the dates indicated:

   September 30,
2012
   Dec. 31,
2011
   September 30,
2011
 
   (In thousands) 

Fee-for-service claims incurred but not paid (IBNP)

  $414,725    $301,020    $283,160  

Capitation payable

   55,314     53,532     49,259  

Pharmacy

   42,681     26,178     16,615  

Other

   23,743     21,746     12,021  
  

 

 

   

 

 

   

 

 

 
  $536,463    $402,476    $361,055  
  

 

 

   

 

 

   

 

 

 

 March 31,
2013
 December 31, 2012 March 31,
2012
 (In thousands)
Fee-for-service claims incurred but not paid (IBNP)$378,926
 $377,614
 $347,307
Capitation payable45,048
 49,066
 37,289
Pharmacy39,495
 38,992
 38,443
Other27,676
 28,858
 32,794
 $491,145
 $494,530
 $455,833
The determination of our liability for claims and medical benefits payable is particularly important to the determination of our financial position and results of operations in any given period. Such determination of our liability requires the application of a significant degree of judgment by our management.

As a result, the determination of our liability for claims and medical benefits payable is subject to an inherent degree of uncertainty. Our medical care costs include amounts that have been paid by us through the reporting date, as well as estimated liabilities for medical care costs incurred but not paid by us as of the reporting date. Such medical care cost liabilities include, among other items, unpaid fee-for-service claims, capitation payments owed providers, unpaid pharmacy invoices, and various medically related administrative costs that have been incurred but not paid. We use judgment to determine the appropriate assumptions for determining the required estimates.

The most important element in estimating our medical care costs is our estimate for fee-for-service claims which have been incurred but not paid by us. These fee-for-service costs that have been incurred but have not been paid at the reporting date are collectively referred to as medical costs that are “Incurred But Not Paid,” or IBNP. Our IBNP, as reported on our balance sheet, represents our best estimate of the total amount of claims we will ultimately pay with respect to claims that we have incurred as of the balance sheet date. We estimate our IBNP monthly using actuarial methods based on a number of factors. As indicated in the table above, our estimated IBNP liability represented $414.7$378.9 million of our total medical claims and benefits payable of $536.5$491.1 million as of September 30, 2012.March 31, 2013. Excluding amounts that we anticipate paying on behalf of a capitated provider in Ohio (which we will subsequently withhold from that provider’s monthly capitation payment), our IBNP liability at September 30, 2012,March 31, 2013, was $408.3$372.0 million.

The factors we consider when estimating our IBNP include, without limitation, claims receipt and payment experience (and variations in that experience), changes in membership, provider billing practices, health care service utilization trends, cost trends, product mix, seasonality, prior authorization of medical services, benefit changes, known outbreaks of disease or increased incidence of illness such as influenza, provider contract changes, changes to Medicaid fee schedules, and the incidence of high dollar or catastrophic claims. Our assessment of these factors is then translated into an estimate of our IBNP liability at the relevant measuring point through the calculation of a base estimate of IBNP, a further reserve for adverse claims development, and an estimate of the administrative costs of settling all claims incurred through the reporting date. The base estimate of IBNP is derived through application of claims payment completion factors and trended PMPM cost estimates.

For the fifth month of service prior to the reporting date and earlier, we estimate our outstanding claims liability based on actual claims paid, adjusted for estimated completion factors. Completion factors seek to measure the cumulative percentage of claims expense that will have been paid for a given month of service as of the reporting date, based on historical payment patterns.

The following table reflects the change in our estimate of claims liability as of September 30, 2012March 31, 2013 that would have resulted had we changed our completion factors for the fifth through the twelfth months preceding September 30, 2012,March 31, 2013, by the percentages indicated. A reduction in the completion factor results in an increase in medical claims liabilities. Dollar amounts are in thousands.

(Decrease) Increase in Estimated Completion Factors

  Increase (Decrease) in
Medical Claims and
Benefits Payable
 

(6%)

  $144,100  

(4%)

   96,067  

(2%)

   48,033  

2%

   (48,033

4%

   (96,067

6%

   (144,100



53

Table of Contents

  
(Decrease) Increase in Estimated Completion Factors
Increase (Decrease) in
Medical Claims and
Benefits Payable
(6)%$156,550
(4)%104,366
(2)%52,183
2%(52,183)
4%(104,366)
6%(156,550)
For the four months of service immediately prior to the reporting date, actual claims paid are not a reliable measure of our ultimate liability, given the inherent delay between the patient/physician encounter and the actual submission of a claim for payment. For these months of service, we estimate our claims liability based on trended PMPM cost estimates. These estimates are designed to reflect recent trends in payments and expense, utilization patterns, authorized services, and other relevant factors. The following table reflects the change in our estimate of claims liability as of September 30, 2012March 31, 2013 that would have resulted had we altered our trend factors by the percentages indicated. An increase in the PMPM costs results in an increase in medical claims liabilities. Dollar amounts are in thousands.

(Decrease) Increase in Trended Per member Per Month Cost Estimates

  Increase (Decrease) in
Medical Claims and
Benefits Payable
 

(6%)

  $(76,155

(4%)

   (50,770

(2%)

   (25,385

2%

   25,385  

4%

   50,770  

6%

   76,155  

  
(Decrease) Increase in Trended Per member Per Month Cost Estimates
Increase (Decrease) in
Medical Claims and
Benefits Payable
(6)%$(76,431)
(4)%(50,954)
(2)%(25,477)
2%25,477
4%50,954
6%76,431
The following per-share amounts are based on a combined federal and state statutory tax rate of 37.5%, and 46.346.4 million diluted shares outstanding for the ninethree months ended September 30, 2012.March 31, 2013. Assuming a hypothetical 1% change in completion factors from those used in our calculation of IBNP at September 30, 2012,March 31, 2013, net income for the ninethree months ended September 30, 2012March 31, 2013 would increase or decrease by approximately $15.0$16.3 million, or $0.32$0.35 per diluted share. Assuming a hypothetical 1% change in PMPM cost estimates from those used in our calculation of IBNP at September 30, 2012,March 31, 2013, net income for the ninethree months ended September 30, 2012March 31, 2013 would increase or decrease by approximately $7.9$8.0 million, or $0.17 per diluted share. The corresponding figures for a 5% change in completion factors and PMPM cost estimates would be $75.1$81.5 million, or $1.62$1.76 per diluted share, and $40.0$39.8 million, or $0.86 per diluted share, respectively.

It is important to note that any change in the estimate of either completion factors or trended PMPM costs would usually be accompanied by a change in the estimate of the other component, and that a change in one component would almost always compound rather than offset the resulting distortion to net income. When completion factors areoverestimated, trended PMPM costs tend to beunderestimated. Both circumstances will create an overstatement of net income. Likewise, when completion factors areunderestimated, trended PMPM costs tend to beoverestimated, creating an understatement of net income. In other words, errors in estimates involving both completion factors and trended PMPM costs will usually act to drive estimates of claims liabilities and medical care costs in the same direction. If completion factors were overestimated by 1%, resulting in an overstatement of net income by approximately $15.0$16.3 million, it is likely that trended PMPM costs would be underestimated, resulting in an additional overstatement of net income.

After we have established our base IBNP reserve through the application of completion factors and trended PMPM cost estimates, we then compute an additional liability, once again using actuarial techniques, to account for adverse developments in our claims payments which the base actuarial model is not intended to and does not account for. We refer to this additional liability as the provision for adverse claims development. The provision for adverse claims development is a component of our overall determination of the adequacy of our IBNP. It is intended to capture the potential inadequacy of our IBNP estimate as a result of our inability to adequately assess the impact of factors such as changes in the speed of claims receipt and payment, the relative magnitude or severity of claims, known outbreaks of disease such as influenza, our entry into new geographical markets, our provision of services to new populations such as the aged, blind or disabled (ABD), changes to state-controlled fee

54

Table of Contents

schedules upon which a large proportion of our provider payments are based, modifications and upgrades to our claims processing systems and practices, and increasing medical costs. Because of the complexity of our business, the number of states in which we operate, and the need to account for different health care benefit packages among those states, we make an overall assessment of IBNP after considering the base actuarial model reserves and the provision for adverse claims development. We also include in our IBNP liability an estimate of the administrative costs of settling all claims incurred through the reporting date. The development of IBNP is a continuous process that we monitor and refine on a monthly basis as additional claims payment information becomes available. As additional information becomes known to us, we adjust our actuarial model accordingly to establish IBNP.

On a monthly basis, we review and update our estimated IBNP and the methods used to determine that liability. Any adjustments, if appropriate, are reflected in the period known. While we believe our current estimates are adequate, we have in the past been required to increase significantly our claims reserves for periods previously reported, and may be required to do so again in the future. Any significant increases to prior period claims reserves would materially decrease reported earnings for the period in which the adjustment is made.

In our judgment, the estimates for completion factors will likely prove to be more accurate than trended PMPM cost estimates because estimated completion factors are subject to fewer variables in their determination. Specifically, completion factors are developed over long periods of time, and are most likely to be affected by changes in claims receipt and payment experience and by provider billing practices. Trended PMPM cost estimates, while affected by the same factors, will also be influenced by health care service utilization trends, cost trends, product mix, seasonality, prior authorization of medical services, benefit changes, outbreaks of disease or increased incidence of illness, provider contract changes, changes to Medicaid fee schedules, and the incidence of high dollar or catastrophic claims. As discussed above, however, errors in estimates involving trended PMPM costs will almost always be accompanied by errors in estimates involving completion factors, and vice versa. In such circumstances, errors in estimation involving both completion factors and trended PMPM costs will act to drive estimates of claims liabilities (and therefore medical care costs) in the same direction.

Assuming that base reserves have been adequately set,our initial estimate of claims incurred but not paid (IBNP) is accurate, we believe that amounts ultimately paid out shouldwould generally be between 8% and 10% less than the liability recorded at the end of the period as a result of the inclusion in that liability of the allowance for adverse claims development and the accrued cost of settling those claims. However,Because the amount of our initial liability is merely an estimate (and therefore not perfectly accurate), we will always experience variability in that estimate as new information becomes available with the passage of time. Therefore, there can be no assurance that amounts ultimately paid out will not be higher or lower than this 8% to 10% range, as shown by our resultsrange. For example, for the yearthree months ended DecemberMarch 31, 2011, when 2012, the amounts ultimately paid out were less than the amount of the reserves we had established as of December 31, 2011 by9.1%. Furthermore, because our initial estimate of IBNP is derived from many factors, some of which are qualitative in nature rather than quantitative, we are seldom able to assign specific values to the beginningreasons for a change in estimate - we only know when the circumstances for any one or more factors are out of that year by 14.6%.

the ordinary.

As shown in greater detail in the table below, the amounts ultimately paid out on our liabilities in fiscal years 20122013 and 2011 2012were less than what we had expected when we had established our reserves. While many related factors working in conjunction with one another determine the specific reasons for the overestimationaccuracy of our liabilities were differentestimates, we are seldom able to quantify the impact that any single factor has on a change in eachestimate. In addition, given the variability inherent in the reserving process, we will only be able to identify specific factors if they represent a significant departure from expectations. As a result, we do not expect to be able to fully quantify the impact of the periods presented,individual factors on changes in general the overestimations were tied to our assessment of specific circumstances at our individual health plans which were unique to those reporting periods.

estimates.

We recognized favorable prior period claims development in the amount of $37.7$58.4 million for the ninethree months ended September 30, 2012.March 31, 2013. This amount represents our estimate as of September 30, 2012March 31, 2013 of the extent to which our initial estimate of medical claims and benefits payable at December 31, 20112012 was more than the amount that will ultimately be paid out in satisfaction of that liability. TheWe believe the overestimation of our claims liability at December 31, 20112012 was due primarily to the following factors:

At our Texas health plan, we saw a reduction in STAR+PLUS (the state’s program for aged and disabled members) membership during mid to late 2012. This caused a reduction in costs per member that we did not fully recognize in our December 31, 2012 reserve estimates.
At our Washington health plan, prior to July 2012, certain high-cost newborns that were approved for SSI coverage by the state were retroactively dis-enrolled from our Healthy Options (TANF) coverage, and the health plan was reimbursed for the claims paid on behalf of these members. Starting July 1, 2012, these newborns, as well as other high-cost disabled members, are now covered by the health plan under the Health Options Blind and Disabled (HOBD) program. At the end of 2012, we did not have enough claims history to accurately estimate the claims liability of the HOBD members, and as a result the liability for these high-cost members was overstated.

55

Table of Contents

For our New Mexico health plan, we overestimated the impact of certain high-dollar outstanding claim payments as of December 31, 2012.
We recognized favorable prior period claims development in the amount of $36.6 million for the three months ended March 31, 2012. This amount represents our estimate as of December 31, 2012 of the extent to which our initial estimate of medical claims and benefits payable at December 31, 2011 was more than the amount that will ultimately be paid out in satisfaction of that liability. We believe the overestimation of our claims liability at December 31, 2011 was due primarily to the following factors:
At our Washington health plan, we underestimated the amount of recoveries we would collect for certain high-cost newborn claims, resulting in an overestimation of reserves at year end.

For

At our Texas health plan, we overestimated the cost of new members in STAR+PLUS (the name of our ABD program in Texas), in the Dallas region.

In early 2011, the state of Michigan was delayed in the enrollment of newborns in managed care plans; the delay was resolved by mid-2011. This caused a large number of claims with older dates of service to be paid during late 2011, resulting in an artificial increase in the lag time for claims payment at our Michigan health plan. We adjusted reserves downward for this issue at December 31, 2011, but the adjustment did not capture all of the claims overestimation.

Offsetting some

The overestimation of the overestimation items described above,our liability for medical claims and benefits payable was partially offset by an underestimation of that liability at our Missouri health plan, reserves were underestimated as a result of the costs associated with an unusually large number of premature infants during the fourth quarter of 2011.

We recognized favorable prior period claims development in the amount of $47.0 million for the three months ended September 30, 2012. This amount represents our estimate as of September 30, 2012 of the extent to which our initial estimate of medical claims and benefits payable at June 30, 2012 was more than the amount that will ultimately be paid out in satisfaction of that liability. The overestimation of claims liability at June 30, 2012 was due primarily to the following factors:

For our Texas health plan, we had only four months of paid claims data for the expansion regions that were added March 1, 2012. As a result, we overestimated the medical costs for those regions.

Our contract with the state of Missouri expired without renewal on June 30, 2012; however we continue to be liable for services rendered to members who were admitted to the hospital on or before June 30, 2012, until the earlier of 90 days or their date of discharge. We overestimated the impact of 90 days of run-out claims for these members.

For our Washington health plan, we overpaid certain outpatient claims during 2011 and early 2012, disrupting our payment patterns and leading to an overstatement of our liability at June 30, 2012.

For our Michigan health plan, certain inpatient claims with an unusually long run-out were paid in late 2011 and early 2012, resulting in an artificial increase in the amount of time we typically apply for claims payments when estimating the reserve. In the process of developing the reserves as of June 30, 2012, an adjustment was applied to offset these late claim payments, but the adjustment did not completely remove the effect. As a result, reserves were overstated as of June 30, 2012.

We recognized favorable prior period claims development in the amount of $49.5 million and $51.8 million for the nine months ended September 30, 2011, and the year ended December 31, 2011, respectively. This was primarily caused by the overestimation of our liability for claims and medical benefits payable at December 31, 2010, as a result of the following factors:

We overestimated the impact of a buildup in claims inventory in Ohio.

We overestimated the impact of the settlement of disputed provider claims in California.

We underestimated the reduction in outpatient facility claims costs as a result of a fee schedule reduction in New Mexico effective November 2010.

In estimating our claims liability at September 30, 2012,March 31, 2013, we adjusted our base calculation to take account of the following factors which we believe are reasonably likely to change our final claims liability amount:

OurIn our Texas health plan, although the reduction in STAR+PLUS membership nearly doubled effectivehas leveled off in 2013, we have seen a reduction in per member per month (PMPM) cost for outpatient services and an increase in PMPM costs for inpatient services over the past six to nine months. We have estimated the impact of these shifts in cost in our March 1, 2012. In addition, effective March 1, 2012, we assumed inpatient medical liability for ABD members for which we were not previously responsible. Reserves for new coverage and new regions are now based on the newly developing claims lag patterns and comparisons with similar coverage in other regions with more historical data. The lag patterns are still incomplete and therefore the true reserve liability is more uncertain than usual.

31, 2013 liability.

Our CaliforniaWisconsin health plan has enrolledis experiencing significant membership increases, and is expected to approximately 20,000 new ABD members since September 30, 2011, as a result of the mandatory assignment of ABD members to managed care plans effective July 1, 2011. These new members converted from a fee-for-service environment. Due to the relatively recent transition of these members to managed care, their utilization of medical services is less predictable than it is for many of our other members.

Our claims inventory had increased significantlydouble in size during the first quarterfour months of 2013. This new membership is transitioning to our health plan from a terminated health plan. We enrolled approximately 40,000 new members in February and March 2013.We have computed a separate reserve analysis for these members and have noted that paid claims are less than what we would expect for newly transitioned members. Therefore, we have increased the reserves for this membership, in anticipation of higher claims costs later than usual for these members.

Our Washington health plan began covering disabled members, including newborns, that were previously covered by the state under a separate state program. Coverage for this segment began in July of 2012, followed by a significant reductionwith gradual growth in claims inventory inmembership. As of March 2013 the second quarterhealth plan covered approximately 28,000 members under this program. Because of 2012the high costs for these members and a slight drop in the third quarter. Changes in claims inventory can impact historical claims lag patterns.

relative newness of the product category, there is still some uncertainty about the cost and reserve liability for these members as of March 31, 2013.

The use of a consistent methodology in estimating our liability for claims and medical benefits payable minimizes the degree to which the under- or overestimation of that liability at the close of one period may affect consolidated results of operations in subsequent periods. In particular, the use of a consistent methodology should result in the replenishment of reserves during any given period in a manner that generally offsets the benefit of favorable prior period development in that period. Facts and circumstances unique to the estimation process at any single date, however, may still lead to a material impact on consolidated results of operations in subsequent periods. Any absence of adverse claims development (as well as the expensing through general and administrative expense of the costs to settle claims held at the start of the period) will lead to the recognition of a benefit from prior period claims development in the period subsequent to the date of the original estimate. In 20112012 and for the ninethree months ended September 30, 2012,March 31, 2013, the absence of adverse development of the liability for claims and medical benefits payable at the close of the previous period resulted in the recognition of substantial favorable prior period development. In both years, however, the recognition of a benefit from prior period claims development did not have a material impact on our consolidated results of operations because the amountreplenishment of benefit recognized in each year was roughly consistent with that recognizedreserves in the previous year.

respective periods generally offset the benefit from the prior period.


56

Table of Contents

The following table presents the components of the change in our medical claims and benefits payable for the periods presented.indicated. The amounts displayed for “Components of medical care costs related to: Prior periods” represent the amount by which our original estimate of claims and benefits payable at the beginning of the period were (more) or less than the actual amount of the liability based on information (principally the payment of claims) developed since that liability was first reported.

   Nine Months Ended September 30,  Three Months Ended September 30,  Year Ended 
   2012  2011  2012  2011  Dec. 31, 2011 
   (Dollars in thousands, except per-member amounts) 

Balances at beginning of period

  $402,476   $354,356   $525,538   $341,613   $354,356  

Components of medical care costs related to:

      

Current period

   3,860,825    2,871,515    1,361,539    990,449    3,911,803  

Prior periods

   (37,689  (49,466  (46,968  (31,291  (51,809
  

 

 

  

 

 

  

 

 

  

 

 

  

 

 

 

Total medical care costs

   3,823,136    2,822,049    1,314,571    959,158    3,859,994  
  

 

 

  

 

 

  

 

 

  

 

 

  

 

 

 

Payments for medical care costs related to:

      

Current period

   3,332,896    2,522,374    875,236    670,066    3,516,994  

Prior periods

   356,253    292,976    428,410    269,650    294,880  
  

 

 

  

 

 

  

 

 

  

 

 

  

 

 

 

Total paid

   3,689,149    2,815,350    1,303,646    939,716    3,811,874  
  

 

 

  

 

 

  

 

 

  

 

 

  

 

 

 

Balances at end of period

  $536,463   $361,055   $536,463   $361,055   $402,476  
  

 

 

  

 

 

  

 

 

  

 

 

  

 

 

 

Benefit from prior period as a percentage of:

      

Balance at beginning of period

   9.4  14.0  8.9  9.2  14.6

Premium revenue

   0.9  1.5  3.2  2.7  1.1

Total medical care costs

   1.0  1.8  3.6  3.3  1.3

Claims Data:

      

Days in claims payable, fee for service

   45    39    45    39    40  

Number of members at end of period

   1,826,000    1,678,000    1,826,000    1,678,000    1,697,000  

Number of claims in inventory at end of period

   163,600    132,200    163,600    132,200    111,100  

Billed charges of claims in inventory at end of period

  $304,600   $187,000   $304,600   $187,000   $207,600  

Claims in inventory per member at end of period

   0.09    0.08    0.09    0.08    0.07  

Billed charges of claims in inventory per member at end of period

  $166.81   $111.44   $166.81   $111.44   $122.33  

Number of claims received during the period

   15,455,000    12,864,800    5,079,200    4,149,600    17,207,500  

Billed charges of claims received during the period

  $14,339,700   $10,573,900   $4,951,000   $3,610,700   $14,306,500  


 Three Months Ended March 31, Year Ended December 31, 2012
 2013 2012 
 (Dollars in thousands, except per-member amounts)
Balances at beginning of period$494,530
 $402,476
 $402,476
Components of medical care costs related to:     
Current period1,347,181
 1,167,580
 5,136,055
Prior periods(58,427) (36,592) (39,295)
Total medical care costs1,288,754
 1,130,988
 5,096,760
Payments for medical care costs related to:     
Current period916,426
 750,994
 4,649,363
Prior periods375,713
 326,637
 355,343
Total paid1,292,139
 1,077,631
 5,004,706
Balances at end of period$491,145
 $455,833
 $494,530
Benefit from prior period as a percentage of:     
Balance at beginning of period11.8% 9.1% 9.8%
Premium revenue3.8% 2.8% 0.7%
Total medical care costs4.5% 3.2% 0.8%
Claims Data:     
Days in claims payable, fee for service38
 44
 40
Number of members at end of period1,820,000
 1,825,000
 1,797,000
Number of claims in inventory at end of period135,400
 260,800
 122,700
Billed charges of claims in inventory at end of period$236,700
 $403,800
 $255,200
Claims in inventory per member at end of period0.07
 0.14
 0.07
Billed charges of claims in inventory per member at end of period$130.05
 $221.26
 $142.01
Number of claims received during the period5,271,000
 4,855,600
 20,842,400
Billed charges of claims received during the period$5,170,700
 $4,337,000
 $19,429,300

Compliance Costs
Our health plans are regulated by both state and federal government agencies. Regulation of managed care products and health care services is an evolving area of law that varies from jurisdiction to jurisdiction. Regulatory agencies generally have discretion to issue regulations and interpret and enforce laws and rules. Changes in applicable laws and rules occur frequently. Compliance with such laws and rules may lead to additional costs related to the implementation of additional systems, procedures and programs that we have not yet identified.
Inflation

We use various strategies to mitigate the negative effects of health care cost inflation. Specifically, our health plans try to control medical and hospital costs through contracts with independent providers of health care services. Through these contracted providers, our health plans emphasize preventive health care and appropriate use of specialty and hospital services. There can be no assurance, however, that our strategies to mitigate health care cost inflation will be successful. Competitive pressures, new health care and pharmaceutical product introductions, demands from health care providers and customers, applicable regulations, or other factors may affect our ability to control health care costs.

Compliance Costs

Our health plans are regulated by both state and federal government agencies. Regulation of managed care products and health care services is an evolving area of law that varies from jurisdiction to jurisdiction. Regulatory agencies generally have discretion to issue regulations and interpret and enforce laws and rules. Changes in applicable laws and rules occur frequently. Compliance with such laws and rules may lead to additional costs related to the implementation of additional systems, procedures and programs that we have not yet identified.


Item 3.Quantitative and Qualitative Disclosures About Market Risk


57


Concentrations of Credit Risk

Financial instruments that potentially subject us to concentrations of credit risk consist primarily of cash and cash equivalents, investments, receivables, and restricted investments. We invest a substantial portion of our cash in the PFM Fund Prime Series — Institutional Class, and the PFM Fund Government Series. These funds represent a portfolio of highly liquid money market securities that are managed by PFM Asset Management LLC (PFM), a Virginia business trust registered as an open-end management investment fund. Our investments and a portion of our cash equivalents are managed by professional portfolio managers operating under documented investment guidelines. No investment that is in a loss position can be sold by our managers without our prior approval. Our investments consist solely of investment grade debt securities with a maximum maturity of five years and an average duration of two years or less. Restricted investments are invested principally in certificates of deposit and U.S. treasury securities. Concentration of credit risk with respect to accounts receivable is limited due to payors consisting principally of the governments of each state in which our Health Plans segment and our Molina Medicaid Solutions segment operate.

We are also exposed to interest rate risk relating to contractual variable interest rates under our Term Loan Agreement which matures on November 30, 2018. We manage this floating rate debt using an interest rate swap agreement that we expect will reduce our exposure to the impact of changing interest rates to our consolidated results of operations and future outflows for interest. The interest rate swap is not designated as a hedging instrument.

Item 4.Controls and Procedures

Evaluation of Disclosure Controls and Procedures:Our management, with the participation of our Chief Executive Officer and our Chief Financial Officer, has concluded, based upon its evaluation as of the end of the period covered by this report, that the Company’s“disclosure controls and procedures”(as (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934 (the“Exchange Act”)) are effective to ensure that information required to be disclosed in the reports that we file or submit under the Exchange Act is recorded, processed, summarized, and reported within the time periods specified in the Securities and Exchange Commission’s rules and forms.

Changes in Internal Control Over Financial Reporting: There has been no change in our internal control over financial reporting during the fiscal quarter ended September 30, 2012March 31, 2013 that has materially affected, or is reasonably likely to materially affect, our internal controls over financial reporting.


PART II — OTHER INFORMATION
Item 1.

Item 1.Legal Proceedings

Legal Proceedings

The health care and business process outsourcing industries are subject to numerous laws and regulations of federal, state, and local governments. Compliance with these laws and regulations can be subject to government review and interpretation, as well as regulatory actions unknown and unasserted at this time. Penalties associated with violations of these laws and regulations include significant fines and penalties, exclusion from participating in publicly funded programs, and the repayment of previously billed and collected revenues.

We are involved in legal actions in the ordinary course of business, some of which seek monetary damages, including claims for punitive damages, which are not covered by insurance. We have accrued liabilities for certain matters for which we deem the loss to be both probable and estimable. Although we believe that our estimates of such losses are reasonable, these estimates could change as a result of further developments of these matters. The outcome of legal actions is inherently uncertain and such pending matters for which accruals have not been established have not progressed sufficiently through discovery and/or development of important factual information and legal issues to enable us to estimate a range of possible loss, if any. While it is not possible to accurately predict or determine the eventual outcomes of these items, an adverse determination in one or more of these pending matters could have a material adverse effect on our consolidated financial position, results of operations, or cash flows.

Item 1A.Risk Factors


Item 1A.    Risk Factors
Certain risk factors may have a material adverse effect on our business, financial condition, cash flows, or results of operations, and you should carefully consider them. In addition to the other information set forth in this report, you should carefully consider the risk factors discussed in Part I, Item 1A — Risk Factors, in our Annual Report on Form 10-K for the year ended December 31, 2011, as updated in Part II, Item 1A—Risk Factors, in our Quarterly Report on Form 10-Q for the quarterly period ended June 30, 2012. The risk factors described herein and in our 2011 Annual Report on2012 Form 10-K as updated by our Quarterly Report on Form 10-Q for the quarterly period ended June 30, 2012 are not the only risks facing our Company. Additional risks and uncertainties not currently known to us or that we currently deem to be immaterial also may materially adversely affect our business, financial condition, cash flows, or results of operations.


58


There have been no material changes to the risk factors disclosed in our 20112012 Form 10-K as updated by our Quarterly Report on Form 10-Q for the quarterly period ended June 30, 2012.

Item 2.Unregistered Sales of Equity Securities and Use of Proceeds

10-K.


Item 2.    Unregistered Sales of Equity Securities and Use of Proceeds
Issuer Purchases of Equity Securities
Common Stock Repurchase in Connection with Offering of 1.125% Cash Convertible Senior Notes Due 2020.

We used a portion of the net proceeds in this offering to repurchase $50.0 million of our common stock in negotiated transactions with institutional investors in the offering, concurrently with the pricing of the offering. On February 12, 2013, we repurchased a total of 1,624,959 shares at $30.77 per share, which was our closing stock price on that date.

Securities Repurchase Program.Effective as of October 26, 2011,February 13, 2013, our board of directors authorized the repurchase of $75 million in aggregate of either our common stock or our convertible senior notes due 2014.the 3.75% Notes, in addition to the $50.0 million common stock repurchase discussed above. The repurchase program expired October 25, 2012. No securities were purchased under this program in the nine months ended September 30, 2012.

extends through December 31, 2014.

Purchases of common stock made by or on our behalf of the Company during the quarter ended September 30, 2012,March 31, 2013, including shares withheld by the Companyus to satisfy our employees’ income tax obligations, are set forth below:

   Total  Number
of
Shares
Purchased (a)
   Average Price Paid
per Share
   Total Number of Shares
Purchased as Part of
Publicly Announced Plans
or Programs
   Maximum Number (or
Approximate Dollar Value)
of Shares that May Yet Be
Purchased Under the Plans
or Programs
 

July 1—July 30

   13,220    $26.48     —      $—    

August 1—August 31

   2,444    $24.44     —      $—    

September 1—September 30

   638    $24.24     —      $—    
  

 

 

     

 

 

   

Total

   16,302    $26.09     —      
  

 

 

     

 

 

   

 
Total  Number
of
Shares
Purchased (a)
 
Average Price Paid
per Share
 
Total Number of Shares
Purchased as Part of
Publicly Announced Plans
or Programs
 
Maximum Number (or
Approximate Dollar Value)
of Shares that May Yet Be
Purchased Under the Plans
or Programs
January 1—January 313,445
 $27.06
 
 $75,000,000
February 1—February 281,626,960
 $30.77
 
 $75,000,000
March 1—March 31140,641
 $31.95
 
 $75,000,000
Total1,771,046
 $30.85
 
  
(a)During the three months ended September 30, 2012, we did not repurchase any shares of our common stock outside of our publicly announced stock repurchase program. During the quarterMarch 31, 2013, we withheld 16,302146,087 shares of common stock under our 2002 Equity Incentive Plan and 2011 Equity Incentive Plan to settle our employees’ income tax obligations.



59


 Item 6.    Exhibits
Item 6.Exhibits

Exhibit No.

 

Title

10.1
Amended and Restated Base Warrants Confirmation, dated as of April 22, 2013, between Molina Healthcare, Inc. and JPMorgan Chase Bank, National Association, London Branch.

10.2Amended and Restated Base Warrants Confirmation, dated as of April 22, 2013, between Molina Healthcare, Inc. and Bank of America, N.A.
10.3Additional Amended and Restated Base Warrants Confirmation, dated as of April 22, 2013, between Molina Healthcare, Inc. and JPMorgan Chase Bank, National Association, London Branch.
10.4Additional Amended and Restated Base Warrants Confirmation, dated as of April 22, 2013, between Molina Healthcare, Inc. and Bank of America, N.A.
31.1 Certification of Chief Executive Officer pursuant to Rules 13a-14(a)/15d-14(a) under the Securities Exchange Act of 1934, as amended.
31.2 Certification of Chief Financial Officer pursuant to Rules 13a-14(a)/15d-14(a) under the Securities Exchange Act of 1934, as amended.
32.1 Certification of Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
32.2 Certification of Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
101.INS (1) XBRL Taxonomy Instance Document.
101.SCH (1) XBRL Taxonomy Extension Schema Document.
101.CAL (1) XBRL Taxonomy Extension Calculation Linkbase Document.
101.DEF (1) XBRL Taxonomy Extension Definition Linkbase Document.
101.LAB (1) XBRL Taxonomy Extension Label Linkbase Document.
101.PRE (1) XBRL Taxonomy Extension Presentation Linkbase Document.

(1)Pursuant to Rule 406T of Regulation S-T, XBRL (eXtensible Business Reporting Language) information is furnished and not filed or a part of a registration statement or prospectus for purposes of Sections 11 or 12 of the Securities Act of 1933, as amended, is deemed not filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and otherwise is not subject to liability under these sections.


60


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 MOLINA HEALTHCARE, INC.
 (Registrant)
Dated: October 26, 2012May 2, 2013 

/s/ JOSEPH M. MOLINA, M.D.

 Joseph M. Molina, M.D.
 Chairman of the Board,
 Chief Executive Officer and President
 (Principal Executive Officer)
Dated: October 26, 2012May 2, 2013 

/s/ JOHN C. MOLINA, J.D.

 John C. Molina, J.D.
 Chief Financial Officer and Treasurer
 (Principal Financial Officer)



61


EXHIBIT INDEX

Exhibit No.

 

Title

10.1Amended and Restated Base Warrants Confirmation, dated as of April 22, 2013, between Molina Healthcare, Inc. and JPMorgan Chase Bank, National Association, London Branch.
10.2Amended and Restated Base Warrants Confirmation, dated as of April 22, 2013, between Molina Healthcare, Inc. and Bank of America, N.A.
10.3Additional Amended and Restated Base Warrants Confirmation, dated as of April 22, 2013, between Molina Healthcare, Inc. and JPMorgan Chase Bank, National Association, London Branch.
10.4Additional Amended and Restated Base Warrants Confirmation, dated as of April 22, 2013, between Molina Healthcare, Inc. and Bank of America, N.A.
31.1 Certification of Chief Executive Officer pursuant to Rules 13a-14(a)/15d-14(a) under the Securities Exchange Act of 1934, as amended.
31.2 Certification of Chief Financial Officer pursuant to Rules 13a-14(a)/15d-14(a) under the Securities Exchange Act of 1934, as amended.
32.1 Certification of Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
32.2 Certification of Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
101.INS (1) XBRL Taxonomy Instance Document.
101.SCH (1) XBRL Taxonomy Extension Schema Document.
101.CAL (1) XBRL Taxonomy Extension Calculation Linkbase Document.
101.DEF (1) XBRL Taxonomy Extension Definition Linkbase Document.
101.LAB (1) XBRL Taxonomy Extension Label Linkbase Document.
101.PRE (1) XBRL Taxonomy Extension Presentation Linkbase Document.

(1)Pursuant to Rule 406T of Regulation S-T, XBRL (eXtensible Business Reporting Language) information is furnished and not filed or a part of a registration statement or prospectus for purposes of Sections 11 or 12 of the Securities Act of 1933, as amended, is deemed not filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and otherwise is not subject to liability under these sections.

54



62